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Abstract  
 
The study of pluripotent cells in mouse has revealed a core transcription 
factor network.  Pluripotent cells have not been identified in many 
non-mammalian organisms, but cells with pluripotent properties are 
found in axolotl (Ambystoma mexicanum) a urodele amphibian.  
Similarities, between the morphological processes in amniotes and 
those in urodeles led to the suggestion that amniotes may have arisen 
from a urodele-like ancestor.  Thus, studying the pluripotency network 
in axolotl may be key to understanding the evolution of mechanisms 
governing pluripotency in amniotes.  This study describes the 
investigation of two of the core pluripotency trancription factors, 
Axnanog and Axoct4.  Coexpression of axnanog and axoct4 was 
detected in the undifferentiated tissues of blastula and gastrula stage 
embryos, suggesting a conserved role in pluripotency/multipotency.  
Antisense morpholino oligonucleotides were employed to investigate 
the function of these two molecules.  Gastrulation was disrupted in 
Axnanog morphant embryos.  Additionally, they maintained expression 
of genes associated with pluripotency and early lineage specification, 
but only expressed low levels of terminal differentiation markers.  There 
are two explanations for this phenotype, a cell migration defect or a 
developmental block.  Axoct4 morphant embryos had a similar 
phenotype suggesting that Axoct4 may function in a common pathway. 
 
Primordial germ cells (PGCs) are the only cells that retain the ability 
throughout development to derive all of the tissues of the embryo, upon 
fertilisation, and these cells express many pluripotency-associated 
factors.  Little is known about PGC development in axolotl.  In this 
study, the roles of Axoct4, Axnanog and Axblimp1 were investigated.  
Neither Axnanog nor Axoct4 were found to have a role in PGC 
development.  Axblimp1 is unlikely to have a role in PGC specification, 
as in mouse, but a role in PGC maintenance was not ruled out.   
 i
Acknowledgements 
 
Foremost, thanks to the University of Nottingham for allowing me to 
undertake my PhD and the MRC for funding.   
 
I could not have completed my PhD without the support and advice of 
many people.  Thanks go to past and present members of the AJ, 
Gering, and Loose labs.  For experimental and technical advice thanks 
go to James (The Deuce), Maz, Ramiro, Cinzia, Yuhong and Matt.  
For excellent technical support my thanks go to Jodie and Dave.  
Thanks also go to my project students Katie and Matt. 
 
Special thanks go to Dr Gem for her continued support and friendship; I 
think I will pass on the black sambuca in future though.  Extra special 
thanks go to my husband, Mark, without whom this definitely wouldnt 
have been possible.  He has provided with me with all of the support I 
could possibly ask for and lots lots more. 
 
Finally, thanks to my family and friends for sticking with me through it 
all.  Particularly, thanks to my Mum who is always there when I need to 
whinge and have a two-hour phone conversation.  Special thanks also 
go to my nephew, Michael, who has continuely asked me throughout 
my PhD, Dont you have your own lab yet?. 
 ii
Table of Contents 
 
Chapter 1. Introduction...................................................................................1 
1.1 Pluripotency...........................................................................................1 
1.2 Pluripotency in mouse ...........................................................................1 
1.3 The core pluripotency transcription factor network in mouse: Oct4, 
Sox2 and Nanog.................................................................................4 
1.3.1 Oct4.................................................................................................4 
1.3.2 Sox2 ................................................................................................5 
1.3.3 Nanog..............................................................................................7 
1.3.4 Oct4 and Nanog in the establishment of the trophectoderm and 
primitive endoderm lineages.........................................................8 
1.3.5 A central self-organising transcription factor network governing 
pluripotency ................................................................................11 
1.4 Interactions of Oct4 and Nanog with epigenetic regulators.................14 
1.5 Conserved roles for Oct4, Sox2 and Nanog........................................16 
1.5.1 Human...........................................................................................16 
1.5.2 Chicken .........................................................................................21 
1.5.3 Xenopus ........................................................................................22 
1.5.4 Zebrafish .......................................................................................24 
1.5.5 Axolotl............................................................................................26 
1.5.6 Summary of conserved roles.........................................................27 
1.6 Pluripotency in axolotls........................................................................28 
1.7 Focus of this study ..............................................................................35 
Chapter 2. Materials and Methods...............................................................37 
2.1 Solutions and buffers...........................................................................37 
2.2 Extraction of protein, DNA and RNA ...................................................39 
2.2.1 RNA extraction from embryos and oocytes...................................39 
2.2.2 Poly-A+ RNA extraction .................................................................40 
2.2.3 Protein extraction from oocytes.....................................................40 
2.2.4 Extraction of genomic DNA from erythrocytes ..............................40 
2.3 Preparation and manipulation of DNA.................................................41 
2.3.1 Minipreps.......................................................................................41 
2.3.2 cDNA synthesis .............................................................................41 
2.3.3 Determination of DNA and RNA concentration .............................42 
2.3.4 Amplification of DNA by polymerase chain reaction (PCR)...........42 
2.3.5 Restriction enzyme digest .............................................................46 
2.3.6 Agarose gel electrophoresis..........................................................46 
2.3.7 Phenol:chloroform extraction.........................................................46 
2.3.8 Ethanol precipitation of DNA .........................................................47 
2.3.9 Purification of DNA from agarose gels ..........................................47 
2.3.10 Ligation of DNA fragments ..........................................................47 
2.3.11 Transformations ..........................................................................48 
2.3.12 DNA sequencing .........................................................................48 
2.3.13 Sequence analysis and comparison............................................49 
2.4 Treatment and preparation of embryos and oocytes...........................49 
2.4.1 Axolotl matings ..............................................................................49 
2.4.2 Culture of axolotl embryos.............................................................50 
2.4.3 Preparation of oocytes for microinjection ......................................50 
2.4.4 In vitro transcription of mRNA for microinjection ...........................50 
2.4.5 Preparation of morpholinos ...........................................................52 
iii 
2.4.6 Microinjection of embryos and oocytes .........................................52 
2.5 In situ hybridisation (ISH) ....................................................................53 
2.5.1 Preparation of axolotl embryos for ISH .........................................53 
2.5.2 Embedding embryos for sectioning ...............................................53 
2.5.3 Sectioning......................................................................................54 
2.5.4 Hemisectioning..............................................................................54 
2.5.5 Preparation of dioxigenin (DIG) labelled RNA probes...................55 
2.5.6 Whole-mount in situ hybridisation (WISH).....................................56 
2.5.7 In situ hybridisation (ISH) on sections ...........................................58 
2.5.8 Microscopy and photography ........................................................60 
2.6 Real-time PCR (qRT-PCR) .................................................................61 
2.6.1 Primer and probe design ...............................................................61 
2.6.2 Data analysis.................................................................................62 
2.7 Handling and manipulating protein......................................................64 
2.7.1 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) ................64 
2.8 Detection of tagged proteins by Western blot and ECL ......................64 
Chapter 3 Development of the axolotl as a model organism....................67 
3.1 Amphibians as model organisms ........................................................67 
3.2 Axolotl gastrulation..............................................................................69 
3.3 The molecular control of gastrulation in axolotl; Axmix and 
Axbrachyury. ....................................................................................74 
3.4 Cloning and characterising genes for the further development of the 
axolotl as a model organism.............................................................80 
3.5 Pluripotency genes..............................................................................80 
3.5.1 Identification of an axolotl nanog homologue (axnanog)...............80 
3.5.2 Temporal and spatial co-expression of axnanog and axoct4 ........86 
3.6 Ectodermal genes ...............................................................................91 
3.6.1 Formation of neural and epidermal tissue .....................................91 
3.6.2 Neural Cell Adhesion Molecule (Ncam) ........................................92 
3.6.3 Cytoskeletal keratin .......................................................................93 
3.6.4 Identification of axncam.................................................................94 
3.6.5 Axncam temporal and spatial expression......................................97 
3.6.6 Identification of axck....................................................................103 
3.6.7 Temporal and spatial expression of axck ....................................103 
3.7 Putative PGC gene............................................................................106 
3.7.1 Blimp1 .........................................................................................106 
3.7.2 Previously identified roles for Blimp1 ..........................................106 
3.7.3 Identification of axblimp1 .............................................................109 
3.7.4 Temporal and spatial expression of axblimp1 .............................112 
3.8 Epigenetic markers............................................................................120 
3.8.1 Carm1..........................................................................................120 
3.8.2 Identification of an axolotl carm1 homologue (axcarm1) .............120 
3.8.3 Temporal and spatial expression of axcarm1..............................123 
3.9 Discussion.........................................................................................126 
3.9.1 Summary .....................................................................................128 
Chapter 4. Investigating the function of axnanog and axoct4 using 
antisense morpholino oligonucleotides..................................130 
4.1 Introduction........................................................................................130 
4.2 Confirmation of the activity of axnanog translation-blocking and splice-
blocking morpholinos......................................................................130 
4.3 Depletion of Axnanog disrupts gastrulation.......................................135 
4.3.1 The transcription profile of axnanog morphant embryos .............139 
4.5 Confirmation of Axoct4 translation-blocking morpholino activity .......153 
iv 
4.6 Axoct4 depletion severely disrupts gastrulation ................................154 
4.7 Discussion.........................................................................................156 
4.7.1 Summary .....................................................................................165 
Chapter 5 Investigating PGC development in axolotl..............................167 
5.1 Preformation......................................................................................167 
5.2 Epigenesis.........................................................................................173 
5.3 Maintenance of PGCs .......................................................................174 
5.4 Maternal inheritance of pluripotency genes and germ line marker 
genes..............................................................................................179 
5.5 The expression of axoct4, axnanog and axblimp1 in PGC-induced 
caps................................................................................................181 
5.6 Conservation of the maternal inheritance of pluripotency factors .....186 
5.7 Discussion.........................................................................................188 
5.7.1 Summary .....................................................................................192 
Chapter 6 Overall conclusions ..................................................................193 
7. References...............................................................................................196 
8. Appendices..............................................................................................211 
8.1 Nucleotide Sequences ......................................................................211 
8.2 Intron sequences...............................................................................214 
8.3 Axnanog splice products ...................................................................219 
 
v 
List of Figures 
 
Figure 1.1 Cell lineage development in the early mouse embryo. ....................4 
Figure 1.2 A schematic demonstrating Nieuwkoops transplantation 
experiments. .................................................................................30 
Figure 1.3 Animal caps induced to make PGCs (PGC-induced caps) and 
expression of axdazl in PGC-induced caps. .................................34 
Figure 3.1 Urodele gastrulation.......................................................................72 
Figure 3.2 Temporal and spatial expression of axmix and axbrachyury .........78 
Figure 3.3 An alignment of artificially translated Axnanog and Nanog 
homologues from other vertebrates..............................................83 
Figure 3.4  Alignment of axnanog intron boundaries with intron boundaries 
from other vertebrate nanog homologues.....................................84 
Figure 3.5 Temporal and spatial expression of axnanog and axoct4..............89 
Figure 3.6 Alignment of axncam with Cynops pyrrhogaster ncam-140...........96 
Figure 3.7 Temporal expression of axncam and spatial expression of axncam 
in neurula embryos .......................................................................99 
Figure 3.8 Spatial expression of axncam in tailbud stage embryos. .............101 
Figure 3.9 Temporal and spatial expression of axck.....................................104 
Figure 3.10  Alignment of Human Blimp1 (PRDM1) and Axblimp1 amino acid 
sequence. ...................................................................................111 
Figure 3.11 Temporal expression of axdazl, axvasa and axblimp1. .............113 
Figure 3.12 Axblimp1 expression in late-gastrula and neurula stage embryos
....................................................................................................116 
Figure 3.13 Expression of axblimp1 in tailbud embryos................................118 
Figure 3.14 An alignment of the artificially translated Axcarm1 sequence with 
Homo sapiens Carm1. ................................................................122 
Figure 3.15 Temporal and spatial expression of axcarm1 ............................124 
Figure 4.1 Confirmation of activity of Axnanog translation-blocking and 
splice blocking morpholinos........................................................134 
Figure 4.2 Axnanog morphant phenotype.....................................................137 
Figure 4.3 Expression of pluripotency genes in morphant embryos .............141 
Figure 4.4 Expression of early mesodermal and endodermal genes in 
morphant embryos......................................................................145 
Figure 4.5 Expression of late mesodermal genes in morphant embryos ......148 
Figure 4.6 Expression of late ectodermal genes in morphant embryos ........151 
Figure 4.7 Confirmation of activity of Axoct4 translation-blocking morpholino
....................................................................................................154 
Figure 4.8 Phenotype of embryos injected with Axoct4 ATG-morpholino.....155 
Figure 5.1 Modes of germ cell specification: Preformation and Epigenesis..172 
Figure 5.2 Expression of germline and PGC markers in axolotl ovary tissue.
....................................................................................................180 
Figure 5.3 Analysis of gene expression in PGC-induced animal caps..........184 
Figure 5.4 Spatial expression of stnanog and stoct4 in ovary tissue ............187 
 
 
 
 
 
 
vi 
List of Tables 
 
Table 1.1 Comparison of phenotypes in mESCs and hESCs. ........................18 
Table 2.1 RT-PCR primer sequences .............................................................42 
Table 2.2 Degenerate PCR primer sequences ...............................................43 
Table 2.3 Semi-degenerate PCR primer sequences ......................................44 
Table 2.4 Intron PCR primer sequences.........................................................45 
Table 2.6 Vectors for RNA synthesis. .............................................................51 
Table 2.7 Morpholino sequences ....................................................................52 
Table 2.8 Vectors for ISH probe synthesis......................................................56 
Table 2.9 qRT-PCR primer and probe sequences. .........................................63 
vii 
Common Abbreviations 
 
ATG-morphant embryos injected with translation-blocking morpholino 
 
BLAST basic local alignment search tool 
 
Blimp1 b-lymphocyte maturation factor 1 
 
CK cytoskeletal keratin 
 
CT value cycle threshold value 
 
DNA deoxyribose nucleic acid 
 
E embryonic day 
 
ES cell embryonic stem cell 
 
EST expression sequence tag 
 
ISH in situ hybridisation 
 
Ncam neural cell adhesion molecule 
 
NODE Nanog and Oct4 associated histone deacetylase 
 
NuRD nucleosome remodelling and histone deacetylase 
 
ODC ornithine decarboxylase 
 
ORF open reading frame 
 
PCR polymerase chain reaction 
 
PCR polycomb repressor complex 
 
PFA paraformaldehyde 
 
PGC primordial germ cell 
 
PR-domain positive regulatory domain 
 
qRT-PCR quantitative RT-PCR 
 
RACE rapid amplification of cDNA ends 
 
RNA ribose nucleic acid 
 
RT-PCR reverse transcriptase PCR 
 
S.D. standard deviation 
 
Splice-morphant embryos injected with splice-blocking morpholino 
 
UTR untranslated region 
 
WISH whole-mount in situ hybridisation 
 
ZnF zinc-finger 
 
viii 
Chapter 1. Introduction 
 
1.1 Pluripotency 
 
Pluripotency is defined as the ability of a cell to develop into all of the 
cells of an embryo including the germline [Smith 2005].  Cells with this 
potential are found in early mammalian embryos and in cultured 
mammalian cells, such as embryonic stem (ES) cells.  Cells with 
equivalent potential have not been identified in most non-mammalian 
model systems.  However, axolotl animal cap cells have pluripotent 
properties being able to develop into derivatives of all three germ layers 
(ectoderm, mesoderm and endoderm) and primordial germ cells 
(Section 1.6).  However, only transplantation experiments can prove 
that these cells have the ability to contribute to all of the cell lineages of 
the embryo.  The derivation of pluripotent cells during murine 
development and the factors involved in establishing pluripotency will 
be discussed along with the pluripotent properties of axolotl animal cap 
cells. 
 
1.2 Pluripotency in mouse 
 
Pluripotency is first established in the mouse embryo as the inner cell 
mass (ICM) develops from the inner cells of the morula (Figure 1.1A).  
All the cells of the morula are totipotent, having the ability to derive all 
the tissues of the embryo and the extra-embryonic tissues, until the 
8-cell stage [Tarkowski 1959; Tsunoda and McLaren 1983; Zernicka-
Goetz 1998; Ciemerych et al. 2000; Johnson and McConnell 2004].  
The inner cells of the morula subsequently form the ICM and the outer 
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cells form the trophoblast [Fleming 1987] (Figure 1.1B).  The ICM gives 
rise to all of the tissues of the embryo, whereas the trophoblast forms 
only extraembryonic tissues that contribute to the placenta [Pedersen et 
al. 1986; Fleming 1987].   
 
At the late-blastocyst stage the ICM gives rise to the epiblast (primitive 
ectoderm) and the extraembryonic endoderm (primitive endoderm) 
(Figure 1.1C) [Niwa 2007].  The epiblast retains the ability to develop 
into all of the cells of the embryo, but it does not have the same 
developmental potential as the ICM, as it cannot give rise to 
extraembryonic endoderm or trophectoderm (TE) (TE cells can be 
derived from ICM cells in vitro) [Gardner and Rossant 1979].  Thus, the 
epiblast has restricted development in comparison to the ICM, but 
retains pluripotency.  The epiblast subsequently derives the embryo 
proper, giving rise to derivatives of all three germ layers and the germ 
cells (Figure 1.1D). 
 
The study of pluripotent cells in mammalian embryos is complicated by 
placental development.  However, the derivation of embryonic stem 
(ES) cells has enabled more detailed study of pluripotency in vitro.  ES 
cells can be derived from the morula [Chung et al. 2006 and references 
therein] and the ICM [Evans and Kaufman 1981].  They can be 
maintained in an undifferentiated state indefinitely under specific culture 
conditions and retain the ability to derive all three somatic germ layers 
including the germ cells both in vivo and in vitro [Suda et al. 1987].  
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More recently it was shown that cells derived from the epiblast, epiblast 
stem cells (EpiSCs), can also be maintained in culture in an 
undifferentiated state [Brons et al. 2007; Tesar et al. 2007].  EpiSCs 
can, like ES cells, give rise to derivatives of all three somatic germ 
layers in vivo and in vitro, but unlike ES cells they have not been shown 
to contribute to the germ line in chimeras [Brons et al. 2007].  The 
inability to contribute efficiently to the tissues of chimeras was attributed 
to a developmental asynchrony between the EpiSCs and the 
blastocysts into which they were transplanted.  Notably, EpiSCs were 
isolated at E5.75 and PGCs in mouse are specified at E5.5 [Ohinata et 
al. 2005].  Thus, the inability of EpiSCs to contribute to the germ line 
might also be associated with the developmental capabilities of the 
epiblast cells at the time of isolation. 
 
Pluripotency is determined by a complex interplay of extrinsic cell 
signalling and intrinsic transcription factor networks [recent reviews 
Niwa 2007; Pan and Thomson 2007].  The study of pluripotency in ES 
cells and embryos has revealed a network of transcription factors that is 
central to the establishment and maintenance of pluripotency both in 
vivo and in vitro.  The pluripotency transcription factor network includes 
three key molecules, Oct4, Sox2 and Nanog. 
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 Figure 1.1 Cell lineage development in the early mouse embryo. 
Pluripotent cell lineages are shown in green.  The inner cells of the morula (A) 
form the inner cell mass (ICM) of the blastocyst (B) and the outer cells form 
the trophectoderm.  The ICM gives rise to the epiblast (primitive ectoderm) (C) 
and the primitive endoderm. The primitive ectoderm (D) gives rise to all three 
somatic germ layers and the germ cells.  Reciprocal inhibition between Oct4 
and Cdx2 are thought to be involved in the establishment of the ICM and 
trophectoderm lineages.  Similarly, reciprocal inhibition between Nanog and 
Gata6 is thought to be involved in the segregation of the epiblast and the 
primitive endoderm [Figure adapted from Niwa 2007] 
 
 
1.3 The core pluripotency transcription factor network in 
mouse: Oct4, Sox2 and Nanog. 
 
1.3.1 Oct4 
 
Oct4 is a POU-domain transcription factor that can bind to octamer 
sequence motifs via its homeodomain to activate or repress the 
transcription of target genes [Pesce and Schöler 2001].  Three 
independent studies identified murine Oct4 (also referred to as Oct3/4) 
as a pluripotency associated transcription factor [Schöler et al. 1989; 
Okamoto et al. 1990; Rosner et al. 1990]. Oct4 was identified as a 
molecule that was specifically expressed in undifferentiated ES cells, 
undifferentiated embryonal carcinoma (EC) cells, pluripotent cells of the 
embryo and germ cells.  Maternal oct4 RNA and protein are present in 
oocytes and persists in early embryos until the 2 cell stage [Rosner et 
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al. 1990; Palmieri et al. 1994].  Zygotic transcription commences at the 
2 cell stage and RNA initially accumulates in all of the cells of the 
morula [Rosner et al. 1990].  RNA and protein are then progressively 
restricted to pluripotent cells, first the ICM and then the epiblast 
[Schöler et al. 1989; Rosner et al. 1990; Palmieri et al. 1994].  
Expression progressively decreases in the epiblast during gastrulation 
in an anterior to posterior direction as the cells begin to differentiate.  
The only cells that express Oct4 post-gastrulation are the primordial 
germ cells (PGCs) [Schöler et al. 1989]. 
 
Functional analyses showed that Oct4 was essential for the formation of 
pluripotent tissues in mouse embryos.  Oct4-null embryos fail to form a 
pluripotent ICM [Nichols et al. 1998].  Blastocyst-like structures form but 
the putative ICM diverts to the trophectoderm (TE) lineage.  In addition, 
perturbations of Oct4 expression in ES cells cause them to differentiate 
[Niwa et al. 2000; Ivanova et al. 2006].  Increased Oct4 expression 
causes differentiation to primitive endoderm and mesoderm [Niwa et al. 
2000], whereas a decrease causes differentiation to TE [Niwa et al. 
2000; Ivanova et al. 2006] and extraembryonic endoderm [Hay et al. 
2004].  Thus, a critical level of Oct4 is required to maintain self-renewal. 
 
1.3.2 Sox2 
 
Sox2 is an SRY-related HMG (High Mobility Group) box transcription 
factor that is predominantly expressed in pluripotent and multipotent 
cells of mouse embryos [Avilion et al. 2003].  Maternal protein is 
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present at high levels in mature oocytes and persists in embryos until at 
least the blastocyst stage.  RNA and protein encoded by sox2 is 
expressed in the ICM and persists throughout the epiblast.  Protein is 
also detected in the trophoblast where it is mainly cytoplasmic, whereas 
in the ICM it is mainly nuclear [Avilion et al. 2003].  Sox2 expression is 
downregulated as epiblast cells differentiate, and persists only in the 
neuroectoderm.  At later stages of development expression is detected 
in neural tissues (including neural stem cells), branchial arches, gut 
endoderm and male and female germ cells. 
 
Consistent with expression in pluripotent tissues, Sox2-null mice form 
an ICM-like structure but fail to survive beyond implantation 
(late-blastocyst) [Avilion et al. 2003].  Furthermore, the ICM-like cells 
are not pluripotent, differentiating only into TE cells in culture, and less 
frequently into extraembryonic endoderm [Avilion et al. 2003].  
Sox2-null embryos resemble Oct4-null embryos, but the phenotype is 
not quite as severe, perhaps due to the persistence of maternal protein 
or the presence of functionally redundant Sox genes [Avilion et al. 
2003].  Perturbations of Sox2 expression in ES cells cause their 
differentiation.  Depletion of Sox2 in ES cells, similar to Oct4 depletion, 
yields TE cells [Ivanova et al. 2006; Li et al. 2007] and also multiple 
epiblast lineages (ectoderm,mesoderm and neural crest) [Ivanova et al. 
2006].  Slight increases in expression also result in the differentiation of 
ES cells into multiple lineages [Ivanova et al. 2006; Kopp et al. 2008].  
Together this data indicates that Sox2 is essential for the maintenance 
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of pluripotency and only slight perturbations in expression cause ES 
cells to differentiate.  Sox2 has additionally been found to have a role in 
neural development, coinciding with the reported expression in neural 
tissues [Reviewed in Wegner and Stolt 2005]. 
 
1.3.3 Nanog 
 
Nanog is the most recently discovered member of the core pluripotency 
transcription factor network.  It is a homeobox transcription factor 
closely related to the NK-2 family of homeobox transcription factors, but 
distinct from the NK-2 family as it does not contain the NK2 or TN 
(tinman) domain [Mitsui et al. 2003].  Two independent groups identified 
Nanog as a pluripotency associated factor.  Mitsui et al. (2003) 
identified Nanog as a molecule that was enriched in undifferentiated ES 
cells and preimplantation mouse embryos.  Chambers et al. (2003) 
identified nanog in a screen for genes that could maintain self-renewal 
of ES cells in the absence of LIF (Leukaemia inhibitory factor), which is 
normally required [Smith et al. 1992].  Nanog RNA is first detected in 
the interior cells (future ICM) of morula stage embryos [Wang et al. 
2003].  Expression continues in the ICM and epiblast; and is excluded 
from extraembryonic tissues [Chambers et al. 2003].  By the late 
blastocyst stage expression decreases in the epiblast but it is later 
detected in migrating PGCs [Yamaguchi et al. 2005].  Expression is 
maintained in the PGCs until they reach the gonads and differentiate 
into mature germ cells. 
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Nanog-null embryos fail to form an epiblast [Mitsui et al. 2003].  
Presumptive embryonic cells from these embryos divert to 
extraembryonic endoderm in culture.  This implied that Nanog 
expression was required to prevent differentiation into the primitive 
endoderm lineage.  However, recent investigations using RNA 
interference (RNAi) showed that depletion of Nanog in ES cells results 
in differentiation into multiple lineages including trophectoderm and 
epiblast derived lineages; ectoderm, mesoderm and neural crest 
[Ivanova et al. 2006].  This suggests that Nanog might be a global 
regulator, repressing multiple programmes of differentiation.  Nanog 
expression in murine ES cells, however, is dispensable for the 
maintenance of self-renewal [Chambers et al. 2007].  Nanog-null ES 
cells are prone to differentiation but continue to self-renew and express 
other pluripotency associated factors such as Oct4 and Sox2.  They can 
also contribute to all of the tissues of chimeric embryos including the 
germ cells, showing that they retain pluripotency.  Nanog-null germ 
cells, however, cannot differentiate into mature germ cells once they 
reach the genital ridges. 
 
1.3.4 Oct4 and Nanog in the establishment of the trophectoderm 
and primitive endoderm lineages 
 
The establishment of the ICM and the TE in the early mouse embryo is 
the first lineage decision in mouse development.  There has been 
debate as to whether the segregation of morula cells into the ICM and 
trophoblast lineages is a random or programmed event [Zernicka-Goetz 
2006].  Niwa et al (2005) proposed a reciprocal interaction between 
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Oct4 and another transcription factor, Cdx2 (Caudal-related homeobox 
2) [Niwa et al. 2005]  Initially, both Cdx2 and Oct4 are expressed in all 
of the cells of the morula, but Cdx2 expression becomes restricted to 
the outer cells that will derive the TE and Oct4 to the inner cells that will 
derive the ICM [Schöler et al. 1989; Rosner et al. 1990; Beck et al. 
1995; Niwa et al. 2005].  Both Cdx2 and Oct4 can be autoregulated and 
additionally Oct4 and Cdx2 can form a complex, which may act as a 
transcriptional repressor complex [Niwa et al. 2005].  Based on this it 
was proposed that once expression of Cdx2 and Oct4 reach threshold 
levels an asymmetrical distibution of the two molecules might be 
amplified by reciprocal inhibition.  Thus, downregulation of Oct4 results 
in upregulation of Cdx2, and vice versa.  Subsequently, leading to the 
segregation of the TE and ICM lineages by establishing their mutually 
exclusive expression [Niwa et al. 2005].  Accordingly, overexpression of 
Cdx2 in ES cells causes differentiation into TE, mimicking the effect of 
Oct4 depletion [Niwa et al. 2005; Tolkunova et al. 2006].  In addition, 
Cdx2-null embryos fail to correctly form trophectoderm, maintaining 
expression of Oct4 and Nanog in the outer cells of the blastocyst 
[Strumpf et al. 2005].  Recent investigations, however, have shown that 
Cdx2-mutant cells, which show cell-autonomous expression of Nanog 
and Oct4 do not preferentially contribute to the inner cell mass [Ralston 
and Rossant 2008].  Thus, it is likely that Cdx2 expression is not the 
primary event in this lineage segregation, but a secondary process 
resulting in functional maturation.  Interestingly, cell polarisation events 
that occur at the 8-cell stage are independent of Cdx2 erxpression 
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[Ralston and Rossant 2008].  Thus, upstream molecules that regulate 
this polarisation may regulate Cdx2 expression and lineage 
segregation.  A recent study showed that cells of the 4-cell stage 
embryo, with increased histone H3 arginine methylation on specific 
residues, were biased towards the ICM lineage [Torres-Padilla et al. 
2007].  This histone modification was associated with expression of a 
histone methyltransferase, Carm1.  Overexpression of Carm1 in 
specific-blastomeres results in increased histone H3 arginine 
methylation and increased expression of nanog and sox2.  
Subsequently, these blastomeres contributed more frequently to the 
ICM.  Carm1 may operate upstream of Cdx2 and Oct4 in this lineage 
segregation event. 
 
Similar to the proposed interaction between Oct4 and Cdx2, it has been 
suggested that mutual inhibition between Nanog and Gata6 could be 
involved in the segregation of primitive endoderm and the epiblast 
[Niwa 2007].  Cells expressing Nanog and Gata6 are fated to form the 
epiblast and the extraembryonic endoderm, respectively.  The ICM 
initially develops as a mosaic of Nanog and Gata6 expressing cells, 
which subsequently sort into two distinct cell layers [Chazaud et al. 
2006].  Mutual inhibition between Nanog and Gata6 could result in the 
establishment of this salt and pepper appearance.  In agreement with 
this hypothesis, overexpression of Gata6 in ES cells, similarly to 
depletion of Nanog, causes them to differentiate into extraembryonic 
endoderm [Fujikura et al. 2002].  In addition, depletion of Gata6 in ES 
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cells or embryos inhibits primitive endoderm differentiation [Morrisey et 
al. 1998; Koutsourakis et al. 1999].  However, there is no evidence for a 
direct interaction between Nanog and Gata6 [Niwa 2007].  FGF 
signalling and the Grb2-Ras-Mapk signalling pathway have also been 
implicated in the establishment of these two cell-lineages [Arman et al. 
1998; Chazaud et al. 2006]. Inactivation of Grb2, a component of the 
Grb2-Ras-Mapk signalling pathway, results in all ICM cells expressing 
Nanog [Chazaud et al. 2006].  Likewise, targeted disruption of the 
fibroblast growth factor receptor 2 (FGFR2) in mouse embryos results in 
a failure to form the primitive endoderm [Arman et al. 1998].  Much 
remains to be determined about this lineage segregation event but it is 
clear that Nanog has a pivotal role in the maintenance of pluripotency at 
this crucial stage in development. 
 
1.3.5 A central self-organising transcription factor network 
governing pluripotency 
 
The studies decribed above outline the critical roles that Nanog, Oct4 
and Sox2 have in the establishment/maintenance of pluripotent cells, 
both in vivo and in vitro.  Reprogramming studies have also identified 
Nanog, Oct4 and Sox2 as critical molecules.  Mouse fibroblasts are 
successfully reprogrammed to a pluripotent state by the introduction of 
Oct4, Sox2, Klf4 and cMyc, although only Oct4 and Sox2 were 
absolutely necessary [Takahashi and Yamanaka 2006; Wernig et al. 
2007].  Furthermore, it has been reported that to reach a fully 
reprogrammed state both nanog and oct4 must also be transcriptionally 
activated [Brambrink et al. 2008].  This data, along with several other 
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recent studies, led to the suggestion that there is a central 
self-organising transcription factor network governing pluripotency in 
mouse ES cells, in which Nanog, Oct4 and Sox2 have pivotal roles.   
 
Loh et al (2006) carried out a large-scale study that identified binding 
sites for Nanog, Oct4 and Sox2.  They were found to have many 
common targets (44.5% of genes were found to have binding sites for 
both Nanog and Oct4 and the majority of Oct4 bound genes also had 
binding sites for Sox2.), amongst which were the genes encoding each 
of the three molecules.  This led to the suggestion that these three 
molecules might not only coordinately regulate the expression of their 
targets, but also their own expression levels, thus stably maintaining 
pluripotency.  RNAi experiments demonstrated that Nanog could 
regulate the expression of Oct4 and Sox2, supporting this suggestion. 
 
Ivanova et al (2006) used an integrated functional genomics approach 
to identify genetic mechanisms controlling mouse ES cell self-renewal.  
They identified Nanog, Oct4, Sox2, Esrrb, Tbx3 and Tcl1.  
Downregulation of each of these genes resulted in differentiation 
towards specific lineages.  Interestingly, overexpression of Nanog was 
shown to compensate for the loss of Esrrb, Tbx3 and Tcl1, leading to 
the suggestion that these molecules are part of an interconnected 
network governing pluripotency where the loss of one molecule might 
sometimes be compensated for by upregulation of another.  The 
relatively late embryonic stages at which Esrrb, Tbx3 and Tcl1 
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knockouts exhibit a phenotype could be explained by the presence of a 
stablising interconnected network of transcription factors. 
 
Some studies, however, have challenged the pivotal roles that Oct4, 
Nanog and Sox2 have in the pluripotency network.  Given the similarity 
of Oct4 and Sox2 knockout phenotypes [Nichols et al. 1998; Avilion et 
al. 2003] and the identification of Oct4 and Sox2 binding sites in close 
proximity within the regulatory regions of many genes [Loh et al. 2006], 
it has long been considered that Oct4 and Sox2 could cooperate in the 
regulation of target genes.  Oct4 and Sox2 are able to heterodimerize 
and moderate the expression of multiple genes in mouse ES cells 
[Yuan et al. 1995; Botquin et al. 1998; Nishimoto et al. 1999].  However, 
it was recently reported that although Sox2 was indispensable for the 
self-renewal of ES cells, it was not required for the activation of Oct-Sox 
enhancers [Masui et al. 2007].  The regulatory regions of many key 
pluripotency factors, including oct4 and nanog contain Oct-Sox binding 
sites [Loh et al. 2006].  The expression of many of these factors 
including oct4 was reduced following the depletion of Sox2 in ES cells 
[Masui et al. 2007].  The authors proposed that a reduction of Oct4 
expression could have caused the resulting phenotype.  Given that 
Oct-Sox enhancers remained active, it was suggested that Sox2 might 
indirectly affect Oct4 expression in ES cells by regulating upstream 
molecules.  To support this hypothesis, Oct4 overexpression was able 
to rescue the Sox2-null ES cells.  This data suggests Sox2 and Oct4 
may not coordinately regulate targets in the central self-organising 
 
network proposed by Loh et al. (2006) and also that Sox2 may not 
directly regulate Oct4 expression.   
 
Chambers et al (2007) challenged the pivotal role of Nanog in a central 
self-organising network governing pluripotency.  They showed that 
Nanog-null ES cells could continue to self-renew and maintain the 
expression of Oct4 and Sox2, although these cells were prone to 
differentiation and could not form mature germ cells in vivo.  These 
findings highlight how much remains to be discovered about the 
establishment and maintenance of pluripotency both in vivo and in vitro, 
even in the context of these three highly studied transcription factors. 
 
1.4 Interactions of Oct4 and Nanog with epigenetic 
regulators 
 
Recent observations by Chambers et al. (2007) suggest that Nanog is 
not required for the maintenance of pluripotency (Section 1.3.5).  At 
both time-points when Nanog function is required, establishment of the 
epiblast, as determined by gene deletion [Mitsui et al. 2003], and 
differentiation of PGCs into mature germ cells [Chambers et al. 2007], 
are associated with genome-wide epigenetic changes [Surani et al. 
2007].  Based on these observations, Chambers et al (2007) proposed 
that Nanog might have a role in the establishment of the epigenetically 
erased states in pluripotent cells and germ cells.  In agreement with 
this, Nanog expression is first detected in the inner cells of the morula 
[Wang et al. 2003], preceding the establishment of the epigenetic 
modifications that distinguish the ICM and the TE in mouse [Surani et 
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al. 2007].  In addition, a Nanog protein-protein interaction study has 
identified multiple interactions with epigenetic modifiers, including 
polycomb group repressor complex 2 (PRC2), SWI/SNF complex, and 
the NuRD (Nucleosome Remodelling and histone Deacetylase) 
complex [Wang et al. 2006].  Each of these complexes has an essential 
role in early murine development [Reviewed in Surani et al. 2007] and 
components of each are necessary for ES cell maintenance [Kaji et al. 
2006; Rajasekhar and Begemann 2007; Gao et al. 2008].  For example, 
MBD3, a component of the NuRD complex is required for development 
of the epiblast [Kaji et al. 2007].  Gene deletion of MBD3 is embryonic 
lethal.  These embryos develop an ICM, which subsequently fails to 
derive mature epiblast cells.  In addition, pluripotency is disrupted in 
MBD3-/- ES cells [Kaji et al. 2006].  MBD3-null ES cells fail to respond to 
differentiation signals and they maintain expression of pluripotency 
genes.  Thus, it could be the absence of the correct epigenetic 
modifications in Nanog-null embryos that results in failure to derive 
epiblast cells from the ICM [Mitsui et al. 2003]. 
 
In addition to Nanog interactions with the aforementioned complexes, a 
recent study identified interactions of both Nanog and Oct4 with a 
modified NuRD complex in mES cells, named NODE (Nanog and Oct4 
associated Deacetylase) [Liang et al. 2008].  Depletion of NODE in 
mES cells resulted in increased expression of Nanog and Oct4 target 
genes, normally repressed in ES cells, and subsequently, differentiation 
of the ES cells.  This suggests that both Nanog and Oct4 may have key 
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roles in the establishment of epigenetically erased states during 
development. 
 
1.5 Conserved roles for Oct4, Sox2 and Nanog 
 
1.5.1 Human 
 
Human ES (hES) cells differ from mouse ES (mES) in many ways 
including their response to growth factors, regulation of pathways 
involved in senescence signalling, cell surface antigen expression, rate 
of proliferation and sensitivity to differentiation factors [Daheron et al. 
2004; Amit and Itskovitz-Eldor 2006; Fong et al. 2008].  Nevertheless, 
the three transcription factors, Oct4, Sox2 and Nanog, have roles in the 
maintenance of pluripotency in hES cells (Table 1.1), and Oct4 
expression has also been detected in the ICM of early human 
blastocysts [Hansis et al. 2000].  Furthermore, the reprogramming of 
human somatic cells to pluripotency has been achieved using the same 
conditions that reprogram mouse cells (Oct4, Sox2, Klf4 and cMyc) 
[Takahashi et al. 2007].  This indicates that the pluripotency network is 
conserved in mammals.  Surveys of Oct4 and Nanog binding sites in 
hES cells and mES cells however, has revealed only limited 
conservation of targets (9.1% of Oct4 bound genes and 13% of Nanog 
bound genes), this may indicate that there are differences in the 
transcription factor circuitry in the two types of cells [Boyer et al. 2005; 
Loh et al. 2006].  However, it is also possible that this limited overlap is 
due to the differing methods used to survey the binding sites in the two 
studies.  For example, Boyer et al (2005) only surveyed 6% of the 
human genome, whereas Loh et al (2006) carried out an unbiased 
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survey of the entire mouse genome.  Similarly to mouse, it is also 
thought that Sox2 has a function in neural development in adults 
[Fantes et al. 2003; Ragge et al. 2005]. 
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Table 1.1 Comparison of phenotypes in mESCs and hESCs.   
Knock-down and overexpression phenotypes for each of the three core transcription factors, Oct4, Sox2 and Nanog are described in mouse 
embryonic stem (mES) cells and human embryonic stem (hES) cells 
 
 
 Overexpression in HESCs Overexpression in mESCS Knock-down in hESCs Knock-down in mESCs 
Oct4 Not Known. A small increase (less than 2-fold) 
causes differentiation into primitive 
endoderm and mesoderm as 
determined by increased 
expression of Gata4 and Brachyury, 
respectively [Niwa et al. 2000].  A 
critical amount is required to 
maintain self-renewal, up or down 
regulation induces divergent 
developmental programmes. 
Hay et al (2004) found that 
knock-down by transfecting 
siRNAs (small interfering 
RNAs) induces epithelial-
like differentiation and 
expression of genes 
associated with endoderm 
differentiation, and 
restricted induction of 
trophoblastic markers.  
Whereas, Zaehres et al 
(2005) with the use of 
retroviral and lentiviral 
vectors to deliver siRNAs 
found that knock-down 
results in upregulation of 
trophoblastic markers [Hay 
et al. 2004; Zaehres et al. 
2005]. 
 
 
Niwa et al (2000) and Ivanova et al 
(2006) reported loss of pluripotency 
and increased expression of 
trophectodermal markers, 
suggesting dedifferentiation towards 
the trophectoderm lineage (mESC 
cannot normally contribute to the 
trophectoderm lineage) [Niwa et al. 
2000]. Hay et al (2004), however, 
additionally reported induction of 
markers of extraembryonic 
endoderm, suggesting 
differentiation towards both 
trophectoderm and extraembryonic 
endoderm lineages. 
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 Overexpression in HESCs Overexpression in mESCS Knock-down in hESCs Knock-down in mESCs 
Sox2 Not known Zhao et al 2004 reported that 
overexpression does not impair the 
propogation of ES cells, but on 
removal of LIF these cells 
differentiate exclusively into neural 
phenotypes [Zhao et al. 2004].  
Contrastingly, Kopp et al 2008 
reported that small increases (2-fold 
or less) reduce self-renewal 
coincident with reduced Nanog 
expression and trigger 
differentiation into multiple lineages 
including neuroectoderm, 
mesoderm, and trophectoderm, but 
not endoderm.  There is a bias 
towards differentiation into 
neuroectoderm lineages.  
Additionally, 4-fold or higher levels 
of overexpression induces 
significant cell death, in agreement 
with previously published data 
[Mitsui et al. 2003].   
 
Loss of stem cell identity, 
coincident with reduced 
expression of stem cell 
markers including nanog 
and oct4 and increased 
expression of 
trophectodermal markers 
[Fong et al. 2008]. 
 
 
Loss of pluripotency and induction 
of markers of trophectoderm and 
epiblast-derived lineages 
(mesoderm, ectoderm and neural 
crest), suggesting differentiation 
towards multiple lineages [Ivanova 
et al. 2006]. 
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 Overexpression in HESCs Overexpression in mESCS Knock-down in hESCs Knock-down in mESCs 
Nanog Maintenance of pluripotency in 
the absence of conditioned media 
[Normally required for the 
maintenance of pluripotency in 
HESCs; Xu et al. 2001] but 
growth is slowed, suggesting that 
Nanog cannot substitute for all of 
the components of the 
conditioned media [Darr et al. 
2006].  Additionally, the gene 
expression profile is altered from 
one characteristic of ICM to that 
characteristic of primitive 
ectoderm (as judged by 
comparison to known expression 
profiles in murine cells as human 
primitive ectoderm cells have not 
been isolated in culture). 
Pluripotency and self-renewal is 
maintained in the absence of LIF 
and ES cells have enhanced 
resistance to some differentiation 
signals [Chambers et al. 2003; 
Mitsui et al. 2003]. 
Loss of stem cell identity, 
downregulation of oct4, and 
upregulation of markers of 
trophectoderm and 
extraembryonic endoderm, 
suggesting differentiation 
toward extraembryonic 
lineages [Hyslop et al. 
2005; Zaehres et al. 2005]. 
 
 
Cells can continue to self-renew 
and remain pluripotent (as 
determined by integration into the 
tissues of chimeras), but renewal 
efficiency is reduced and cells are 
prone to differentiation [Chambers 
et al. 2007].  Original studies 
reported that depleted cells 
differentiate towards the 
extraembryonic endoderm lineages 
[Mitsui et al. 2003], but more recent 
studies reported that cells 
differentiate towards multiple 
lineages including trophectoderm 
and epiblast-derived lineages 
(mesoderm, ectoderm and neural 
crest) [Ivanova et al. 2006]. 
 
. 
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1.5.2 Chicken 
 
Homologues of Oct4 and Nanog have been identified in chicken and 
similar to their murine counterparts are predominantly expressed in 
pluripotent tissues and germ cells [Lavial et al. 2007].  Functional 
analyses confirmed roles for cOct4 and cNanog in the maintenance of 
chicken ES (cES) cells [Lavial et al. 2007].  Similar to observations with 
mES cells, overexpression of cNanog in cES cells promotes feeder-free 
growth, and knock-down of cOct4 (PouV) induces the expression of 
trophectoderm and endoderm markers, Cdx2 and Gata4/6 respectively.  
Conversly, depletion of cOct4 or cNanog leads to the loss of 
proliferation and induction of differentiation, marked by increased 
expression of Gata6.  Furthermore, cOct4 can partially rescue Oct4-null 
mES cells, and cNanog can completely rescue Nanog-null mES cells.  
Collectively, this data indicates that the function of cNanog and cOct4 is 
conserved. 
 
Chicken Sox2 (cSox2) is expressed in the primitive ectoderm (epiblast) 
of pre-streak stage embryos [Streit and Stern 1999], suggesting that it 
may have a role in pluripotency.  However, a role in pluripotency is yet 
to be identified.  cSox2 is also widely expressed in neural tissues, 
similarly to the mouse homologue [Streit et al. 1997], and has a 
conserved role in neural development [Bylund et al. 2003; Graham et al. 
2003].  Future analyses may identify a role in pluripotency. 
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1.5.3 Xenopus 
 
Three oct4 homologues have been identified in Xenopus laevis, 
xlpou91, xlpou60 and xlpou25, which have overlapping expression 
patterns [Hinkley et al. 1992; Morrison and Brickman 2006].  Xlpou60 
expression is detected in oocytes, where it is mainly localised to the 
animal hemisphere [Whitfield et al. 1993; Morrison and Brickman 2006].  
mRNA and protein encoded by xlpou60 is maternally inherited by the 
embryo [Hinkley et al. 1992].  The mRNA persists in the animal pole 
and marginal zone (presumptive mesodermal cells) of the embryo until 
late-blastula and is undetectable by early gastrulation [Hinkley et al. 
1992; Whitfield et al. 1993; Morrison and Brickman 2006].  Xlpou25 
mRNA is also detected at low levels in oocytes and early embryos 
[Hinkley et al. 1992].  However, protein is not detected until gastrulation 
when transcription is dramatically upregulated [Hinkley et al. 1992; 
Morrison and Brickman 2006].  Similar to xlpou60, xlpou25 expression 
is localised to the animal pole and marginal zone of embryos [Cao et al. 
2004; Morrison and Brickman 2006].  Transcription of the third 
homologue, xlpou91, is not activated until after the onset of zygotic 
transcription (mid-blastula transition (MBT) [Hinkley et al. 1992; 
Morrison and Brickman 2006].  The highest level of expression is 
detected at late-gastrula.  Xlpou91 expression, like xlpou60 and 
xlpou25, is also localised to the animal pole and the marginal zone of 
embryos [Morrison and Brickman 2006].  Later in development xlpou25 
and xlpou91 are also expressed in the neuroectoderm, [Cao et al. 2004; 
Morrison and Brickman 2006].  The composite expression pattern of the 
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three Xenopus homologues during blastula and gastrula stages has 
been proposed to resemble the expression of murine oct4 [Morrison 
and Brickman 2006].  The three homologues are expressed throughout 
blastula and gastrula stages in multipotent tissues that will derive 
differentiated ectodermal and mesodermal tissues.  Expression is only 
detected in marginal zone cells that have not started to ingress during 
gastrulation.  Similar to murine oct4, expression of all three homologues 
is reduced post-gastrulation. 
  
Antisense morpholino oligonucleotides targeted to disrupt expression of 
each of the three Xenopus oct4 homologues were used in functional 
analyses [Morrison and Brickman 2006].  Morpholinos targeted to 
xlpou60 or xlpou25 had no discernable effect, which was attributed to 
functional redundancy between the three homologues.  Morphant 
embryos injected with xlpou91 morpholino (mo) alone, xlpou91 and 
xlpou25 mos or a combination of all three mos, had posterior truncation 
and anterior neural defects.  The depletion of all three molecules 
produced the most severe phenotype.  Analysis of gene expression in 
gastrula-stage morphant embryos showed reduced expression of genes 
associated with multipotent marginal zone cells, and increased 
expression of genes associated with more mature cell states.  Similar to 
the mouse oct4 knockout [Nichols et al. 1998] depletion of the three 
Xlpou molecules also resulted in the ectopic expression of xcad3, a 
cdx2 homologue.  It was therefore proposed that the Xlpou molecules 
have a conserved function, suppressing differentiation and maintaining 
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a multipotent population of cells.  Accordingly, Xlpou91, Xlpo60 and 
Xlpou25 were shown to partially rescue Oct4-null mES cells.  The most 
effective rescue was achieved with Xlpou91.  Additionally, 
overexpression of Xlpou25, Xlpou60 or Xlpou91 was shown to inhibit 
mesendoderm differentiation [Cao et al. 2004; Cao et al. 2006].  
Xlpou25 and Xlpou91 also have a role in anterior and posterior neural 
development coincident with the anterior neural defects observed in 
morphant embryos [Morrison and Brickman 2006].  Furthermore, 
overexpression of Xlpou25 in presumptive ectoderm has been shown to 
promote a neuroectoderm fate whilst suppressing terminal 
differentiation of neurons [Cao et al. 2006]. 
 
The Xenopus Sox2 homologue has a role in neural induction [Mizuseki 
et al. 1998].  It is widely expressed in the dorsal ectoderm during early 
gastrula, stages when neural induction first takes place.  Expression 
persists in neural tissues throughout embryonic development, including 
the central nervous system (CNS), neural crest, placodes and lateral 
line.  Xenopus Sox2 is essential for neuroectoderm formation and 
functions as a neural competence factor [Kishi et al. 2000].  A role in 
pluripotency/multipotency, however, has not been identified. 
 
1.5.4 Zebrafish 
 
An oct4 homologue, pou2, was identified in zebrafish [Takeda et al. 
1994; Hauptmann and Gerster 1995].  Pou2 is initially uniformly 
expressed in oocytes and is subsequently restricted to the animal 
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oocyte region [Howley and Ho 2000].  After fertilisation pou2 is 
ubiquitously expressed in all blastomeres until MBT and is then 
restricted to the epiblast during gastrulation [Takeda et al. 1994; 
Hauptmann and Gerster 1995; Reim et al. 2004].  Towards the end of 
gastrulation expression is confined to the neural plate, predominantly in 
the prospective hindbrain and spinal cord [Hauptmann and Gerster 
1995]. 
 
Depletion of Pou2 in Zebrafish mutants or through the use of antisense 
morpholino oligonucleotides has revealed multiple functions during 
development [Belting et al. 2001; Burgess et al. 2002; Reim and Brand 
2002; Lunde et al. 2004; Reim et al. 2004; Reim and Brand 2006].  
Embryos depleted of both maternal and zygotic Pou2 exhibit extreme 
dorsal-ventral (D-V) patterning defects and independently, a blastoderm 
specific arrest of epiboly [Reim and Brand 2006].  Analysis of 
maternal-zygotic mutants additionally revealed a function in endoderm 
development [Lunde et al. 2004; Reim et al. 2004].  The D-V patterning 
defect and the defect in endoderm development are considered 
independent as the D-V defect occurs shortly after MBT, whereas the 
disruption in endoderm development occurs from the beginning of 
gastrulation onwards [Reim and Brand 2002].  Later in development 
Pou2 was shown to have a role in the establishment of the 
midbrain-hindbrain organiser [Belting et al. 2001; Burgess et al. 2002; 
Reim and Brand 2002].  A role for Pou2 in the 
establishment/maintenance of pluripotency or the maintenance of 
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primordial germ cells during development has not been identified 
[Lunde et al. 2004; Reim and Brand 2006].  Pou2 cannot rescue 
Oct4-null ES cells, also suggesting that it does not have a conserved 
function in pluripotency [Morrison and Brickman 2006].  However, the 
function of Pou2 shares some similarities with Xenopus homologues, 
Xlpou25 and Xlpou91, which have also been shown to have a role in 
neural development [Cao et al. 2006; Morrison and Brickman 2006].   
 
Similarly, to other vertebrate homologues, the Zebrafish sox2 
homologue is expressed predominantly in neural tissues [Okuda et al. 
2006].  Zebrafish sox2 is initially uniformly expressed in the presumptive 
ectoderm and then becomes restricted to the neuroectoderm.  
Subsequently, strong expression is detected in the presumptive 
forebrain and weak expression is detected in the presumptive spinal 
cord.  Thus, Zebrafish Sox2 is likely to have a conserved role in neural 
development and is unlikely to have a role in pluripotency. 
 
1.5.5 Axolotl 
 
A homologue of oct4, axoct4, was identified in axolotls.  Axoct4 
expression was detected in the animal pole of blastula stage embryos 
and in the ectoderm and presumptive mesodermal cells (marginal zone 
cells) of gastrula stage embryos [Bachvarova et al. 2004; Chapter 3].  
Interestingly, this expression pattern closely resembles the combined 
expression of the three Xenopus homologues suggesting as in mouse 
that there is only one oct4 homologue [Bachvarova et al. 2004; 
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Morrison and Brickman 2006].  The role of Axoct4 in embryonic 
development has yet to be determined.  However, Axoct4 has been 
shown to partially rescue Oct4 deficient mES cells and Xenopus 
embryos depleted of all three homologues, suggesting that it may have 
a conserved function [Morrison and Brickman 2006].  Thus, preliminary 
evidence indicates that Axoct4 may also have a function in the 
maintenance of pluripotency/multipotency. 
 
1.5.6 Summary of conserved roles 
 
Early indications suggest that Nanog, Sox2 and Oct4 have conserved 
roles in the maintenance of pluripotency in amniotes, and Oct4 may 
have a conserved role in the maintenance of pluripotency/multipotency 
in anamniotes.  Sox2 has a conserved role in neural development in 
vertebrates [Reviewed in Wegner and Stolt 2005] but a role in 
pluripotency has not been identified in non-mammalian organisms.  
Although it is possible that other Sox family transcription factors 
[Soullier et al. 1999] may have a role in pluripotency in the absence of 
Sox2 function.  The study of these molecules in other organisms is 
necessary to uncover their ancestral roles during embryonic 
development. 
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1.6 Pluripotency in axolotls 
 
Cells with pluripotent properties were first identified in axolotl 
(Ambystoma mexicanum), a urodele amphibian.  A series of in vitro 
experiments showed that axolotl animal cap cells, from which ectoderm 
normally derives during development, could be induced to make 
mesoderm and endoderm [Nieuwkoop 1969].  For example, Grunz 
(1968) induced mesoderm and endoderm in axolotl animal caps in 
response to Li ions.  He showed that axolotl animal caps are first 
competent to respond to mesoderm and endoderm inducing signals at 
late-cleavage stages of development, with competence peaking at the 
mid-late blastula stage and terminating at early gastrula.  Subsequently, 
Nieuwkoop (1969) carried out a series of transplantation experiments to 
determine the origin of mesoderm in vivo, and showed that in vivo 
signals also induced mesoderm in axolotl animal caps.  Importantly, he 
showed that the entire mesoderm was derived from the animal cap.  
Blastula (stage 8-9) embryos were divided into four zones (Figure 
1.2A).  Each of the four zones was cultured in isolation (Figure1.2C) 
and various different combinations of the four zones were cultured as 
recombinates (Figure 1.2B).  During normal development, zone I 
develops into neuroectoderm, zone II develops predominantly into 
neuroectoderm and some mesoderm, zone III develops into mesoderm 
and endoderm derivatives and zone IV is comprised mainly of nutritive 
yolk that is absorbed by the embryo during development.  Cultured in 
isolation zones I and II develop only into undifferentiated ectoderm, 
zone III is comprised of ectoderm, mesoderm and endoderm, and zone 
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IV develops only into undifferentiated endoderm (Figure 1.2C).  By 
combining the different zones of the embryo, Nieuwkoop showed that 
mesoderm and endoderm could be induced in the ectodermal animal 
cap (zones I and II) in response to signals from the underlying 
endoderm.  The most striking result was observed when zones I and II 
were combined with zone IV, causing the induction of mesoderm, 
ectoderm and endoderm derivatives in zones I and II (Figure 1.2B).  
Thus, derivatives of all three somatic germ layers can be induced in the 
animal cap cells of blastula stage axolotl embryos. 
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Figure 1.2 A schematic 
demonstrating Nieuwkoop’s 
transplantation experiments. 
Blastula (stage 8/9) embryos were 
divided into four zones (A).  The 
four zones were cultured as 
recombinates (B) or isolates (C).  
When zones I and II were cultured 
with zone IV (B), mesoderm, 
ectoderm and endoderm derivatives 
were induced in zones I and II.  In 
contrast, in isolation, zones I and II 
only develop into undifferentiated 
ectoderm, and zone IV develops 
only into undifferentiated endoderm.
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It had previously been shown that primordial germ cells (PGCs), the 
precursor cells of eggs and sperm, develop in the lateral plate 
mesoderm of mid-gastrula stage axolotl embryos [Humphrey 1925a; 
Nieuwkoop 1947].  The complete derivation of mesoderm from 
presumptive-ectoderm in the animal cap (zones I and II) would, 
therefore, be expected to include PGCs.  PGCs can be distinguished 
from other mesodermal cells by their distinct morphology; they retain 
the size and yolk content of an early embryonic cell [Humphrey 1925b].  
Additionally, the chromatin is less highly packaged resulting in the 
nucleus in PGCs having a spherical appearance, which is distinct from 
the flattened nuclei of other mesodermal cells.  In similar transplantation 
experiments to those described above, Boterenbrood and Nieuwkoop 
(1973) showed that the PGCs were a characteristic component of the 
ventral mesoderm when it was induced in animal caps in response to 
signals from the ventral endoderm [Boterenbrood and Nieuwkoop 1973]  
This suggested that PGCs could be induced in the 
presumptive-ectoderm in response to signals from the ventral 
vegetative yolk mass.  However, the presumptive-ectodermal origin of 
the PGCs could not be proven without lineage tracing.  A series of 
xenoplastic and homoplastic transplantation experiments carried out by 
Sutasurja and Nieuwkoop (1974) confirmed that PGCs were derived 
from the animal cap.  In the xenoplastic transplantation experiments, 
animal caps from one urodele amphibian (including axolotl) were 
transplanted onto the vegetative yolk mass of another urodele species 
[Sutasurja and Nieuwkoop 1974]. Differences in pigmentation and yolk 
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platelet size were used to discern the origin of the PGCs.  The PGCs 
were always derived from the species that had furnished the animal 
cap.  Homoplastic transplantation experiments carried out with axolotl 
yielded the same result.  In these experiments, either the animal cap or 
the vegetal endoderm was radioactively labelled with methyl-tritiated 
thymidine (3H) and combined with unlabelled halves.  The origin of the 
PGCs was traced by the presence or absence of radioactive label.  In 
further experiments different regions of axolotl animal caps were 
combined with different regions of the endoderm [Sutasurja and 
Nieuwkoop 1974].  The results showed that the entire animal cap was 
competent to form PGCs.  Thus, all of the animal cap cells in blastula 
stage axolotl embryos can give rise to derivatives of all three germ 
layers, including the PGCs. 
 
The derivation of PGCs from axolotl animal cap cells was confirmed 
more recently in animal cap explant experiments (Figure 1.3).  Axolotl 
embryos were injected at the 1-2 cell stage with Xenopus BMP4 RNA 
and eFGF RNA to induce PGCs [Johnson et al. 2003b; O'Reilley et al. 
unpublished].  In Xenopus embryos FGF is known to induce posterior 
mesoderm [Amaya et al. 1991], and a high level of BMP is known to 
induce ventral mesoderm [Jones and Smith 1998].  Co-injection of the 
two RNAs was predicted to induce posterior ventral mesoderm, the 
tissue from which axolotl PGCs are derived [Nieuwkoop 1947].  Animal 
caps were isolated from injected embryos at late-blastula (stage 9) and 
cultured until stage 42.  At stage 42 PGC induction was determined by 
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the expression of RNA binding proteins axdazl and axvasa, which are 
PGC specific genes [Johnson et al. 2001; Bachvarova et al. 2004].  
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 Figure 1.3 Animal caps induced to make PGCs (PGC-induced caps) and expression of axdazl in PGC-induced caps.  
[Johnson et al unpublished].  Embryos were injected at the 1-2 cell stage with BMP4 RNA alone or eFGF RNA alone or BMP4 and eFGF RNA.  
Animal caps were cut at stage 9 (late-blastula).  Panels AD show the phenotypes of animal caps at stage 16 (mid-neurula).  Panel A 
shows uninjected caps.  Panel B shows caps injected with 5 ng Xenopus BMP4 RNA.  Panel C shows caps injected with 5 pg Xenopus eFGF 
RNA.  Panel D shows PGC-induced caps (injected with 5 ng Xenopus BMP4 RNA and 20 pg eFGF RNA).  The scale bar in panel D applies to 
panels A-D.  Panels E-H show ISH for axdazl expression on 15 ȝm sections of animal caps at stage 42.  Axdazl expression is only visible in 
PGC-induced caps, panel H, indicated by arrows and uninjected whole embryos (inset panel E).  The scale bar in panel H applies to panels E-
H. 
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Additionally, similar to murine pluripotent cells, axolotl animal cap cells 
express axoct4 (Section 1.5.5 and Chapter 3), a pluripotency 
associated transcription factor.  Evidence suggests that Axoct4 has a 
conserved function in the maintenance of pluripotency (Section 1.5.5).  
Thus, axolotl animal cap cells have pluripotent properties, similar to 
pluripotent cells in mammals, having the ability to derive all three 
somatic germ layers and the PGCs, and additionally express markers of 
pluripotency. 
 
1.7 Focus of this study 
 
In order to understand the evolution of mechanisms governing 
pluripotency it is necessary to study them in a wider variety of 
organisms.  This study describes the investigation of Axnanog, the first 
Nanog homologue to be identified in an anamniote model organism, 
and Axoct4 during axolotl embryonic development (Chapter 4).  There 
are a number of similarities between the morphological processes in 
axolotl development and those in amniotes (outlined in Chapter 3).  
Based on these it has been proposed that amniotes may have arisen 
from a urodele-like ancestor.  Thus, studying the function of these 
molecules in axolotl might be informative with regards to the evolution 
of the mechanisms governing pluripotency in amniotes.  Unfortunately, 
genomic sequence is unavailable for axolotl.  Therefore, it was 
necessary to clone and characterise multiple genes for use in this study 
(Chapter 3). 
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Primordial germ cells (PGCs) are the embryonic precursors of the 
gametes, sperm or oocytes.  These cells have restricted developmental 
potential.  Yet, paradoxically they are the only cells that can contribute 
to the next generation, retaining the ability to derive all of the cells of the 
embryo upon fertilisation.  Additionally, pluripotent cells, embryonic 
germ (EG) cells, can be derived from PGCs in culture [McLaren and 
Durcova-Hills 2001].  Thus, understanding how PGCs retain this ability 
throughout embryonic development might be valuable in understanding 
the mechanisms governing pluripotency and totipotency.  How the 
germline is segregated from the somatic cells during development is a 
fundemental question in developmental biology.  Little is known about 
PGC development in axolotls; hence it forms a focus of this study 
(Chapter 5). 
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Chapter 2. Materials and Methods 
 
2.1 Solutions and buffers 
 
Agarose plates 2% agarose in dH2O + 0.1% Tris-HCl pH8 
Antibiotics (1000x) 
10 mg/ml penicillin/streptomycin;  
10 mg/ml fungizone;  
10 mg/ml kanamycin 
Bleaching solution 5% formamide; 1x SSC pH 4.5; 3 - 5% H2O2  
Blocking Reagent MAB containing 2% (w/v) Blocking reagent (Roche) 
Bouins fixative 
25% formaldehyde; 5% glacial acetic acid; 5% methanol; 
1% picric acid. dH2O to final volume  
Collagenase/Dispase 
(4x) 
80 mg collagenase type II (Sigma), 48 mg dispase II, 
dissolved in 10 ml of 1x MBS. Store at 20
o
C in 5 ml 
aliquots and dilute to 1x solution with 1x MBS before use.  
Denaturing solution 1.5 M NaCl; 0.5 M NaOH 
DNA-gel loading dye  
0.1% Bromophenol blue, 0.1% Xylene Cyanol FF, 30% 
glycerol 
Electrophoresis 
Buffer  aka Laemmli 
electrolyte buffer 
25 mM Tris-HCl; 192 mM Glycine; 0.1% w/v SDS; H20 to 
volume; pH to 8.3 using Glycine 
High Phosphate 
Buffer (HPB)  
0.5 M NaCl; 0.1 M Na2HPO4/7H2O; 5 mM EDTA 
Homogenisation 
buffer 
50 mM NaCl; 5 ml dH20; 300 ȝl protease inhibitor cocktail 
(Sigma); 0.5 M PMSF (phenylmethylsulfonylflouride);  
Hybridisation mix for 
ISH 
50% (v/v) formamide (Sigma); 4x SSC (pH 4.5); 5 mM 
EDTA; 0.05 mg/ml tRNA (Sigma); 0.1 mg/ml heparin 
(Sigma); 1% SDS  
LB Agar LB Broth containing 15 g Bacto Agar/litre 
Luria Broth (LB)  
10 g Bacto Tryptone, 5 g Bactoyeast, 10 g NaCl in 1 litre 
distilled water. To pH 7.0 with NaOH. Autoclave 
Maleic acid buffer 
(MAB) 
0.1 M Maleic Acid; 0.15 M NaCl adjusted to pH 7.5 with 
NaOH 
Marcs Modified 
Ringers (MMR) (10 x) 
1 M NaCl, 20 mM KCl, 20 mM CaCl2 10mM MgCl2, 50 mM 
Hepes to pH 7.5 
Modified Barths 
Saline (MBS) 
88 mM NaCl; 1 mM KCl, 2.4 mM NaHCO3; 15 mM Hepes; 
0.3 mM CaNO3; 0.41 mM CaCl2; 0.82 mM MgSO4. pH 7.8 
with NaOH and autoclave 
Neutralising solution 1 M Tris-HCl (pH 7.5) 1.5 M NaCl 
NTMT 
0.08 M NaCl; 0.1 M Tris-HCl (pH 9.5); 0.05 M MgCl2; 1% 
(v/v) Tween 
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NZY Agar NZY Broth with 1.5% (w/v) Bacto Agar 
NZY Broth 
5 g NaCl, 2 g MgSO4·7H2O, 5 g yeast extract, 10 g NZ 
amine (casein hydrolysate). Made up to 1 litre with dH2O, 
to pH 7.5 with NaOH. Autoclave. 
NZY Top Agar NZY Broth with 0.7% (w/v) Bacto Agar  
Phosphate buffered 
saline (PBS) (10 x) 
27 mM Potassium Chloride; 14.7 mM Potassium 
Phosphate monobasic; 1.38 M NaCl; 80.6 mM Sodium 
Phosphate dibasic (Invitrogen) 
PBS-Tween 1x PBS; 0.1% Tween 
Paraformaldehyde 
(PFA) (4%) 
4% paraformaldehyde in 1x PBS 
Resolving Gel (10%) 
pH 8.8 
375 mM Tris-HCl pH 8.8; 10% acrylamide (from 30%:0.8% 
acrylamide:bisacrylamide stock (Protogel  BioRad); 0.1% 
SDS; 375 mM. Immediately before pouring add to 10 ml 
gel; 100 ȝl 10% Ammonium persulphate; 10 ȝl TEMED  
RNA-gel loading dye 
95% formamide; 0.025% xylene cyanol; 0.025% 
bromophenol blue; 18 mM EDTA; 0.025% SDS 
Sodium dodecyl 
sulfate (SDS) gel-
loading buffer (2 x) 
100 mM Tris-Cl (pH 6.8); 4% w/v SDS; 0.2% w/v 
bromophenol blue; 20% glycerol; 200 mM Dithiothreitol 
(DTT) 
SDS-PAGE running 
buffer 
0.1% SDS; 0.25 M glycine; 25 mM Tris-HCl pH 8.3 
SET buffer (20 x) 3 M NaCl; 1 M Tris-HCl pH8; 0.02 mM EDTA 
SM buffer 
100 mM NaCl; 8 mM MgSO4.7H2O; 0.05 M Tris-HCl 
(pH7.5); 0.01% (w/v) gelatine 
SOC 
20 g Bacto Tryptone; 5 g Bacto Yeast; 10 mM NaCl; 
2.5 mM KCl; 10 mM MgCl2; 10 mM MgSO4; 20 mM 
Glucose 
SSC (20 x):  
3 M NaCl; 0.3 M sodium citrate.  pH to 7 (blotting) or 4.5 
(ISH) with NaOH 
Stacking Gel (4%) pH 
6.8 
125 mM Tris-HCl pH 6.8; 4% acrylamide (from 30%: 0.8% 
acrylamide:bisacrylamide stock (Protogel  BioRad); 0.1% 
SDS. Immediately before pouring add to 5 ml gel: 50 ȝl 
10% Ammonium persulphate; 5 ȝl TEMED 
Tris-acetate-EDTA 
(TAE) buffer (50 x) 
2 M Tris-acetate; 0.05M EDTA 
Tris-EDTA (TE) 
buffer 
10 mM Tris-HCl (pH 7.5); 1 mM EDTA 
Wet Transfer Buffer 25% Methanol; 24 mM Tris-HCl; 153 mM Glycine 
 
 
38
2.2 Extraction of protein, DNA and RNA 
 
2.2.1 RNA extraction from embryos and oocytes 
 
RNA was extracted from embryos/ oocytes using TRI reagent® (Sigma) 
following the standard protocol (T9424).  Staged embryos/ oocytes 
were homogenised on ice in TRI reagent® until completely suspended.  
Large embryo debris was removed from the homogenate by 
centrifugation (12,000 g, 5 min) and the supernatant was then 
transferred to a fresh tube.  200 µl of chloroform was added per ml of 
TRI reagent® before the mixture was vortexed and separated by 
centrifugation (12,000 g, 10 min).  The upper aqueous phase was 
removed and 500 µl of isopropanol was added per ml of TRI reagent®.  
RNA was precipitated for 20 min at -20oC.  The RNA was then pelleted 
at room temperature by centrifugation (12,000 g 10 min).  The pellet 
was resuspended in non-DEPC treated nuclease free water (Ambion) 
and an equal volume of 8 M LiCl was added.  Precipitation of the RNA 
was then carried out at 4oC for 1-2 days.  This further precipitation 
ensured the removal of contaminating genomic DNA.  The RNA was 
pelleted at room temperature by centrifugation (12,000 g, 10 min).  The 
pellet was resuspended in an appropriate volume of nuclease free 
water and the RNA was then treated with DNAseI (Ambion) for 
30-40 min at 37oC to remove remaining genomic contamination.  
Quality was checked by gel electrophoresis (1.5% agarose as 
described in Section 2.3.6) and by measurement of concentration 
(Section 2.3.3).  Purified RNA was stored at 80oC until use. 
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2.2.2 Poly-A+ RNA extraction 
 
Poly-A+ RNA was isolated from total RNA extracted from embryos and 
oocytes using an Oligotex mRNA Mini Kit (Qiagen) according to the 
manufacturers guidelines.  The integrity of the poly-A+ RNA was 
checked on a 2% (w/v) agarose gel (Section 2.3.6) and it was 
quantified (Section 2.3.3) prior to storage at 80oC. 
 
2.2.3 Protein extraction from oocytes 
 
Protein extractions were carried out according to the method described 
by [Johnson et al. 1990].  Oocytes were homogenised in 50 mM NaCl 
containing 0.5 M phenylmethylsululfonyl fluoride (PMSF) and protease 
inhibitor cocktail (Sigma).  Homogenates were separated by 
centrifugation (12,000 g, 5 min) into three phases; the top phase 
contained fat, the supernatant contained non-membrane bound proteins 
and the pellet contained membrane bound proteins.  The supernatant 
was removed and precipitated with 4 volumes of acetone for 15 min at 
-20oC.  Precipitated protein was resuspended in 1 x SDS gel loading 
buffer and stored at 20oC until use. 
  
2.2.4 Extraction of genomic DNA from erythrocytes 
 
An axolotl was sacrificed by administering MS-222 (Tricaine methane 
sulfonate; 0.5-2 g/l; pH 7.0).  Blood was extracted and mixed 
immediately with 1 x SET solution.  The mixture was separated by 
centrifugation (6000 g, 3 min) and the pelleted red blood cells were 
resuspended in 1 x SET solution.  Proteinase K was added to a 
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concentration of 200 µg/ml and SDS or SDS buffer was added to 0.5% 
(w/v).  The red blood cells were then incubated at 37oC overnight. 
 
The following day genomic DNA was purified by two phenol:chloroform 
extractions (Section 2.3.7) and an ethanol precipitation (Section 2.3.8). 
The pelleted DNA was resuspended in TE buffer, quantified  (Section 
2.3.3) and stored at 20oC until use. 
 
2.3 Preparation and manipulation of DNA 
 
2.3.1 Minipreps 
 
Plasmid DNA was prepared using QIAprep® Spin Miniprep Kit, (Qiagen) 
according to the manufacturers protocol. 
 
2.3.2 cDNA synthesis  
 
cDNA was synthesised using SuperScriptTM reverse transcriptase III 
(Invitrogen) according to the manufacturers guidelines.  A maximum of 
4 ȝl of RNA was added to each reaction and 200 ng of random hexamer 
primers were used.  Reactions were carried out in a Techne thermal 
cycler (TC-312) using standard reaction conditions (Invitrogen).  
Reaction volumes were typically made up to 50 ȝl with non-DEPC 
treated nuclease free water (Ambion), aliquoted and stored at -20oC 
until use. 
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2.3.3 Determination of DNA and RNA concentration 
 
DNA and RNA preparations were quantified using a Nanodrop 1000 
spectrophotometer. Absorbance ratios of 260/280 and 260/230 nm 
were used to confirm product purity. 
 
2.3.4 Amplification of DNA by polymerase chain reaction (PCR)  
 
All PCR [Saiki et al. 1985] reactions were carried out in Techne thermal 
cyclers (TC-312). 
 
RT-PCR 
 
PCRs were carried out in a final volume of 20 ȝl and consisted of: 
1 x REDTaq® Ready Mix PCR mix (Sigma), 5 ȝl dH20, typically 
<100 ng (1ȝl) DNA and 2 ȝl each of forward and reverse primer at 
1 mM final concentration.  DNA was amplified according to the following 
program: 94oC for 2 min followed by 20-30 cycles; 94oC for 45 sec; 
Tm-5 for 45 sec; 72oC for 1 min. This was followed by a final extension 
at 72oC for 2 min. 
 
 Forward Reverse 
axnanog GTTCCAGAACCGAAGGATGA CGAAGGGTACTGCAGAGGAG 
axnanog ORF ATGCCCGCCCACTGCATGAC ACATGCCCTGCGTGCTCTGA 
axodc TGCGTTGGTTTAAAGCTCTC ACATGGAAGCTCACACCAAT 
axck AACGAGCGCCTGGCCTCCTAC CATGGCGCCAAATTAAACTGAAC 
 
Table 2.1 RT-PCR primer sequences 
Sequence is given 5 to 3. 
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Degenerate PCR 
 
Primers were designed in conserved regions identified from the 
alignment of amino acid sequences from human, mouse, Xenopus and 
zebrafish.  Alignments of the corresponding nucleotide sequences were 
utilised to reduce the degeneracy of the primers; degenerate 
nucleotides were replaced with single nucleotides at positions where all 
of the aligned sequences showed usage of the same nucleotide. 
 
PCRs were carried out in a final volume of 20 ȝl and consisted of 
1 x Extensor Hi-Fidelity PCR Master Mix with Buffer 1 (Abgene), 7 ȝl 
dH20, typically <100 ng (1 ȝl) DNA and 1 ȝl each of forward and reverse 
primers at 2.5 mM final concentration.  DNA was amplified using the 
following program: 94oC for 2 min followed by 45 cycles: 94oC 45 sec, 
45oC for 45 sec, 68oC for 1 min per kb.  This was followed by a final 
extension at 68oC for 2 min. 
 
 Forward Reverse 
axblimp1 ACTGGATGGGCTAYGTIAAY YTTRTGRCAIACCTGRCAYTC 
axcarm1 ATCGGIGACGCIAAYGGIGAI CTGRTCCACYTGIGCIACAAT 
axncam GGMATYAARAARACAGATGARGGI RCTTGCTTGRACMAGIATGAAYTC
 
Table 2.2 Degenerate PCR primer sequences 
Sequence is given 5 to 3.  Base codes: I = inosine; R = A + G, Y = C + T, 
M = A + C, K = G + T, H = A + T +C, D = G + A + T. 
 
 
Semi-degenerate PCR 
 
PCRs were carried out by the same method as degenerate PCRs 
except that only one degenerate primer was used at a final 
concentration of 2.5 mM and a specific primer, designed to the 
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sequence obtained by degenerate PCR, was used at a final 
concentration of 1 mM. 
 
 Degenerate Primer Specific Primer 
axblimp1 5’ ATGAARATGGAYATGGARGA GAGTTCTCCCGAGGAAGGGTAGTTC
axcarm1 3’ RCTCCCRTARTGCATTGTGTTGGT TCTCGGGGACTGTCCTCCTTATAG 
axncam 5’ ATGCTGCARAYTCAGGARCTCATC CACAACCACTTGGATATCCCTGAAG
axncam 3’ TGCYTTGCTCTCATTCTCRTTTGT ACTGCACAGCAGTCAACCGCATTG 
 
Table 2.3 Semi-degenerate PCR primer sequences 
Sequence is given 5 to 3.  Base codes: R = A + G, Y = C + T. 
 
Identification of introns by PCR 
 
Exon-exon boundary sequences were identified in order to amplify 
intron sequences from genomic DNA.  Boundary sequences were 
predicted from known boundaries in human homologues and by the 
alignment of the axolotl nucleotide sequences with homologues from 
human, mouse, Xenopus and zebrafish.  Primers were then designed 
50, 80, and 100 bp (where possible) upstream and downstream of the 
predicted boundaries. 
 
PCRs were carried out in a final volume of 20 ȝl and consisted of 
1 x Extensor Hi-Fidelity PCR Master Mix with Buffer 1 (Abgene), 5 ȝl 
dH20, 150200 ng genomic DNA and 2 ȝl each of forward and reverse 
primers at 1 mM final concentration.  DNA was amplified according to 
the following program; 94°C for 2 min, followed by 40 cycles: 94°C for 
45 sec, annealing temperature (Tm-5) for 45 sec, 68°C typically for 
2-5 min (extension times were estimated according to the length of 
human introns; 1 min/kb).  This was followed by a final extension at 
68°C for 2 min. 
 
44
 Forward primers Reverse primers 
axnanog 
intron 1 
50bp  
CGTGTGCTGTGGCGGCGAAC 
80bp 
GCCTACCCGGAACTGAACCAAC 
100bp 
CGCAAATGAGGGTGCCAGGATAC 
50bp 
CTGGTGGCTGAGTCGGGGGAAG 
80bp 
TCCGGGGCACACTGGGCGAAC 
50bp 
TGTCCAGCCACACTGAGTCCTTC 
axnanog 
intron 2 
50bp 
AAGCAGCATTACATGAACCCAATG 
80bp CTCGTGGCCCTGCACCGAATG 
100bp 
GACGAAGGCCCAGGCGAGAAAG 
axoct4 
intron 1 
50bp  
AGCAGCGCCAGCCCGGACCTG  
80bp  
GTCCGATGACAGCCCGCACAG 
100bp 
GCCAGGTCGCCTGCGTCCGTG  
50bp  
CCACGGACGCAGGCGACCTG  
80bp 
CCTGCGTAAAGCCCAGCGTGATG  
axoct4 
intron 2 
50bp 
AAGCGCATCACGCTGGGCTTTAC  
80bp 
GAACAGTTTGCCAAGGAGCTGAAG 
50bp 
ACACATGTTCTTGAAGCTCAGTTG 
80bp 
CTGGAGCAGGGGTCTCAGTTTAC  
100bp CCTCGACCAGCCAGCGCTG
axoct4 
intron 3 
50bp 
GTAAACTGAGACCCCTGCTCCAG  
100bp 
CGAGGCCCTGCAACTGAGCTTC 
50bp 
GACGCTGTTCTCGATGCTGGTTC 
100bp 
ATGGGTGGGCTTCGGACACTTC 
axoct4 
intron 4 
50bp 
AAGTGTCCGAAGCCCACCCATC  
100bp 
CGGAAGAGGAAAAGAACCAGCATC 
50bp 
CAAATGCTGCGCTTCCCCTTCTG  
100bp 
CCCGGCTGCATCCCTGGGTAC 
axblimp1 
intron 4 
50bp 
CGGGACTTTGCAGATAGGCTGAAC  
80bp 
CATTCCCGCCAACCAGGAGCTAC  
100bp 
GGACATCTACTTCTACACCATCAAG 
50bp 
GGCACTTTTGTGGTGAAGCACCTC 
80bp 
AAGAATCTCCTTCATGCTGTGTTC 
100bp 
TGCCTTTGGATTGGCTTACAGAAG 
axblimp1 
intron 5 
50bp  
CAAGAAGCAGAACGGGAAGATTAAG 
80bp 
GACTGGTTACAAAACGCTTCCATATC
100bp 
GCCAGCAACGAAGAAGCAATGAATC 
50bp 
TGGGCCAGCTGCGTGAATCCTTTG 
80bp 
TACAAGGTAGTGCTTCTGCAGATG 
100bp 
GTGTGGCTTTTCTCCCGTGTGTAC 
axcarm1 
intron 2 
50bp 
GAGTCGGCAAGCAGTCTTTTATTG 
80bp 
AAGTGTTCGGTGTCCCGTGAAAC 
100bp  
TGTGTGCGTATTTAAGTGTTC 
50bp 
TGAAGACGGACCGCTCAGAGTTG 
80bp 
AATACTGAACAGCTGACGACTCCTC
100bp 
CCATAGAACTGGAAATACTGAAC 
 
Table 2.4 Intron PCR primer sequences 
Sequence is given 5 to 3.  Values indicate locations relative to the exon:exon 
boundary. 
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2.3.5 Restriction enzyme digest 
 
DNA was digested using restriction enzymes (NEB) according to 
manufacturers guidelines.  Digested DNA was analysed on 1.2-2% 
(w/v) agarose gels. 
 
2.3.6 Agarose gel electrophoresis 
 
Agarose gels were prepared with 1 x TAE buffer and electrophoresis 
was carried out in 1 x TAE buffer.  Ethidium bromide was added to 
cooled molten gels, to enable visualisation of nucleic acids, at a final 
concentration of 1 µg/ml.  RNA preparations were analysed on 1.5-2% 
(w/v) agarose gels.  DNA preparations were analysed on 1.2-2% (w/v) 
agarose gels.  Prior to electrophoresis DNA and RNA samples were 
mixed with the appropriate loading buffers (Section 2.1) and RNA 
samples were heated to 60-80°C for denaturation and quenched on ice 
to prevent renaturation.  Care was taken to prevent RNAse 
contamination when handling RNA preparations.  100 bp and 1 kb DNA 
ladders (NEB) were utilised for size estimation.  Gels were visualised in 
a MultiMageTM light cabinet and photographed using an Alpha-ImagerTM 
1220 Documentation & Analysis System (Alpha Innotech Corporation). 
 
2.3.7 Phenol:chloroform extraction 
 
Phenol:chloroform:isoamylalcohol (25:24:1; pH 8.0) (Fluka) was 
equilibrated to room temperature and then mixed in a 1:1 ratio with the 
DNA/RNA samples.  Samples were vortexed before separating by 
centrifugation (5-10 min, maximum speed).  The aqueous phase 
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containing DNA/RNA was transferred to a clean tube and an equal 
volume of chloroform:isoamylalcohol (24:1) was added and mixed by 
vortexing before separating by centrifugation (as previous).  The 
aqueous phase was removed to a new tube. 
 
2.3.8 Ethanol precipitation of DNA 
 
DNA and RNA samples were precipitated with 1/10th volume (final 
concentration 0.3 M) 10 M ammonium acetate (pH 5.2) and 
2.5 x volume 100% ethanol.  For low concentration samples 1 ȝl 
glycogen (Roche) was added as a carrier and to aid pellet visualisation.  
Samples were mixed by vortexing and incubated at 20°C for 15 min.  
After incubation samples were separated by centrifugation (10-15 min, 
maximum speed).  The supernatant was removed with care and the 
pellet was resuspended in an appropriate volume of dH2O. 
 
2.3.9 Purification of DNA from agarose gels 
 
DNA was separated by electrophoresis on a 1.2% (w/v) agarose gel.  
Separated DNA was then visualised using a low intensity UV 
transilluminator and excised from the gel using a scalpel.  Excised DNA 
fragments were purified from the agarose gel using spin columns from a 
QIAquick gel extraction Kit (Qiagen) or a MinElute kit (Qiagen) 
according to manufacturers guidelines. 
 
2.3.10 Ligation of DNA fragments 
 
Insert and vector were mixed at a ratio of approximately 10:1, 
respectively.  Ligations were typically carried out with 50-100 ng of 
 
vector.  1 ȝl of T4 DNA ligase (NEB) was added to reactions and the 
provided buffer was added to 1 x concentration.  Reactions were 
incubated at room temperature for 2-16 hours. 
 
Calculating Vector Insert Ratio: 
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2.3.11 Transformations  
 
Chemically competent E. coli strain XL1-Blue Mrf- were thawed slowly 
on ice.  Half the volume of a ligation reaction or 50-100 ng of plasmid 
DNA was added to 150 µl of competent cells and incubated on ice for 
30 min.  The cells were then heat-shocked in a 42°C water bath for 
90 sec and cooled on ice for 90 sec.  Following cooling, 250 µl of SOC 
media was added and the cells were incubated in a 37°C shaking 
incubator for 45 min.  20 µl and 200 µl of the transformation were 
spread onto LB agar plates containing the appropriate antibiotic.  The 
plates were then incubated overnight at 37°C.  For blue/white selection, 
40 µl of 20 mg/ml X-GAL and 15 µl of 100 mM IPTG were spread onto 
the agar prior to plating. 
 
2.3.12 DNA sequencing 
  
DNA sequencing reactions were performed using 100 ng plasmid DNA, 
1 ȝl Big Dye sequencing buffer (Applied Biosystems), 1 ȝl Big Dye mix 
(Applied Biosystems), 0.5 ȝl Primer (10 ȝM) (primer varied according to 
the template), and 5.5 ȝl dH2O to make up the reaction volume to 10 ȝl.  
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The DNA was amplified according to the following PCR program: 25 
cycles at 96°C for 30 sec, 50°C for 15 sec and 60°C for 4 min.  
Following the PCR, the reactions were precipitated with 2 ȝl 3 M sodium 
acetate (pH 5.6) and 100 ȝl 100% ethanol at room temperature for 
15 min.  The DNA was pelleted by centrifugation (maximum speed, 
15 min) before washing with 150 ȝl 80% ethanol and air-drying.  
Air-dried pellets were sent to Geneservice (Nottingham, UK) for 
analysis. 
 
2.3.13 Sequence analysis and comparison 
 
Sequence comparisons were carried out using NCBI Basic Local 
Alignment Tool (BLAST) (version 2.2.18).  All alignments were 
performed using the Clustal W feature [Thompson et al. 1994] of the 
Bioedit sequence alignment program [Hall 1999]. 
 
2.4 Treatment and preparation of embryos and oocytes 
 
2.4.1 Axolotl matings 
 
Male and female axolotls were housed in separate water systems until 
mating.  A male and a female animal were selected randomly from a 
database and placed together in a chilled mating tank containing gravel 
and stones in darkness overnight.  The next day the tank was checked 
for the presence of spermatophores and the male was removed.  The 
female remained covered to minimise disturbance.  If the female began 
to lay embryos on the same day, she was chilled to 16°C overnight in 
order to obtain 1-2 cell stage embryos the following day. 
 
49
 2.4.2 Culture of axolotl embryos 
 
Embryos obtained from fertilisations were de-jellied manually at the 
1-2 cell stage or stage 8 (for ISH) and placed in 0.1 x MBS with added 
antibiotics and fungizone.  Embryos for microinjection were placed in 
1 x MBS plus 4% ficoll400 (Sigma) and antibiotics before use in order to 
shrink the pre-vitelline space, whereas embryos for ISH were cultured in 
0.1 x MBS at 16-22°C.  Staging was according to [Bordzilovskaya et al. 
1989]. 
 
2.4.3 Preparation of oocytes for microinjection 
 
A mature Xenopus tropicalis female was sacrificed by administering a 
lethal dose of MS-222 (Tricaine methane sulfonate; 0.5-2 g/l; pH 7.0) 
and ovary tissue was removed surgically and placed directly into 
1 x MBS to preserve the oocytes.  In order to liberate the oocytes, ovary 
tissue was placed into a solution of type II collagenase (Sigma) and 
dispase (Gibco BRL) on a rocking platform at room temperature.  
Oocytes were collected and washed with 1 x MBS to remove traces of 
collagenase and then stored in a petri dish containing 1 x MBS plus 4% 
Ficoll400 (Sigma) until injection. 
 
2.4.4 In vitro transcription of mRNA for microinjection 
 
Plasmid DNA templates were linearised with an appropriate restriction 
enzyme and purified by phenol:chloroform extraction (Section 2.3.7) 
and a subsequent ethanol precipitation (Section 2.3.8).  mRNA was 
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reverse transcribed from linearised templates using the appropriate 
Message Machine kit (Ambion).  All reactions were carried out for 
2 hours to achieve the maximum yield.  Unincorporated nucleotides 
were removed by two phenol:chloroform extractions and isopropanol 
precipitations according to the manufacturers guidelines.  RNA was 
resuspended in 20 ȝl of non-DEPC treated nuclease free water 
(Ambion) and the concentration was determined (Section 2.3.3) prior to 
aliquoting for storage at 80°C.  Aliquots were thawed on ice before 
dilution for microinjection. 
 
 Vector Linearise Transcribe Reference 
axnanog full-length pBut3HA SfiI T3 This work 
axnanog ORF 
(-5’UTR) 
pBut3HA SfiI T3 This work 
GFP pCSGFP2 EcoRI Sp6 A.D. Johnson 
Xenopus BMP4 pSP64T EcoRI Sp6 [Dale et al. 1992] 
Xenopus eFGF pSP64T SacI Sp6 [Isaacs et al. 1994] 
 
Table 2.6 Vectors for RNA synthesis. 
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2.4.5 Preparation of morpholinos 
 
Morpholinos were designed and supplied by Genetools 
(www.genetools.com).  They were rehydrated in non-DEPC treated 
nuclease free water (Ambion) to a stock concentration of 40 ng/nl.  
Repeated vortexing and heating to 65°C ensured complete suspension.  
Stock solutions were stored at 4°C.  Prior to use stock solutions were 
again heated to 65°C and diluted aliquots were incubated at 37°C until 
injection. 
Morpholino Sequence 
GGTCAATCCAAAAGCTCCTCCTAAG Axnanog translation-blocking 
GGTGAATGCAAAACCTCGTCGTAAG Axnanog mismatch control 
GGCAGGACTGAAACAAAACGAAGAC Axnanog splice-blocking (intron-exon) 
GGATTTCAAGGTTGTTTACCTGCCG Axnanog splice-blocking (exon-intron) 
TCTCCTGTCCCAAATGCCCAGCCAT Axoct4 translation-blocking 
 
Table 2.7 Morpholino sequences 
Sequence is given 5 to 3. 
 
 
2.4.6 Microinjection of embryos and oocytes  
 
Embryos 
 
Axolotl embryos were placed in a specially designed injection dish 
containing 1 x MBS plus 4% ficoll400 (Sigma).  Glass needles pulled on 
a micropipette puller (Flaming/Brown Model P-9) were calibrated to 
inject 4 nl using a graticule and 1-2 cell stage embryos were injected 
twice with 4 nl of RNA or morpholino using a PL1-100 (Harvard 
Apparatus Medical Systems Research Products) microinjector.  Injected 
embryos were cultured in 1 x MBS plus 4% ficoll400 and antibiotics until 
stage 8 (mid-blastula) when they were transferred to 0.1 x MBS with 
antibiotics and cultured until they reached appropriate stages.  For 
capping experiments, animal caps were disected from stage 9 
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(late-blastula) embryos immersed in 0.5 x MMR plus antibiotics.  Caps 
were then cultured on agarose plates in 0.5 x MMR plus antibiotics.  
The staging of cultured caps was determined using untreated sibling 
embryos. 
Oocytes 
 
Xenopus tropicalis oocytes were injected in the same way as axolotl 
embryos but with 2 nl of RNA or morpholino, and cultured in 1 x MBS 
plus 4% ficoll400 at 18°C.  
 
2.5 In situ hybridisation (ISH) 
 
2.5.1 Preparation of axolotl embryos for ISH 
 
Staged embryos were placed in 4% paraformaldehyde (PFA) in 
round-bottomed 2 ml tubes (no more than 5 embryos per tube).  
Embryos were fixed for 5-7 days at 4°C, before being dehydrated in 
100% methanol and stored at 20°C until use.  The 100% methanol 
was changed once during storage to ensure complete dehydration.  
 
2.5.2 Embedding embryos for sectioning 
 
Embryos stored as above were washed twice in xylene for 45 min.  
Xylene was replaced with a pre-warmed 50:50 solution of xylene:wax 
and embryos were incubated at 65°C for 45 min.  Subsequently, they 
were incubated in 100% wax 3 times for 45 min each at 65°C.  For the 
final incubation embryos were transferred to embedding moulds.  They 
were orientated in the final wax change using heated forceps and a light 
microscope.  Tailbud stage embryos could be orientated by eye.  
Embedded embryos were stored at 4°C. 
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 2.5.3 Sectioning 
 
Embryos were removed from embedding moulds and orientated on 
mounting blocks for sectioning.  Ribbons of 15 ȝM sections were 
generated on a Leica microtome (RM2265) and were then floated 
briefly in a 42°C water bath and mounted onto SuperFrostTM Plus slides 
(VWR).  Sections were stored for up to 1 month before use in ISH 
experiments. 
 
2.5.4 Hemisectioning 
 
Embryos were hemisectioned following a modification of the protocol 
described for Xenopus laevis [Lee et al. 2001].  Embryos stored as 
described above (Section 2.5.1) were rehydrated through a methanol 
series to PBST; 100% methanol, 75% methanol, 50% methanol, 25% 
methanol and 100% PBST each for 5 mins.  Following rehydration they 
were washed 3 times for 1 hour in PBS plus 0.3 M sucrose.  They were 
then visualised by light microscopy and embedded and orientated in 4% 
(w/v) low melting point agarose (Promega) made up with PBS plus 
0.3 M sucrose.  Once the embryos had set in the agarose it was 
covered with PBS plus 0.3M sucrose and the embryos were bisected 
using a scalpel.  Hemisectioned embryos were transferred to 100% 
methanol in 2 ml tubes and stored at 20°C until use.  ISH was carried 
out on hemisections according to the whole-mount protocol (Section 
2.5.6). 
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2.5.5 Preparation of dioxigenin (DIG) labelled RNA probes 
 
Plasmids containing probe sequences were linearised at the 5 end of 
the inserted sequence to produce antisense probes and at the 3 end to 
produce sense probes using an appropriate restriction enzyme.  
Linearisation was checked on an agarose gel.  Impurities were removed 
from linearised templates by phenol:chloroform extraction (Section 
2.2.7) followed by an ethanol precipitation (Section 2.2.8).  Linearised 
template was then resuspended in non-DEPC treated nuclease free 
water (Ambion). 
 
In vitro transcription reactions were performed using 1 ȝg linearised 
template, 2 ȝl of 2 x DIG-UTP NTP mix (Roche), 4 ȝl of 5 x transcription 
buffer (Promega), 20 units of RNase Out (Invitrogen) and 1-2 units of 
the appropriate RNA polymerase (Promega).  The reaction was made 
up to a total volume of 20 ȝl using non-DEPC treated nuclease free 
water (Ambion) and incubated at 37°C for two hours.  Following RNA 
synthesis 1 ȝl of DNaseI (Ambion) was added and the reaction was 
incubated at 37°C for 15 min to degrade the DNA template.  Reaction 
volumes were made up to 50 ȝl with nuclease free water and purified 
from unincorporated nucleotides using a G-50 spin column (GE 
Healthcare) according to manufacturers guidelines.  The synthesised 
probe was quantified (Section 2.3.3) and the integrity was checked on 
an agarose gel (Section 2.3.6).  Synthesised probes were then stored 
at -80°C until use. 
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 Sequence Vector Linearise  Transcribe Reference 
axnanog Full-length pGemT easy 
(Promega) 
 
SpeI T7 J. Dixon 
(Unpublished) 
axoct4 Full-length pBS-SK+ 
 
EcoRI Sp6 A. D.Johnson 
(AY542376) 
axmix Full-length pBS-SK+ 
 
Hind III T3 G. Swiers 
(Unpublished) 
axbrachyury Full-length pBS-SK+ 
 
XhoI T3 G. Swiers 
(AF308870) 
axblimp1 Degenerate 
fragment* 
pGemT easy 
(Promega)  
 
NcoI Sp6 This work 
axncam Degenerate 
fragment* 
pGemT easy 
(Promega) 
 
ApaI Sp6 This work 
axck Full-fragment 
cloned 
pGemT easy 
(Promega) 
 
NcoI Sp6 This work 
axcarm1 Degenerate 
fragment* 
pBS-SK+ 
 
 
Sac II Sp6 This work 
axdazl 
sense 
Full-length pBS-SK+ 
 
Hind III T3 A.D. Johnson 
(AF308872) 
 
Table 2.8 Vectors for ISH probe synthesis 
* See Appendix 8.1 for probe sequences 
 
 
2.5.6 Whole-mount in situ hybridisation (WISH) 
 
Whole-mount and hemisection in situ hybridisations were performed 
using a method adapted from the Harland laboratory protocol 
(http://tropicalis.berkeley.edu/home/gene_expression/in-situ/insitu.html; 
accessed June 2008).  ISH was carried out in glass vials for whole 
embryos or 2 ml round-bottomed microfuge tubes for hemisections.  
Embryos, stored at 20°C in 100% methanol, were first rehydrated to 
PBST through a methanol series; as in Section 2.5.4.  Following 
rehydration they were refixed in 4% PFA for 15-20 min and were then 
washed 3-5 times with PBST to remove all traces of PFA.  Following 
fixation embryos were equilibrated for 5 min in 50:50 hybridisation 
mix:PBST at 60°C which was then replaced with fresh hybridisation mix.  
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They were then incubated in hybridisation buffer (6 hour, 60°C).  After 6 
hours hybridisation buffer was recovered for later use and replaced with 
hybridisation buffer containing DIG-UTP (roche) labelled RNA probe 
(0.5 ng/µl).  Embryos were incubated with probes in a 60°C waterbath 
overnight. 
 
The next day, the hybridisation buffer containing the DIG labelled probe 
was recovered and stored at 20°C for reuse.  The embryos were 
washed for 2 min with recovered pre-warmed hybridisation buffer and in 
pre-warmed 2 x SSC (pH 4.5) at 60°C 3 times for 20-30 min, followed 
by two washes in 0.2 x SSC (pH 4.5) for 20-30 min at 60°C.  They were 
subsequently washed twice in MABT for 10-15 min at room temperature 
before incubation in MAB plus 2% Blocking reagent (Roche) for 5 hours 
at room temperature.  This solution was replaced with MAB plus 2% 
Blocking reagent containing a 1:3000 dilution of anti-DIG antibodies 
conjugated with alkaline phosphatase (Roche) and the embryos were 
incubated at 4°C overnight. 
 
Following antibody incubation embryos were washed once for 5 min in 
MABT followed by at least 4 washes in MABT over a 4-hour period.  
They were then washed three times for 5 min in NTMT.  NTMT was 
replaced with BM purple (Roche) and they were incubated in darkness 
at room temperature to allow colour development for 15 days.  
Incubation times varied according to the probe.  After colour 
 
57
development embryos were washed briefly in MAB and fixed in Bouins 
fixative overnight at room temperature. 
 
Yellow staining, resulting from incubation in Bouins fixative, was 
removed by a number of washes in buffered 70% ethanol (70% 
ethanol:30% PBST) at room temperature.  Embryos were then 
rehydrated through an ethanol series to 1 x SSC (pH 7.0).  To remove 
pigment and facilitate visualisation of staining, bleaching was performed 
on a light box in 2-5% bleaching solution.  Once adequate bleaching 
was achieved embryos were washed twice in 1 x SSC and once in 
100% methanol before transferring to 80% glycerol for storage at 4°C 
and photography. 
 
2.5.7 In situ hybridisation (ISH) on sections  
 
All room temperature steps were carried out in glass coplin jars or 
modified food storage containers (where stated) and plastic coplin jars 
were used for incubations in the 37°C waterbath.  Sections were 
dewaxed by washing the slides three times in 100% histoclear (VWR).  
Slides were then washed once in 100% ethanol and once in 100% 
methanol for 5 min each followed by rehydration to PBST through a 
methanol series, as described in Section 2.5.4.  After rehydration slides 
were incubated in pre-warmed PBST containing proteinase K (Roche) 
(3 µg/ml) at 37°C for 10 min.  Following this incubation slides were 
washed briefly in PBST and then refixed in 4% PFA for 20 min at room 
temperature.  Slides were washed 2-3 times in PBST for 5 min each at 
room temperature to remove any remaining PFA.  They were then 
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rinsed with 300 ȝl of hybridisation buffer and hybri wells (Stratech) 
covered with 300 ȝl of hybridisation buffer containing the appropriate 
DIG UTP (Roche) labelled RNA probe (5 ng/ȝl) were applied to the 
slides.  They were then laid flat in a specially modified food storage 
container lined with wet paper towel.  The air-tight lid was replaced and 
the container was incubated overnight at 60°C in a hybridisation oven.  
Care was taken to select food storage containers having a tight seal to 
prevent the slides from drying during incubation. 
 
The next day, the hybri wells were removed with care to avoid damage 
to the sections and where possible the probe solution was recovered 
and stored at 20°C.  Slides were washed briefly in pre-warmed 
solution 1 (4 x SSC; 50 % formamide; 0.1% SDS (w/v)) at 60°C.  They 
were then washed in solution 1 for 20 min at 60°C, followed by a single 
wash in solution 2 (2xSSC; 50% formamide; 0.1% SDS (w/v)) for 
20 min at 60°C.  This was followed by two washes in MAB for 10-15 min 
at room temperature.  Subsequently, the slides were laid flat in a food 
storage container and covered with approximately 300 ȝl of MAB plus 
2% Blocking reagent (Roche) which was then overlaid with a piece of 
parafilm.  Care was taken to ensure that hybridisation boxes were 
cleaned thoroughly between each use.  Incubation in the blocking 
solution was carried out for 1 hour.  The blocking solution was replaced 
with MAB plus 2% Blocking reagent containing a 1:5000 dilution of 
anti-DIG antibodies conjugated with alkaline phosphatase (Roche) and 
incubated for 2 hours at room temperature.  Excess antibody was 
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removed by two 20 min washes in MABT.  Slides were then washed 
three times in NTMT for 5 min each.  BM purple (Roche) was 
equilibrated to room temperature.  Next, slides were placed flat in the 
hybridisation boxes and covered with 300 ȝl of BM purple and overlaid 
with parafilm.  The lid of the box was replaced and the box was stored 
at room temperature in darkness until appropriate colour development 
was achieved.  Colour development typically took 1-7 days; during long 
incubations the BM purple solution was replaced several times. 
 
When the appropriate colour development had been achieved the 
parafilm was floated off in PBST.  The slides were then washed twice in 
PBST for 5 min and fixed in 4% PFA for 20 min.  Post-fixation they were 
washed twice in PBST for 5 min each.  Sections were then mounted in 
80% glycerol and coverslips were sealed with clear nail-varnish. 
 
2.5.8 Microscopy and photography 
 
Embryos were visualised with Nikon SMZ 1500 microscopes and 
sections were visualised with a Nikon Eclipse 80i.  Embryos were 
photographed on agarose plates.  Photographs of embryos and 
sections were taken using a Nikon DXM 1200F utilising Nikon ACT-1 
software (version 2.70) and a Nikon Digital Sight 5Mc utilising Nikon 
ACT-2U software (version 1.40.85.221).   
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2.6 Real-time PCR (qRT-PCR) 
 
For relative quantification of gene expression 25 ȝl reactions were 
performed in triplicate for each sample on 96 well Fast plates (Applied 
Biosystems).  Reactions consisted of 1 µl cDNA, 1 x AbsoluteTM qPCR 
ROX mix (ABgene), 200 nM (final concentration) of both forward and 
reverse primers and 5 pmol of probe.  Reactions volumes were made 
up to 25 µl with non-DEPC treated nuclease free water (Ambion).  
Plates were sealed with optical adhesive film (Applied Biosystems) and 
air bubbles were removed by brief centrifugation.  They were then run 
on an AB 7500 sequence detection system using a standard program: 
50°C for 2 min, 94°C for 15 min followed by 40 cycles of 94°C for 15 
sec and 60°C for 1 min.  Each plate had an endogenous control (axodc) 
for each sample and controls lacking reverse-transcriptase in the cDNA 
synthesis reaction were included for each gene. 
 
2.6.1 Primer and probe design 
 
Primer Express software (version 3.0) was used for the design of all 
probes and primers for qRT-PCR according to manufacturers 
guidelines using standard parameters.  Where possible primer-probe 
sets were selected so that either a primer or probe spanned a known or 
predicted exon-exon boundary.  Primers and dual-labelled fluorogenic 
probes (5FAM; 3TAMRA) were supplied by Sigma, all primers were 
desalted and all probes were HPLC purified.  Primers and probes were 
suspended to 100 ȝM, aliquoted and stored at 80°C until use; probes 
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were aliquoted into brown tubes to prevent photodegradation.  Primers 
and probes diluted for use were stored at -20°C.  
 
2.6.2 Data analysis 
 
qRT-PCR data was analysed according to the comparative CT method 
(2-ǻǻCt) [Livak and Schmittgen 2001].  The efficiency of primer and 
probe pairs was validated on a 4-fold dilution series of cDNAs from 1 to 
1/256 to ensure the PCR efficiencies of the target and endogenous 
reference (axodc) were approximately equal.  Threshold values were 
set manually and data was exported to Microsoft Excel for analysis.   
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Table 2.9 qRT-PCR primer and probe sequences. 
Sequence is given 5 to 3. 
 
 
 Forward primer Reverse Primer Probe 
axnanog TCACATACAAGCAGGTGAAGAACTG CTCTTGTCCAGCCACACTGAGT TTCCAGAACCGAAGGATGAAGCACAAAC 
axnanog UTR ACTTTACCAAAAAGCGTGACACTAGA ACAGAGCACCCAATTTTCCAA TGCGCCGAATAAAAACAAACCCTACTGA 
axoct4 GCGGACCTTGAACAGTTTGC ACATCCGCCTGCGTAAAGC AGCTGAAGCAGAAGCGCATCACGCT 
axbrachyury CATTGACCACATGTACCAATTGC GATCAAGGGTCAATCGTGAGTTC TACCCATAGTTCTTTTGTGCAGCATCCACG 
axmix AGCTTGGCACGAGCATCTCT TGGTCATTGAGCAGATGGAAGA GCGCTACCCTTTTTTCATGCACCCATATT 
axsox17 TGGATACGACGCTCCACAGA CTCCCTGTAGTGGCCGATGT CATGAGCAGCAGTTCCAGCAGGACAAC 
axblimp1 CGATGGTGACTCCGAAACAGA GGCACTTTTGTGGTGAAGCA AACCCAAAGCAACAGCACACTGAAAAGG 
axcarm1 CGAAGCGGCGCTCATC ACGGGACACCGAACACTTAAA CTCTCTACAGCCACGAAGATGTGTGCGT 
axdazl CAGTTTCGTAGAAGTAAAGCTGTGTTC ATAATCTACTTCTTGGAAGGCTTTGG AACTGTGCCAAACTGAAGTCTGTGGTAAA 
axvasa GATCGAATGCTTGATATGGGTTT TGTTTGCCGTTCTTCTTTGGT AAGACGTTAGTCACCAGTCCAGGAATGCC 
axmbd3 GGGCAAACCGGACTTGAATA TGACTGGCTGTTTGAAGATGGA TGCACTCCCCGTCAGACAAACTGC 
ax-Į-actin GGTCATCCAGGCTGTGTTGTC CATCACCAGAGTCCAAGACGATAC CTACGCTTCCGGCCGCACCA 
axodc ATGCCCGTCATGAGTAGTACCA CCCGGACCCAGGTTACG TGACAGTTCCAAGGTTTCATTCAATTGCTG 
axncam TGAATGTCGTTCAACGTGAGAGA  AAGAAAAGACTCTGGATGGACGTATC AGACCCTGGCGTGACTGCTCACCA 
axck AACCACCAAGAGGAATTGCAA GGAGCCGCGTCCATCTC CGTTTCATCCAGTGCTGCCGGC 
2.7 Handling and manipulating protein 
 
2.7.1 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
 
Proteins were separated by SDS-PAGE.  Resolving gels (typically 
10-15%) were poured between two glass plates, which had previously 
been cleaned using 100% ethanol.  The resolving gel was overlaid with 
isopropanol to aid polymerisation and the formation of a level surface.  
Once the resolving gel had set, the isopropanol was removed and the 
stacking gel was poured on the top.  A gel comb was inserted to form 
loading wells in the stacking gel. 
 
Gels were immersed in electrophoresis buffer in the electrophoresis 
tank prior to loading.  Protein samples were mixed with 2 x SDS-loading 
buffer in a 1:1 ratio and boiled for 5 min.  They were then quenched on 
ice and carefully loaded into the wells of the gel.  Protein Rainbow 
ladder (GE Healthcare) was used for size estimation.  Electrophoresis 
was performed at 120 V for approximately 90 min. 
 
 
2.8 Detection of tagged proteins by Western blot and 
ECL 
 
Following SDS-PAGE electrophoresis the gel was removed carefully 
from the glass plates and placed in transfer buffer.  A piece of 
Immun-Blot® PVDF membrane (Biorad) was cut to the size of the gel, 
equilibrated in methanol for a few seconds and then incubated in 
transfer buffer for at least 5 min.  Pieces of 3 mm Whatmann paper 
were cut to a size slightly larger than the membrane and also incubated 
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in transfer buffer.  A stack was then assembled on a semi-dry blotter 
(Ancos).  First three pieces of 3 mm paper were placed on the blotter, 
followed by the PVDF membrane, the gel, and finally three more pieces 
of 3 mm paper.  Care was taken to remove air bubbles from the stack.  
The lid of the blotter was carefully placed on top of the stack and 
transfer was then carried out for 40 min at 20 V. 
 
Following transfer, the membrane was washed in PBST 2 times for 
5 min each, and then incubated in PBST plus 2% non-fat dried milk for 
120 min at room temperature or overnight at 4°C.  For 
hemagluttanin (HA)-antibody detection the primary antibody (Anti-HA 
High affinity Rat monoclonal (Roche)) was diluted 1:3000 in PBST.  
Incubation with the primary antibody was carried out for 90 min at room 
temperature on a rocking platform.  The primary antibody was removed 
and saved for re-use at 4°C.  The membrane was then washed twice in 
PBST for 5 min each to remove excess primary antibody.  Incubation 
with the secondary antibody (Goat anti-Rat IgG peroxidise conjugate 
(Calibiochem)), which was diluted 1:5000 in PBST, was carried out 
subsequently for 90 min at room temperature on a rocking platform.  
After this incubation the membrane was again washed twice in PBST 
for 5 min each to remove excess antibody.  Antibody detection was 
carried out using ECL plus (GE Healthcare) and Amersham HyperfilmTM 
ECL (GE Healthcare) according to manufacturers guidelines.  The film 
was developed automatically using an SRX-201 Xograph. 
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MAPK detection was carried out by the same method using the primary 
antibody ERK2 (C-14; Santa Cruz Biotechnologies) at a 1:3000 dilution 
and the secondary antibody polyclonal swine anti-rabbit IgG peroxidase 
conjugate (Dako Cytomation) at 1:5000 dilution. 
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 Chapter 3 Development of the axolotl as a 
model organism 
 
3.1 Amphibians as model organisms 
 
Amphibians are often described as organisms that have a dual 
existence on land and water.  However this is not true of all amphibians.  
More accurately, amphibians can be defined as organisms that develop 
from a mesolethical (moderately yolky) egg that undergoes holoblastic 
cleavage (cleavage furrows completely bisect the egg) [Callery 2006].  
There are three living orders of amphibians, the anurans, urodeles and 
caecilians.  Anurans are tailless amphibians such as the frog Xenopus 
laevis.  Urodeles have a tail and two sets of limbs, for example axolotls.  
Caecilians are limbless amphibians with a snake-like form. 
 
The qualities looked for in a model organism are wide-ranging hence, 
no model organism will fulfil all the requirements [Krebs 1975; The 
Krogh Principle].  They have generally been selected because of their 
convenience to researchers.  Features that are often considered 
important include rapid development, short generation time, 
developmental homogeneity and ease of handling.  Amphibians are 
good model organisms for studying embryology because they have 
large externally developing embryos and rapid development.  The large 
cells in the embryos can be easily manipulated in transplantation 
experiments.  Historically axolotls and other species of salamander 
were the amphibian model of choice because they could be induced to 
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lay eggs when the temperature of the tank water was reduced 
[Nieuwkoop 2006].  This meant that embryos could be obtained for 
experiments all year round, whereas embryos could only be obtained 
from other model amphibians during their mating seasons.  
Subsequently, however, it was discovered that the frog Xenopus laevis 
could be induced to ovulate by injecting urine from pregnant women 
due to the presence of chorionic gonadotrophin hormone [Nieuwkoop 
2006].  The use of Xenopus laevis was adopted as a standard method 
for pregnancy testing in the 1950s.  This meant that Xenopus laevis 
was widely available and chorionic gonadotrophin hormone could be 
used to induce the production of embryos at any time of year, making 
Xenopus the amphibian model of choice [Nieuwkoop 2006]. 
 
Both salamanders and frogs initially fell out of favour in the early days of 
developmental genetics because of their long generation times (1-2 
years) [Gilbert 2000a].  However the advent of techniques such as in 
situ hybridisation, antisense oligonucleotides and dominant negative 
proteins has since allowed the study of developmental genetics in these 
organisms.  The difficulty with using Xenopus laevis in genetic studies is 
that it has four copies of each chromosome [Gilbert 2000a].  An 
alternative to Xenopus laevis is Xenopus tropicalis, which has a faster 
generation time (6 months) and is diploid, making genetic studies 
easier.  However, it is now becoming evident that tropicalis also has 
multiple copies of some genes that are present only as a single copy in 
mammals [e.g. Mix genes; D'Souza et al. 2003].  Contrastingly, 
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evidence is now beginning to suggest that gene copy number in axolotls 
is similar to that in amniotes [Swiers 2008; Smith et al. 2009], with 86% 
of genes between humans and axolotls predicted to be 1:1 orthologs 
[Smith et al. 2009].  Additionally, many of the morphological processes 
in axolotl development are more similar to those in amniotes than are 
the processes in Xenopus [Shook and Keller 2008a; Figure 3.1], 
suggesting that axolotl may be a good model organism for 
understanding the evolution of developmental mechanisms in amniotes. 
 
3.2 Axolotl gastrulation 
 
Gastrulation describes the process through which the tissues of the 
blastula embryo are rearranged to form the three primary germ layers: 
ectoderm, mesoderm and endoderm.  It is a complex process requiring 
highly coordinated cell and tissue movements.  The cells that will form 
the mesoderm and endoderm are brought inside the embryo whilst the 
cells that will form the ectoderm spread over the outside surface 
resulting in the formation of a multilayered organism.  The process of 
gastrulation varies widely amongst different organisms but generally 
involves four kinds of cell movement; invagination  the bending 
inwards of cells, involution  the rolling inward movement of an 
expanding outer layer so that it spreads over the internal surface of the 
remaining external cells, ingression  the migration of individual cells 
from the surface layer after detachment from an epithelium into the 
interior of the embryo, delamination  separation into layers and epiboly 
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 the movement of epithelial sheets (usually of ectodermal cells) that 
spread to enclose the deeper layers of the embryo. - [Gilbert 2000b]. 
 
During urodele gastrulation a multi-layered epiblast progressively 
becomes a pseudo-stratified (single-layered) epiblast [Shook et al. 
2002; Figure 3.1A].  A large proportion of the presumptive mesoderm in 
urodeles must move from the superficial cell layer into the deep layer.  
The mesodermal epithelium first involutes through the blastopore to line 
the wall of the gastrocoel, later known as the archenteron, and is then 
internalised to become part of the middle layer [Shook et al. 2002].  The 
mechanism through which the mesodermal epithelium is internalised 
into the deep layer is termed subduction.  The urodele blastopore is 
regarded as dorsally restricted or closed as involution takes place 
solely at the dorsal blastopore lip and ingression via subduction occurs 
laterally and ventrally [Shook et al. 2002; Figure3.1Ai and ii].  
 
The gastrulation mechanisms in urodeles are similar to those in 
amniotes [Shook et al. 2002; Shook and Keller 2008a; Figure 3.1B].  
The subduction process closely resembles the ingression of the 
presumptive mesoderm through the primitive streak during chick and 
mouse development [Shook et al. 2002; Figure 3.1B].  Thus, the lateral 
and ventral urodele blastopore lips are considered to be bilateral 
equivalents of the primitive streak in amniotes [Shook et al. 2002].  It 
has been suggested that the urodele blastopore may represent an 
intermediate in the evolution of the amniote primitive streak and that 
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amniotes may have arisen from a urodele-like anamniote ancestor 
[Shook and Keller 2008a].  Therefore, the study of early developmental 
processes in urodeles may be insightful in understanding the evolution 
of mechanisms in amniotes.  Notably, anurans do not share these 
similarities with amniotes [Discussed in Shook and Keller 2008a]. 
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Figure 3.1 Urodele gastrulation 
A) Gastrulation movements in urodeles [Taken from Shook and Keller 2008a].  
Urodeles begin gastrulation with most of the presumptive mesoderm in the 
superficial layer (i).  Most of the mesoderm ingresses during gastrulation (ii 
and iii; bottle shaped cells), just after involution (ii, arrow) through the dorsally 
restricted blastopore (iii).  The presumptive notochord remains superficial until 
the end of neurulation (ii and iii).  Dorsal is to the right in i and ii and up in iii.  
Anterior is up in ii.  B) A comparison of gastrulation movements in urodele 
amphibians vs birds and mammals [Taken from Shook and Keller 2008b].  In 
urodeles ingression occurs through a bilateral primitive streak running around 
the lateral, and in some cases, ventral sides of the blastopore (dark band).  
Cells move towards the primitive streak and ingress  (dashed arrows in upper 
box) adjacent to the endoderm, at the base of the blastoporal cleft.  In birds or 
mammals ingression occurs through a single primitive streak running down the 
centre of the posterior side of the embryo (dark line).  Cells move towards the 
primitive streak and ingress through its centre (dashed arrows in lower box). 
LV = Lateral ventral mesoderm; Sub-BP = Sub-blastoporal 
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3.3 The molecular control of gastrulation in axolotl; 
Axmix and Axbrachyury. 
 
A complex interplay of molecular signals regulates tissue specification 
during gastrulation.  Nieuwkoop discovered that signals emanating from 
the vegetal hemisphere of amphibian embryos could induce the 
overlying tissue to become mesoderm [Nieuwkoop 1969; Section 1.6].  
Mesoderm in vertebrates is induced and subsequently patterned by 
morphogen gradients; the morphogen originates from a defined point 
and acts in a concentration-dependent fashion to instruct gene 
regulation and, hence, cell fate [Ashe and Briscoe 2006].  The ectoderm 
differentiates into two tissue types, epidermis and neural tissue, in 
response to mesodermal patterning signals [Reviewed in Stern 2006].  
Spemann and Mangold (1923) first demonstrated the ability of dorsal 
mesoderm to induce neural tissue in the overlying ectoderm [Hemmati-
Brivanlou and Melton 1997; Spemann and Mangold 2001].  
Understanding of the molecular signals governing gastrulation and early 
tissue specification during axolotl development is in its infancy.  Recent 
investigations have examined the roles of Axmix and Axbrachyury. 
 
In all organisms examined so far homologues of Mix have been shown 
to have roles in mesoderm and endoderm specification [Henry and 
Melton 1998; Lemaire et al. 1998; Latinkic and Smith 1999; Hart et al. 
2002; Kofron et al. 2004; Izumi et al. 2007].  The expression pattern of 
axmix is consistent with a role in mesoderm and endoderm specification 
[Swiers 2008].  Axmix is expressed from stage 9 until stage 25 (Figure 
3.2A).  Expression is detected in the presumptive endoderm and in the 
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marginal zone with stronger dorsal than ventral expression, and persists 
in the deep endoderm until early neurula (Figure 3.2B).  This 
expression pattern is similar to the combined expression pattern of the 
seven Xenopus mix homologues [Ecochard et al. 1998; Henry and 
Melton 1998; Lemaire et al. 1998; Mead et al. 1998; Tada et al. 1998; 
Swiers 2008].  Only genome sequence could provide definitive 
evidence of gene copy number.  However, this data along with 
Southern blotting and knock-down data (described below) suggests that 
there is only a single mix gene in axolotls.  In amniotes, chicken, mouse 
and human, only a single mix gene has been identified [Peale et al. 
1998; Stein et al. 1998; Pearce and Evans 1999; Robb et al. 2000; Guo 
et al. 2002], consistent with the suggestion that amniotes may have 
arisen from a urodele-like ancestor [Shook et al. 2002].  Swiers (2008) 
suggested that multiple copies of mix in Zebrafish and Xenopus may 
have arisen after divergence from axolotls in order to facilitate more 
rapid early development [Swiers 2008].  Axmix expression persists for 
longer than the Xenopus homologues, similarly to murine mix.  The 
author suggests two explanations for this.  The first is that Xenopus 
may express mix for a shorter more intense period of time than the 
slower developing axolotl, which may require extended expression for 
the same patterning events.  Alternatively, it has recently been 
suggested that the late expression of murine mix is attributable to a role 
in blood specification [Willey et al. 2006].  In support of this, a region of 
cells co-expressing axmix and blood/ endothelial marker axflk-1 was 
identified at stage 12 (late-gastrula) [Swiers 2008]. 
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 Preliminary functional data supports a role for Axmix in endoderm and 
mesoderm specification.  Similarly to Xenopus homologues, Axmix 
overexpression in Xenopus animal cap explant experiments induces 
expression of mesodermal and endodermal genes [Swiers 2008].  The 
response was most similar to that induced by overexpression of 
Xenopus Mixer.  In knock-down experiments gastrulation was severely 
disrupted and axbrachyury expression was reduced suggesting that 
there was a disruption to mesodermal induction [Swiers 2008].  
However, examination of a greater array of marker genes is required to 
fully define the morphant phenotype.  The Axmix morphant phenotype 
was notably far more severe than any one of the reported single 
Xenopus mix gene knock-downs [Henry and Melton 1998; Lemaire et 
al. 1998; Latinkic and Smith 1999; Kofron et al. 2004], further 
supporting the suggestion that there is a single mix gene in axolotl.  The 
knock-down phenotype is most similar to the Xenopus laevis mixer 
knock-down [Kofron et al. 2004] and is inconsistent with the mouse 
knock-down phenotype  [Hart et al. 2002] where the region of brachyury 
expression is expanded [Swiers 2008]. 
 
Brachyury is a T-box transcription factor that has been shown to have a 
role in posterior mesoderm and notochord differentiation in mouse, 
zebrafish and Xenopus [Herrmann 1991; Smith et al. 1991; Schulte-
Merker et al. 1994; Conlon et al. 1996].  Axbrachyury is expressed from 
stage 10.5 (mid-gastrula) through to stage 40, with peak expression at 
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stage 12 (late-gastrula) (Figure 3.2A; This differs slightly from 
previously published data [Johnson et al. 2003b] which suggests a 
slightly earlier onset of expression; stage 10). Consistent with 
expression in other vertebrates, axbrachyury is expressed in nascent 
mesoderm (Figure 3.2B) and subsequently in the notochord [Herrmann 
1991; Smith et al. 1991; Johnson et al. 2003b; Swiers 2008].  In 
Xenopus mix and brachyury are first co-expressed in the dorsal 
mesoderm and mix expression is progressively excluded from the 
dorsal mesoderm [Lemaire et al. 1998].  This is thought to be the result 
of a negative regulatory loop between the two genes.  Axbrachyury and 
axmix are not co-expressed in the dorsal mesoderm (Figure 3.2B).  
However, Swiers (2008) suggests that there may still be a negative 
regulatory loop between Axbrachyury and Axmix to maintain the 
mutually exclusive expression.  It is notable that axbrachyury is not 
expressed early in the dorsal mesoderm as in other vertebrates 
[Herrmann 1991; Smith et al. 1991; Schulte-Merker et al. 1994; Swiers 
2008].  However, the predominant role of Brachyury orthologues has 
been shown to be in posterior mesoderm and notochord formation 
[Herrmann 1991; Halpern et al. 1993; Technau 2001].  Swiers (2008) 
suggests that although other vertebrate orthologues are expressed in 
the dorsal mesoderm that this expression may not be required for the 
formation of dorsal mesodermal structures.  Thus, the function of 
Axbrachyury in posterior mesoderm and notochord formation may be 
conserved.  Functional assays are required to further investigate the 
role of Axbrachyury. 
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Figure 3.2 Temporal and spatial expression of axmix and axbrachyury 
A) Temporal expression of axbrachyury (top) and axmix (bottom) determined 
by real-time PCR.  Primary data was analysed using the 2-ǻǻCT method [Livak 
and Schmittgen 2001] and was calibrated to expression level at stage 12 (late-
gastrula).  The graphs on the left show expression from the 2-cell stage to 
late-tailbud (stage 40).  The graphs on the right show expression through 
gastrulation (stage 10.5-12) and-early neurulation (stage 13-15) at high 
resolution.  Developmental stages exhibiting background levels of expression 
are labelled with an asterisk ( *) .  (Data obtained by author).  B) Spatial 
expression of axbrachyury and axmix as determined by in situ hybridisation on 
hemisectioned embryos (note one half of each embryo was hybridised to 
axbrachyury and the other to axmix to determine regions of overlap.) [Taken 
from Swiers 2008].  Axmix expression was first detected in the blastoporal 
dorsal mesoderm (i and ii; red arrows) at stage 10 (early-gastrula).  
Expression was maintained in the dorsal mesoderm and in dorsal cells that 
had not yet gastrulated (iii and v; green arrows) at stage 10.5 (mid-gastrula).  
At stage 10.75 (late-gastrula) expression was restricted to the anterior dorsal 
mesoderm (vi and vii; pink arrows) and expression was also detected in the 
presumptive ventral mesoderm and endoderm (vi; green arrow).  Expression 
was maintained in the endodermal yolk plug and ventral mesoderm (ix; green 
arrow) and was no longer expressed in the dorsal mesoderm (ix and xi; pink 
arrows) at stage 12 (late-gastrula).  Expression was maintained in the 
posterior ventral mesoderm at stage 14 (xii; pink arrow).  Axbrachyury 
expression was first detected in the posterior dorsal mesoderm (vii and viii; 
pink arrows) and presumptive ventral mesoderm (vii and viii; green arrows) at 
stage 10.75 (late-gastrula).  Expression persisted in the dorsal (x; pink arrow) 
and ventral posterior mesoderm (x; green arrow) at stage 12 (late-gastrula) 
and was additionally detected in aring around the blastopore (xi).  Expression 
was restricted to the dorsal mesoderm (xiii; pink arrow) at stage 14.  The last 
panel in each row shows the two halves of each embryo put together with 
vegetal facing up so that the two expression patterns can be compared. 
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3.4 Cloning and characterising genes for the further 
development of the axolotl as a model organism 
 
In the absence of axolotl genomic sequence it is necessary to clone and 
characterise genes prior to carrying out any investigations.  In this 
chapter the cloning and characterisation of a pluripotency gene 
(axnanog), ectodermal marker genes (axck and axncam), a putative 
PGC gene (axblimp1) and a gene encoding an epigenetic modifier 
(axcarm1) are described. 
 
3.5 Pluripotency genes 
 
3.5.1 Identification of an axolotl nanog homologue (axnanog) 
 
During amphibian development zygotic transcription does not 
commence until the mid-blastula transition (MBT; stage 8).  Early 
development is governed entirely by maternally inherited molecules 
[Newport and Kirschner 1982].  Nieuwkoops experiments (Section 1.6) 
showed that the animal cap cells of MBT stage axolotl embryos are 
pluripotent.  Based on these observations Johnson et al. (2008 
unpublished) proposed that pluripotency in axolotls is maternally 
inherited.  In support of this the transfer of pluripotency from axolotl 
oocytes to primary cells from foetal mice and adult humans was 
demonstrated [Alberio et al. unpublished].  Permeabilised primary cells 
were transplanted into the germinal vesicles (GVs) of axolotl oocytes.  
Subsequently, expression of oct4 and nanog was detected in the 
mammalian cells.  Axolotl oocytes were shown previously to express 
the pluripotency associated transcription factor, axoct4 [Bachvarova et 
al. 2004; Johnson and McConnell 2004].  However, equivalent oocyte 
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transplantation experiments carried out with Xenopus oocytes, which 
express the oct4 homologue, xlpou60, also activated oct4 expression 
but not nanog expression.  It was therefore considered that additional 
molecules must be present in axolotl oocytes that can activate the 
expression of nanog.  Subsequently, an axolotl nanog homologue, 
axnanog, was cloned from oocytes by degenerate PCR [J. Dixon, 
unpublished].   
 
Axnanog has two conserved domains (Figure 3.3), the divergent 
homeodomain (underlined in red) and a second region upstream of the 
homeodomain (underlined in blue). [J. Dixon, unpublished].  Axnanog is 
the first homologue to be identified in an anamniote model organism.  
Nanog has not been identified in the genomes of frogs (Xenopus) or 
teleost fish (Danio rerio; Fugu rubripes). 
 
Axnanog shares only small regions of homology with other homologues.  
However, intronic sequences have provided further evidence to support 
the identification of an axolotl nanog homologue (Figure 3.4).  The 
distance in base pairs from the ATG start site to the first splice junction 
is identical in human, mouse and axolotl sequences and all identified 
splice junctions show a high degree of sequence conservation.  The 
ATG start site of chicken nanog is shifted 3 bases upstream in 
comparison to the other homologues.  In protein BLAST searches the 
closest Xenopus molecule is Xvent2, however, alignments of xvent2 
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nucleotide sequence with axnanog showed that the first splice junction 
was in a dissimilar position (not shown). 
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     ź 
Axnanog MPAHCMTPQMRVPGYQAY--------PELNQPCAVAANYAPAFQGNLQAAEEGRPVP----AVLPSSPDSATSPKVDPFAQCAPDVAVGGETKAQARK-- 86   
NANOG   MSVDPACPQSLP-CFEASDCKESSPMPVICGPEENYPSLQMS-SAEMPHTETVSPLPSSMDLLIQDSPDSSTSPKGKQPTS-AEKSVAKKEDKVPVKKQK 97   
Nanog...MSVGLPGPHSLPSSEEASNSGNASSMPAVFHP-ENYSCLQGS-ATEMLCTEAASPRPSSEDLPLQGSPDSSTSPKQKLSSPEADKGPEEEENKVLARKQK 98   
cNanog  MSAHLAMPSYGSVRCGHYYWPSPGSMDSASAAEAPAADLSLTTEQKTPCHPDASPASSSSGTLIQYTPDSATSPTADHPSHRPTFQKVKDKGESGTRKAK 100  
              ź          ź 
Axnanog -RTCFSQEQLVALHRMFQKQHYMNPMQAQQLAADLNLTYKQVKNWFQNRRMKHKLSLKDSVWLDKRCWQPQASSILTPAQPQSTGCPESSSHLPQRYTVH 185  
NANOG   TRTVFSSTQLCVLNDRFQRQKYLSLQQMQELSNILNLSYKQVKTWFQNQRMKSKRWQK-NNWPKNSNGVTQKASAP-TYPSLYSSYHQGCLVNPTGNLPM 195  
Nanog...MRTVFSQAQLCALKDRFQKQKYLSLQQMQELSSILNLSYKQVKTWFQNQRMKCKRWQK-NQWLKTSNGLIQKGSAPVEYPSIHCSYPQGYLVNASGSLSM 197  
cNanog  SRTAFSQEQLQTLHQRFQSQKYLSPHQIRELAAALGLTYKQVKTWFQNQRMKFKRCQKESQWVDKGIYLPQNGFHQAAYLDMTPTFHQGFPVVANRNLQA 200  
 
Axnanog HSALAQRVTSHP----YQKYSGIQNPHQKVLSEDAATVQHREAAPQCMGPQQYMNRHQNYPTIEYAGARPVEGYNLKTPLQYP---SMAPYPNYYYQQPP 278  
NANOG   WSNQTWNNSTWS-----NQTQNIQSWSNHSWNTQTWCTQSWNNQAWN-SPFYNCGEESLQSCMQFQ--PNSPASDLEAALEAAGEGLNVIQQTTRYFSTP 287  
Nanog...WGSQTWTNPTWSSQTWTNPTWNNQTWTNPTWSSQAWTAQSWNGQPWNAAPLHNFGEDFLQPYVQLQ--QNFSASDLEVNLEAT-------RESHAHFSTP 288  
cNanog  VTSAHQAYSSGQ-------TYGNGQGLYPFMAVEDEGFFGKGGTSCNTQQAMGLLSQQMNFYHGYS--TNVDYDSLQAEDTYS---FQSTSDSITQFSSS 288  
 
Axnanog PYIHQQGRPDIRFQSTQGM-- 297  
NANOG   QTMDLFLNYSMNMQPEDV--- 305  
Nanog...QALELFLNYSVTP-PGEI--- 305  
cNanog  PVRHQYQAPWHTLGTQNGYET 309  
 
Figure 3.3 An alignment of artificially translated Axnanog and Nanog homologues from other vertebrates.   
Axnanog alignment with homologs from Human (NANOG) (NP_079141), mouse (nanog) (NP_082292), and chicken (cNanog) (ABK27429).  
Conserved amino acids are shaded.  Conserved domains are underlined.  The homeodomain is underlined in red and another short conserved 
domain is underlined in blue.  Known intron junctions (third junction is predicted) in the Axnanog sequence are indicated by ź. 
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Figure 3.4  Alignment of axnanog intron boundaries with intron boundaries from other vertebrate nanog homologues. 
Axnanog sequence has been aligned with homologous sequences from Human (NANOG) (ENST00000229307), mouse (Nanog) 
(ENSMUST00000012540), and chicken (cNanog) (ENSGALT00000023143).  Conserved nucleotides are shaded.  Exon:Intron and Intron:Exon 
boundaries are shown for introns 1 and 2 (underlined in blue).  Axnanog intron 3 sequence has not been obtained.  For each boundary 20 bp of 
exon and 20bp of intron sequence is shown, gaps are indicated by dashes.  Exon 1 sequence is shown from the ATG start codon for each 
sequence in order to show the conservation of the positioning of intron 1. 
 
 Axnanog  ~~~ATGCCCGCCCACTGCATGACCCCGCAAATGAGGGTGCCAGGATACCAGGCCTACCCGGAACTGAACCAACCGTGTGC 77   
NANOG    ~~~ATGAGTGTGGATCCAGCTTGTCCCCAAAGCTTGCCTTGCTTTGAAGCATCCGACTGTAAAGAATCTTCACCTATGCC 77   
Nanog    ~~~ATGAGTGTGGGTCTTCCTGGTCCCCACAGTTTGCCTAGTTCTGAGGAAGCATCGAATTCTGGGAACGCCTCATCAAT 77   
cNanog   ATGAGCGCTCACCTGGCCATGCCGTCCTACGGCTCTGTTAGGTGCGGACACTACTACTGGCCCTCTCCGGGCAGCATGGA 80  
 
ATG  
 
Axnanog  TGTGGCGGCGAACTACGCGCCAGCATTCCAGGGGAACCTGCAGGCCGCAGAAGAGGGGCGCCCGGTCCCGGCAGgtgtaa 157  
NANOG    TGTGATTTGTGGGCCTGAAGAAAACTATCCATCCTTGCAAATGTCTTCTGCTGAGATGCCTCACACGGAGACTGgtaaga 157  
Nanog    GCCTGCAGTTTTTCATCCCGAGAACTATTCTTGCTTACAAGGGTCTGCTACTGAGATGCTCTGCACAGAGGCTGgtaagg 157  
cNanog   TAGCGCGTCTGCCGCGGAAGCTCCAGCAGCAGACCTCTCCTTGACCACAGAGCAGAAAACGCCCTGCCACCCAGgtacgt 160  
 
 
 
Axnanog  acaaccttgaaatccag~~~~~~~~~~atgtcttcgttttgtttcagTCCTGCCGTCTTCCCCCGAC~~~~~~~~~~TCA 217  
NANOG    aagaaatttatccttga~~~~~~~~~~cttttatttgttcccaacagTCTCTCCTCTTCCTTCCTCC~~~~~~~~~~TGA 217  
Nanog    aattcagtccccgaaga~~~~~~~~~~tatctatttatttctaacagCCTCTCCTCGCCCTTCCTCT~~~~~~~~~~TGA 217  
cNanog   gggcccgagcagatggc~~~~~~~~~~ttgtgtctctcctcccctagCGCGACACCCCCAGTGCTCC~~~~~~~~~~CAC 220  
 
 
 
Axnanog  ACCTCACATACAAGCAGgtacaggcctaaagagaggg~~~~~~~~~~tcaatccatctcttggtagGTGAAGAACTGGTT 287  
NANOG    ACCTCAGCTACAAACAGgtaggcttgttttgtccttg~~~~~~~~~~ctatcattttttcctgcagGTGAAGACCTGGTT 287  
Nanog    ACCTGAGCTATAAGCAGgtggggtccttagaagttgc~~~~~~~~~~atgtcctgtcactctgcagGTTAAGACCTGGTT 287  
cNanog   GTCGAAGTTTTTATCTGgtgtgactgctcactctagc~~~~~~~~~~~~~tgtcttttctccttagATGCCTCTCCAGCT 287  
In2:Ex3 Ex2:In2 
In1:Ex2 
Ex1:In1 
 
 
 
Axnanog  CCAGAA 293  
NANOG    CCAGAA 293  
Nanog    TCAAAA 293  
cNanog   TCTTCC 293 
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 3.5.2 Temporal and spatial co-expression of axnanog and axoct4 
 
Temporal expression of axnanog and axoct4 was analysed by 
qRT-PCR from early-cleavage (stage 2) to late-tailbud (stage 40), with 
special focus on gastrulation to detect any rapid transcriptional 
changes, coincident with the onset of zygotic transcription (mid-blastula 
transition, stage 8) [Newport and Kirschner 1982; Figure 3.5A].  Axoct4 
expression was previously reported [Bachvarova et al. 2004].  Given the 
closely intertwined roles of amniote homologues of Oct4 and Nanog 
[Loh et al. 2006; Loh et al. 2008] in the maintenance of pluripotency, 
axoct4 expression was reanalysed for comparison to axnanog on the 
same cDNA series.  The temporal expression of axoct4 was in 
agreement with published data.  Maternal expression was detected at 
stage 2 and expression was maintained at an equivalent level following 
the onset of zygotic transcription (stage 8) until mid-neurula (stage 16).  
Expression was significantly reduced at stage 16 and undetectable by 
mid-tailbud (stage 25).  Analysis on the focussed cDNA series also 
revealed a relatively constant level of expression.  Similarly to axoct4, 
maternal axnanog expression was detected at stage 2 and zygotic 
expression was maintained from stage 8 until late-gastrula (stage 12).  
However, contrasting to the relatively constant levels of axoct4 
expression, axnanog expression levels changed significantly over time.  
Low levels of maternal expression were detected at early-cleavage 
(stage 2) and mid-blastula (stage 8) followed by a rapid increase at 
late-blastula (stage 9).  Expression peaked at early-gastrula (stage 10 
to 10.5) followed by a considerable decrease at late-gastrula (stage 12).  
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 Post-gastrulation to late-tailbud (stage 40) only low or background 
expression was detected.  Examination of expression on the focussed 
cDNA series revealed peak expression at stage 10.5 with expression 
beginning to decline rapidly from stage 10.75.  The temporal expression 
patterns of axoct4 and axnanog suggested that as in other vertebrates 
they might function together in the establishment and maintenance of 
pluripotency.  Furthermore, the rapid changes in axnanog expression 
during gastrulation suggest that it may play a key functional role during 
these developmental stages.  Notably, peak axnanog expression 
coincides with the timepoint that axolotl animal caps were previously 
shown to be most responsive to mesoderm and endoderm inducing 
signals [Nieuwkoop 1969]. 
 
To investigate the spatial co-expression of axoct4 and axnanog, in situ 
hybridisations were carried out on hemisectioned blastulae and 
gastrulae using a technique adapted from Xenopus for bisecting 
embryos in order to stain the two halves with two different probes [Lee 
et al. 2001; Figure 3.5D and E].  Axoct4 expression was equivalent to 
previously published data of in situ hybridisations on sections 
[Bachvarova et al. 2004].  Maternal expression of axoct4 was detected 
in the animal hemisphere (presumptive ectoderm) at stage 7 
(early-blastula; Figure 3.5Ei).  In blastula and early gastrula stage 
embryos zygotic expression was maintained in the presumptive 
ectoderm (Figure 3.5 Eii-vii).  At the onset of gastrulation (stage 10) 
expression was also detected in the presumptive mesoderm extending 
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 vegetally (Figure 3.5Eiv).  Expression was maintained in the 
presumptive ectoderm and presumptive mesoderm throughout 
gastrulation.  At stage 10.75 (late-gastula) expression in the 
presumptive mesoderm extended dorsally to the edge of the blastopore, 
but expression was not detected in ingressed dorsal mesoderm as 
reported previously [Bachvarova et al. 2004; Figure 3.5Evi].  Axnanog 
expression was very similar to axoct4 (Figure 3.5D), differing only in 
that expression was not detected until stage 8 (mid-blastula; Figure 
3.5Di), much weaker than that of axoct4 and was undetectable at stage 
12 (late-gastrula; Figure 3.5Dvi).  In murine development nanog and 
oct4 expression is downregulated as cells differentiate [Mitsui et al. 
2003].  The spatial co-expression of axoct4 and axnanog in 
undifferentiated tissues (the presumptive ectoderm and mesoderm) 
suggests that they may have conserved roles, functioning together to 
maintain pluripotency/ multipotency, as suggested in mouse [Loh et al. 
2006; Loh et al. 2008].   
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Figure 3.5 Temporal and spatial expression of axnanog and axoct4 
A) Temporal expression of axnanog (top) and axoct4 (bottom) determined by real-time PCR.  Primary data was analysed using the 2-ǻǻCT 
method [Livak and Schmittgen 2001] and was calibrated to expression level at stage 12 (late-gastrula).  The graphs on the left show expression 
from the 2-cell stage to late-tailbud (stage 40).  The graphs on the right show expression through gastrulation (stage 10.5-12) and-early 
neurulation (stage 13-15) at high resolution.  Developmental stages exhibiting background levels of expression are labelled with an asterisk ( *).  
B) Fate-maps for stage 10 (early-gastrulation) and stage 12.5 (late-gastrulation) urodele amphibians (taken from Shook et al., 2002). 
Presumptive ectoderm is highlighted in light blue (epidermis) or dark blue (neural). Presumptive mesoderm is shown as magenta (notochordal), 
red (somatic) or orange (head, lateral and ventral mesoderm). Endodermal fate is indicated as yellowgreen (supra-blastoporal endoderm) or 
lime green (sub-blastoporal endoderm).  The stage 10 fate map shows only the superficial view. In general, the presumptive fates continue 
radially toward the blastocoel, except that the presumptive head mesoderm continues vegetally under the superficial layer of the supra-
blastoporal endoderm. The stage 12.5 fate map shows a sagittal section of an embryo, such that the stippled tissues are at the face of the cut, 
while the surface of the gastrocoel cavity curves into the page.  C) Schematic representation of axolotl embryos in various developmental 
stages as indicated (i vii) to show how embryos in panels D and E were hemisectioned prior to the in situ hybridisations.  D) Spatial expression 
of axnanog as determined by in situ hybridisations on hemisectioned embryos. Weak expression was detected throughout presumptive 
ectoderm at stage 8 (early-blastula; i) and persisted in the presumptive ectoderm at stage 9 (late-blastula; ii) and stage 10 (early gastrula; iii). In 
addition axnanog expression was detected in the presumptive mesoderm extending vegetally at stage 10 (early-gastrula; iii).  This pattern of 
expression persisted in stage 10.5 (iv) and 10.75 embryos (mid-gastrula; v).. Expression was no longer detected at stage 12 (late-gastrula; vi).  
E) Spatial expression of axoct4 as determined by in situ hybridisation on hemisectioned embryos.  Expression was detected in the presumptive 
ectoderm at stage 7 (64 cells; i) as well as stages 8 (ii), 9 and 10 (iii)).  Expression was also evident in the presumptive mesoderm at stage 10 
(early-gastrula; iv) and this pattern of expression persisted in stages 10.5 (v), 10.75 (vi) and 12 (late-gastrula; vii). A = Anterior; P = Posterior; 
V = Ventral; D = Dorsal; black triangles indicate the dorsal lip. 
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 3.6 Ectodermal genes 
 
In order to study the formation of ectodermal tissues in my 
investigations it was first necessary to clone molecular markers of both 
epidermis and neural tissue.  Neural cell adhesion molecule (Ncam) 
was selected as a marker of neural tissue, and cytoskeletal keratin (CK) 
was selected as a marker of epidermis. 
 
3.6.1 Formation of neural and epidermal tissue 
 
Ectoderm gives rise to two main derivatives during embryogenesis; the 
surface ectoderm (or epidermis) and the nervous tissue.  Neural 
induction converts a portion of the dorsal ectoderm into neural ectoderm 
in response to signals from the underlying mesoderm [Bouwmeester 
2001; Spemann and Mangold 2001 translated from original paper 
1923].  The neural ectoderm gives rise to all derivatives of the central 
and peripheral nervous system.  During neurulation the 
neural-ectoderm first forms the neural plate which will then fold and fuse 
to form the neural tube [Moury and Jacobson 1989; Schoenwolf and 
Smith 1990; Jacobson and Moury 1995; Schoenwolf and Smith 2000; 
Colas and Schoenwolf 2001].  The neural tube separates from the 
surface ectoderm and gives rise to the central nervous system.  Neural 
crest cells develop from the crest of the neural tube [Moury and 
Jacobson 1990]; these cells generate all of the cells of the peripheral 
nervous system.  The ectodermal cells surrounding the embryo at the 
end of neurulation form the presumptive epidermis [Colas and 
Schoenwolf 2001]. 
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3.6.2 Neural Cell Adhesion Molecule (Ncam) 
 
Neural Cell Adhesion Molecule (Ncam) is a member of the 
immunoglobulin superfamily [Hemperly et al. 1986; Barthels et al. 
1987].  Amongst the cell adhesion molecules, members of the 
immunoglobulin superfamily are the most diverse in structure, 
expression and function [Brummendorf and Rathjen 1994, 1995].  Ncam 
is characteristic of the immunoglobulin superfamily as multiple isoforms 
are generated by alternative splicing of pre-mRNA; at least 20-30 
distinct forms are generated by alternative splicing and 
post-translational modifications from a single copy gene of human 
Ncam [Goridis and Brunet 1992].  Murine Ncam has three main 
isoforms named Ncam-180, Ncam-140, and Ncam-120 in reference to 
their molecular weight [Barthels et al. 1987].  Ncam-180 and Ncam-140 
differ only in their cytoplasmic domain [Barthels et al. 1988], whereas 
Ncam-120 lacks the transmembrane domain and cytoplasmic domain 
[Barthels et al. 1988; Edelman and Crossin 1991].  Binding of 
Ncam-120 to the cell-surface membrane is mediated via 
glycosylphosphatidylinositol (GPI) [Barthels et al. 1988; Edelman and 
Crossin 1991].  These three isoforms are developmentally regulated 
and differentially expressed [Barthels et al. 1988].  In addition to 
alternative splicing, Ncam structure and function can also be regulated 
by the addition or removal of polysialic acid [Bonfanti 2006]. 
 
Ncam expression in vertebrate embryos is induced in the 
neural-ectoderm during early neurulation and continues in the 
92 
 neuroepithelium, neural plate and neural tube of later embryos [Boucaut 
et al. 1985; Jacobson and Rutishauser 1986; Kintner and Melton 1987; 
Levi et al. 1987; Saint-Jeannet et al. 1989b; Ballycuif et al. 1993; 
Mizuno et al. 2001].  In adult Xenopus and mouse, Ncam expression is 
predominantly detected in neural tissues [Levi et al. 1987; Cremer et al. 
1994]. 
 
3.6.3 Cytoskeletal keratin 
 
Cytoskeletal keratins (CKs) are the largest group of genes from the 
intermediate filament multigene family [Magin et al. 2007].  The CK 
genes are expressed in epithelial cells in spatially and temporally 
specific patterns during development, and are highly abundant in 
epidermal tissue [Miyatani et al. 1986; Jamrich et al. 1987; Watanabe et 
al. 2001; Magin et al. 2007].  Keratins can be subdivided into two 
groups, type I (acidic) and type II (basic) keratins.  Heterodimers of type 
I and II keratins form a dynamic network of 10-12nm filaments in the 
cytoplasm of cells [Magin et al. 2007]. 
 
It is widely accepted that keratins function to provide protection from 
mechanical stresses to cells [Gu and Coulombe 2007].  However, it is 
now known that the function of keratins within cells is much more 
diverse and complex.  Additional roles include cell-size determination, 
translation control, proliferation, organelle transport, and responses to 
stress [Gu and Coulombe 2007; Magin et al. 2007]. 
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 CK molecules in Xenopus laevis are among the earliest tissue specific 
markers to be expressed [Jamrich et al. 1987].  A group of type I 
cytokeratins including XK81 are expressed from the mid-blastula 
transition (stage 9) in the bipotential ectoderm which gives rise to both 
epidermis and neural tissues [Jamrich et al. 1987].  During neurulation 
these CKs become progressively restricted to epidermal tissues and are 
excluded from neural tissues [Jamrich et al. 1987].  CK genes in 
Xenopus laevis are expressed in a stage-specific manner, with different 
keratins expressed in oocytes, embryos and larva [Jonas et al. 1985; 
Winkles et al. 1985; Franz and Franke 1986; Miyatani et al. 1986].  The 
same is not true of murine CKs, murine CKs found in embryonic or 
foetal tissues are also synthesised in several tissues of the adult. 
 
3.6.4 Identification of axncam 
 
A 900 bp fragment of axncam was cloned by degenerate PCR 
(Methods 2.3.4) from stage 25 (early-tailbud) cDNA.  Further 5 and 3 
coding sequence was obtained by semi-degenerate PCR from the 
same cDNA.  BLAST searches confirmed the identity of the sequence 
obtained.  The most robust alignments were obtained with Cynops 
pyrrhogaster ncam (D85084.1).  Cynops pyrrhogaster ncam has two 
splice forms.  The sequence obtained for axncam most closely 
resembled the short Cynops splice form, Ncam-140 (91% sequence 
identity; Figure 3.6). 
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 In the cloning of axncam, a splice form containing a VASE element 
[Small et al. 1987; Santoni et al. 1989; Mizuno et al. 2001] was also 
identified (Figure 3.6). 
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 Cynops Ncam-140 MLQTQELIWTWLLLGTAVCIQVTVVPSQVDVDVGESKFFSCQVTGGEAKDIFWFSPSGEKISANQQEISIVRNDEVSSTLSIYNVDIDDAGIYKCVVTTE 100 
Axncam          MLHTQDLIWTWLLLGTAVCIQVNVVPNQVDVDVGESKFFSCQVTGGEAKDIFWFAPSGEKIDSNQQELSVIRNDEVSSTLSIYNVDIDDAGIYKCVATTE 100  
             I 
Cynops Ncam-140 GEGEMEATVNVQIYQKMVFRNAPSPQEFTEGEDAVVVCDVVSVQTPSVMWKHKGRDVVLKKDVRFVVLANNYLQIRGIKKTDEGMYRCEGRIQARGEIAF 200  
Axncam          GEGEVEATVNVQIYQKMIFKNAPSPQEFTEGEDAVVICDVSSVQTPSIMWKHKNRDVVLKKDVRFVVLTNNYLQIRGIKKTDEGEYRCEGRILARGEIAF 200  
            II 
Cynops Ncam-140 KDIQVVVNVAPSVRARQTTVNATANLGEAAVLACDADGFPDPEISWTKDGEMIEDDSDKYKFTEDGSEMTIFNIDKSDEGDYTCIAENKAGEQEASILLK 300  
Axncam          RDIQVVVNVAPVVRALQSTVNATANLGESAILACAAEGFPDPEISWTKEGEMIEEDSDKYKFTEDGSQMTIFKVDKSDEGDYTCIAENKAGEQEASILLK 300  
                 III 
Cynops Ncam-140 VYAKPKITYVENKTAMELEEQITLTCEASGDPTPSITWRMATRNISSDEKTLDGRIVVSSHARVSSLTLNDIQYTDAGEYLCIGSNTIGQDSQAMYLEVQ 400  
Axncam          VYAKPKITYVENKTAMELEEQITLTCEATGDPTPSITWRMATRNISSEEKTLDGRIVVSSHARVSSLTLNDIQYTDAGEYFCIASNTIGQDSQAMYLEVQ 400  
             Ÿ IV 
Cynops Ncam-140 YAPKLQGPVAVYTWEGNAVNITCEVFAYPSAVVSWFRDGQALPSSNYSNIKIYSTPSASFLEVVPDSENDFGNYNCTAVNRIGQESSEFILVPADTPSSP 500  
Axncam          YAPKLQGPIAVYTWEGNAVNITCEVFAYPSAVISWFRDGQALPSSNYSNIKIYSTPSASFLEVVPDSENDFGNYNCTAINRIGQDSSEFILVQADTPSSP 500  
          V 
Cynops Ncam-140 SILKLEPYSSSAKMEFDEPDATGGVPILKYRAEWKVLGEGEWSSRMYDAKEASIENAITIVGLKPETVYAVRLSAINGKGLGEYSPVSEFKTEPVQGEPS 600  
Axncam          SILKLDPYSSSAKIEFDEPDATGGVPILKYRAEWKAVTDEEWSSRMYDAKEASIENAVTIVGLKPETFYAVRLSAINGKGLGEYSSISKFQTQPVQGEPS 600  
          I 
Cynops Ncam-140 APKLDGQIGEDGKSIRINLIKQDDGGSPIRHYLYTYRAKNALEWSPETRVPSVSNHFTLKSLAWNAEYEVSVIAENLQGKSKPARFTFKTLFEPTAIPAG 700  
Axncam          APKLDGQMGEDGNSIKVNLIKQDDGGSPIRHYLVTYRAKNALEWKPEIKVPSGSNHVMLKALDWNAEYEVFVIAENQQGKSKPASFSFRTLAQPTAIPAG 700  
         II 
Cynops Ncam-140 PSSGSGLGTGAIVGILIIVFVILLVVVDVTCYFLNKCGLLMCIAVNLCGKSGPGAKGKDIEEGKAAFSKDESKEPIVEVRTEEERTPNHDGGNQTEPNET 800  
Axncam          PSHGSGLGTGAIVGILIIVFVILLVVVDVTCYFLNKCGLLMCIAVNLCGKSGPGAKGKDIEEGKAASSKDESKEPIVEVRTEEERTPNHDGGNQTEPNET 800  
 
Cynops Ncam-140 TPLTEPEKAPVEENSKPEDTEAKTTAPEVKTIPNNATQTNENESKA 846 
Axncam          TPLTEPEKAPVEENSKPEDTEAKTTAPEVKTIPNNAPQTNENESKA 846 
 
Figure 3.6 Alignment of axncam with Cynops pyrrhogaster ncam-140   
Shading shows identical residues.  Immunoglobulin (Ig)  like domains are underlined in blue.  Fibronectin III (FN3)  like domains are 
underlined in red.  Ÿ indicates the position of an identified VASE element (ASWTRSEKQK)[Mizuno et al. 2001].  The overall sequence identity is 
91%.
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 3.6.5 Axncam temporal and spatial expression 
 
Axncam temporal expression was analysed by qRT-PCR (Figure 3.7A).  
Expression was first detected at stage 13 (early-neurula) coincident with 
the specification of neural tissue.  Expression continued to increase 
throughout neurulation, reaching peak expression at mid-tailbud (stage 
30).  This level of expression was maintained through late-tailbud 
stages.   
 
Axncam spatial expression was examined on whole-mounts, 
hemisectioned embryos and sections by in situ hybridisation (Figures 
3.7 and 3.8).  In other vertebrates, including Pleurodeles waltl, another 
urodele amphibian, ncam homologues are expressed predominantly in 
neural tissues but expression is also detected in non-neural tissues 
[Boucaut et al. 1985; Jacobson and Rutishauser 1986; Kintner and 
Melton 1987; Levi et al. 1987; Saint-Jeannet et al. 1989a; Ballycuif et al. 
1993; Cremer et al. 1994].  Taking this into account, the careful 
examination of axncam spatial expression was critical in order to ensure 
that it was a suitable marker of neural tissue.  Weak expression was 
first detected in the neural plate of mid-neurula (stage 16) embryos 
(Figure 3.7C).  Notably, expression was not detected in early-neurula 
(stage 14) embryos (Figure 3.7B).  Expression persisted in the neural 
tube of late-neurula (stage 20) embryos (Figure 3.7D) and tail-bud 
(stage 25-38) embryos (Figure 3.8A-D).  Additionally, expression was 
detected in the brain, optic vesicles, otic vesicles, and cranial nerves of 
mid-tailbud (stage 30 and 35) embryos (Figure 3.8B and C).  Close 
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 examination of expression on sections of a late-tailbud (stage 38; 
Figure 3.8D) embryo showed that axncam was expressed throughout 
all regions of the brain, optic vesicles, otic vesicles, and neural tube.  
Examination of the sections provided evidence of restricted neural 
expression.  Thus, this data provides robust evidence that axncam is a 
reliable marker of neural tissue. 
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Figure 3.7 Temporal expression of axncam and spatial expression of 
axncam in neurula embryos 
A) Temporal expression of axncam determined by real-time PCR.  Primary 
data was analysed using the 2-ǻǻCT method [Livak and Schmittgen 2001] and 
was calibrated to expression level at stage 12 (late-gastrula).  The graphs on 
the left show expression from the 2-cell stage to late-tailbud (stage 40).  The 
graphs on the right show expression through gastrulation (stage 10.5-12) and-
early neurulation (stage 13-15) at high resolution.  Developmental stages 
exhibiting background levels of expression are labelled with an asterisk ( *).  
Spatial expression of axncam in neurula embryos as determined by in situ 
hybridisations on hemisectioned embryos (B-D).  Upper panels B-D i) 
Schematic representation of axolotl embryos at stages 14-20, to show how 
embryos in panels ii were hemisectioned prior to the in situ hybridisation.  B) 
Expression was not detected at stage 14 (early-neurula; ii and iii).  The other 
half of the embryo was stained with an axblimp1 probe to show expression in 
the presumptive neural folds (bottom half; iii) C) Expression was detected in 
the neural plate (arrows; NP) at stage 16 (mid-neurula; ii and iii).  D) 
Expression was detected in the neural tube (arrow; NT) at stage 20 
(late-neurula;ii).  A = Anterior; P = Posterior; V = Ventral; D = Dorsal; NF = 
Neural fold; NP = Neural plate; NT = Neural tube; PA = Pharyngeal arches 
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Figure 3.8 Spatial expression of axncam in tailbud stage embryos. 
Upper panels A-D(i) Schematic representation of axolotl embryos to show how 
embryos in panel ii were hemisectioned or sectioned prior to the in situ 
hybridisation.  A) Expression was detected in the neural tube (arrow; NT) at 
stage 25 (early-tailbud; ii).  iii).  Schematic of an axolotl embryo showing the 
neural tube. B) Expression was detected in the neural tube (ii;arrow; NT) and 
in the brain, optic vesicles, otic vesicles and cranial nerves (ii-iii) at stage 30 
(mid-tailbud).  C) Expression was maintained in the neural tube (ii; arrow; NT) 
and the brain, optic vesicles, otic vesicles and cranial nerves (iii) at stage 35.  
D) Expression was maintained throughout the brain, in the procencephalon 
(ii), diancephalon (iii), infindibulum (iii), and the rhombencephalon (iv) at stage 
38 (late-tailbud).  Expression also persisted throughout the optic vesicles (iii, 
OpV), otic vesicles (iv; OV) and the neural tube (v-vi; NT).  NT = Neural tube; 
B = brain; OpV = Optic vesicles; OV = Otic vesicles; Pro = 
Procencephalon; D = Diancephalon; I = Infindibulum; R = 
rhombencephalon. 
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 3.6.6 Identification of axck 
 
Axolotl cytoskeletal keratin (axck) was identified in the Ambystoma 
mexicanum EST database (http://salamander.uky.edu; 
Mex_NM_000223_Contig_11).  Primers were designed to obtain a 
1.2 kb fragment of axck encoding the majority of the ORF.  PCR was 
carried out on cDNA synthesised from stage 30 (mid-tailbud) embryos.  
The fragment obtained was then used to synthesise an ISH probe to 
characterise axck expression through embryonic development. 
 
3.6.7 Temporal and spatial expression of axck 
 
Axck temporal expression was analysed by qRT-PCR (Figure 3.9A).  
Expression was detected from the onset of zygotic transcription (stage 
8).  Expression levels continued to rise until early-tailbud (stage 25) and 
were maintained at this level throughout the tailbud stages. 
 
Spatial expression was examined by in situ hybridisation on 
hemisectioned and sectioned embryos (Figure 3.9B-H).  Expression 
was first detected in the presumptive-epidermis of late-gastrula (stage 
12) embryos (Figure 3.9B).  Expression was maintained in the 
epidermis of neurula (stage 13-20; Figure 3.9C-E) and tailbud (stage 
25 36; Figure3.9F-H) embryos.  Close examination of expression in 
sections of tailbud (stage 30 and stage 36; Figure 3.9G and H) 
embryos showed that expression was restricted to the epidermis.  Thus, 
axck is a robust marker for epidermis.   
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Figure 3.9 Temporal and spatial expression of axck 
A) Temporal expression of axck determined by real-time PCR.  Primary data was analysed using the 2-ǻǻCT method (Ref) and was calibrated to 
expression level at stage 12 (late-gastrula).  The graphs on the left show expression from the 2-cell stage to late-tailbud (stage 40).  The graphs 
on the right show expression through gastrulation (stage 10.5-12) and-early neurulation (stage 13-15) at high resolution.  Developmental stages 
exhibiting background levels of expression are labelled with an asterisk ( *).  B-H upper panels (i) Schematic representation of axolotl embryos 
to show how embryos in panel ii were hemisectioned or sectioned prior to the in situ hybridisation.  B) Expression was detected throughout the 
presumptive epidermis at stage 12 (late-gastrula; ii and iii).  Expression was maintained throughout the epidermis at stage 13 (early-neurula; Cii 
and iii), stage 16 (mid-neurula; Dii and iii), stage 20 (late-neurula; Eii and iii), stage 25 (early tailbud; Fii and iii), stage 30 (Mid-tailbud; Gii and iii) 
and stage 36 (Hii and iii). 
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 3.7 Putative PGC gene 
 
3.7.1 Blimp1 
 
Blimp1 plays a critical role in PGC development in mouse and there is 
also some indication that Blimp1 may be expressed in chicken PGCs 
[Vincent et al. 2005; Motono et al. 2008].  Based on the similarities 
between axolotl and mouse PGC specification it was considered that a 
homologous molecule might have a role in axolotl PGC development 
(Chapter 5). 
 
3.7.2 Previously identified roles for Blimp1 
 
Blimp1 (Prdm1) was first identified in mouse for its role in B-cell 
differentiation [Shapiro-Shelef et al. 2003; Kallies et al. 2004; Shaffer et 
al. 2004; Kallies et al. 2006; Kallies and Nutt 2007].  It acts as a master 
regulator of B-cell differentiation, restricting cells to a plasma cell fate 
and eliminating partially activated B cells [Kallies et al. 2006; Kallies and 
Nutt 2007].  Blimp1 (PRDMI-BF1) was discovered in humans as a 
silencer of ȕ-interferon gene expression, but it also has a role in B-cell 
differentiation [Keller and Maniatis 1991; Turner et al. 1994]. 
 
Homologues of Blimp1 have been identified in organisms from 
C. elegans to human [Tunyaplin et al. 2000].  Vertebrate blimp1 
homologues are expressed in a wide range of tissues throughout 
embryonic development and expression in many regions is conserved 
[de Souza et al. 1999; Chang et al. 2002; Wilm and Solnica-Krezel 
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 2005].  A general paradigm is that Blimp1 is expressed in tissues as 
they begin to differentiate and is down-regulated once the tissue is fully 
formed [de Souza et al. 1999; Chang et al. 2002; Ha and Riddle 2003; 
Baxendale et al. 2004; Roy and Ng 2004; Wilm and Solnica-Krezel 
2005].  For example, zebrafish neural crest cells, a population of 
multipotent cells that can develop into a variety of neural cell types, 
activate Blimp1 expression as they differentiate towards a sensory 
neuron fate [Roy and Ng 2004].  Blimp1 is thought to regulate terminal 
differentiation through the recruitment of epigenetic modifiers, for 
example Groucho proteins [Ren et al. 1999], which then silence target 
genes. 
 
A major role for Blimp1 in zebrafish and Xenopus was identified in the 
formation of anterior endomesoderm [de Souza et al. 1999; Wilm and 
Solnica-Krezel 2005].  Experiments to disrupt Blimp1 function in 
zebrafish and Xenopus, through the use of morpholinos and dominant 
negative constructs respectively, result in the loss of anterior 
endomesodermal structures and conversely overexpression of Blimp1 
in both organisms also disrupts the antero-posterior axis [de Souza et 
al. 1999; Wilm and Solnica-Krezel 2005].  Contrastingly, a homozygous 
blimp1 knockout in mouse (Blimp1-/-) does not affect early axis 
formation or anterior patterning [Vincent et al. 2005].  In Blimp1-/- mouse 
embryos morphogenesis of the caudal branchial arches is disrupted, 
and the labrinythe layer of the placenta fails to form correctly.  There is 
also widespread tissue apoptosis and PGCs are entirely absent 
107 
 [Vincent et al. 2005].  It is possible that the antero-posterior axis is 
unaffected in the Blimp1 mouse knockout because of functionally 
redundant PR (positive regulatory) domain-containing proteins as more 
than 15 PR domain-containing proteins have been identified in mouse 
[Hoyt et al. 1997]. 
 
Robertson et al (2007) used a conditional knockout of Blimp1 in the 
mouse epiblast to avoid the embryonic lethality caused by the placental 
defects [Vincent et al. 2005; Robertson et al. 2007].  As a result defects 
were observed in the forelimb, heart, pharyngeal arches and sensory 
vibrissae, and PGCs were again absent.  Interestingly, another 
non-embryonic lethal Blimp1 mutant producing a C-terminal truncated 
Blimp1 had a similar profile of defects, but the sensory vibrissae were 
unaffected [Robertson et al. 2007].  
 
Given the differing severity of defects in Blimp1 mouse knockouts, it 
was considered that Blimp1 may be acting in a dose-dependent manner 
[Robertson et al. 2007]. The Blimp1 mutant expressing C-terminal 
truncated Blimp1 was shown to have leaky expression of the full-length 
molecule which could explain the less severe phenotype when 
compared to the conditional knockout [Robertson et al. 2007].  Thus, 
PGCs require the highest level of Blimp1 expression, demonstrated by 
the loss of PGCs in all of the Blimp1 knockouts [Vincent et al. 2005; 
Robertson et al. 2007], and extra-embryonic tissues require the lowest 
levels, demonstrated by their loss only in the full Blimp1 knockout 
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 [Vincent et al. 2005; Robertson et al. 2007].  Vincent et al. (2005) also 
observed a dose-dependent requirement for Blimp1 in PGCs.  It was 
observed that PGCs were reduced in heterozygotes, and completely 
absent in homozygotes [Vincent et al. 2005].   
 
The identification and characterisation of an axolotl blimp1 homologue, 
axblimp1 is described below.  The function of Axblimp1 in PGC 
development is explored in Chapter 5. 
 
3.7.3 Identification of axblimp1 
 
A 1.4kb fragment of axblimp1 was cloned by degenerate PCR 
(Methods 2.3.4) from stage 9 (late-blastula) embryos.  A further 400 bp 
of 5 coding sequence was obtained from stage 40 (late-tailbud) 
embryos by semi-degenerate PCR.  BLAST searches were used to 
confirm the identity of the 1.8 kb sequence obtained.  The most robust 
alignments obtained were with human, mouse and Xenopus laevis.  
Across the entire sequence the artificially translated Axblimp1 fragment 
showed 74% sequence identity to the human sequence (Figure 3.10). 
 
Blimp1 has several important functional domains.  The largest 
functional domain is the PR domain.  The function of the PR domain in 
Blimp1 is not known, however, PR domains are closely related to SET 
domains in sequence, which are found in protein lysine methyl 
transferases and are thought to be involved in protein-protein 
interactions [Huang et al. 1998; Huang 2002; Gyory et al. 2004].  The 
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 ZnF region in human Blimp1, containing five zinc-fingers (ZnF), is 
thought to be multifunctional [Gyory et al. 2004].  Deletion of the first 
two ZnFs does not prevent DNA binding, but inhibits localisation to the 
nucleus and deletion of all five entirely prevents nuclear localisation 
[Gyory et al. 2004].  There are two acidic domains, one in the 
N-terminal region and one in the C-terminal region.  In addition, two 
proline-rich domains are found in the N-terminal.  Deletion of these 
domains results in loss of histone deacetylase (HDAC) activity which is 
thought to be due to a loss in the ability to recruit co-repressors [Ren et 
al. 1999; Yu et al. 2000; Gyory et al. 2004].  The sequence identity of 
the functional domains of Axblimp1 that were cloned in full was 
calculated in comparison to the human sequence (Figure 3.10). All 
functional domains were found to share a high degree of homology; the 
PR domain shows 81% identity, the first proline-rich region shows 79% 
identity, the second proline-rich region shows 69% identity, the first ZnF 
shows 90% identity and the second ZnF shows 100% identity.  (Blimp1 
contains five ZnFs, only the first two ZnFs of Axblimp1 were cloned in 
full.)  Thus, the Axblimp1 sequence is highly conserved, with particularly 
high conservation of the first two ZnFs providing robust evidence for the 
identification of a Blimp1 homologue. 
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 BLIMP1    MKMDMEDADMTLWTEAEFEEKCTYIVNDHPWDSGADGGTSVQAEASLPRNLLFKYATNSEEVIGVMSKEYIPKGTRFGPLIGEIYTNDTVPKNANRKYFW 100  
Axblimp1  MKMDMEDADMTQWTEAGFEEKCTYIVNDHARDPLADAGSASQAEASLPRNLTFKYSDNYKEVIGVVSKEYIPKGTRFGPLVGETYTPDTVPKDANRKYFW 100  
        I 
BLIMP1    RIYSRGELHHFIDGFNEEKSNWMRYVNPAHSPREQNLAACQNGMNIYFYTIKPIPANQELLVWYCRDFAERLHYPYPGELTMMNLTQTQSSLKQPSTEKN 200  
Axblimp1  RIYSGADFDHFIDGFNEDKSNWMRYVNPAHSVQEQSLAACQNGMDIYFYTIKPIPANQELLVWYCRDFADRLNYPSSGELTMVTPKQTSINPKQQHTEKE 200  
                Ÿ 
BLIMP1    ELCPKNVPKREYSVKEILKLDSNPSKGKDLYRSNISPLTSEKDLDDFRRRGSPEMPFYPRVVYPIRAPLPEDFLKASLAYGIERPTYITRSPIPSSTTPS 300  
Axblimp1  VLHHKSAPKKEHSMKEILKTSVSQSKGKDFYLNRISPITPEKDLGDLRKNCSPERPFFPRVVYPIRPHIPEDYLKVSLAYGMDRPNYLSHSPMPSSTTPS 300  
 
BLIMP1    PSARSSPDQSLKSSSPHSSPGNTVSPVGPGSQEHRDSYAYLNASYGTEGLGSYPGYAPLP-HLPPAFIPSYNAHYPKFLLPPYGMNCNGLSAVSSMNGIN 399  
Axblimp1  PSARSSPDQSYKSSSPQSSPGATVSPLMTSLQEQRESYPYLNGPCSTEGLGSYPGYAPHNSHLSSAFLSSYNHHYQKFLLPPFNMGCPSLSTLNNINSLN 400  
       I         II 
BLIMP1    NFGLFPRLCPVYSNLLGGGSLPHPMLNPTSLPSSLPSDGARRLLQPEHPREVLVPAPHSAFSFTGAAASMKDKACSPTSGSPTAGTAATAEHVVQPKATS 499  
Axblimp1  NFSLFPKMYPLCNNLLSGGSLSHHMLNQVALPSSLPHESGRRMLHPEQPRDFLIPAPNSAFSITGAAASMKDKPSTPTSGSPTAATAAASEHLMHPKATS 500  
 
BLIMP1    AAMAAPSSDEAMNLIKNKRNMTGYKTLPYPLKKQNGKIKYECNVCAKTFGQLSNLKVHLRVHSGERPFKCQTCNKGFTQLAHLQKHYLVHTGEKPHECQV 599  
Axblimp1  AALAA-SNEEAMNLIKNKRNMTGYKTLPYPLKKQNGKIKYECNICSKTFGQLSNLKVHLRVHSGERPFKCQTCNKGFTQLAHLQKHYLVHTGEKPHECQV 599  
                I   Ÿ            II 
BLIMP1    CHKRFSSTSNLKTHLRLHSGEKPYQCKVCPAKFTQFVHLKLHKRLHTRERPHKCSQCHKNYIHLCSLKVHLKGNCAAAPAPGLPLEDLTRINEEIEKFDI 699  
Axblimp1  CHK------------------------------------------------------------------------------------------------- 602  
            III       IV          V 
BLIMP1    SDNADRLEDVEDDISVISVVEKEILAVVRKEKEETGLKVSLQRNMGNGLLSSGCSLYESSDLPLMKLPPSNPLPLVPVKVKQETVEPMDP 789  
Axblimp1  ------------------------------------------------------------------------------------------ 602  
            II 
 
 
Figure 3.10  Alignment of Human Blimp1 (PRDM1) and Axblimp1 amino acid sequence. 
Human Blimp1(NP_001189 ) (top).  Axblimp1 (bottom).  Shading shows identical residues.  Acidic domains are underlined in green; the PR 
domain is underlined in purple; proline rich regions are underlined in red; and ZnFs are underlined in blue.  The overall identity between the two 
sequences is 74%.  The functional domains show a high level of sequence identity; PR domain 81% identity, first proline rich region 79% 
identity, second proline rich region 69% identity, first ZnF 90% identity and the second ZnF 100% identity. Ÿ indicates the position of exon-exon 
boundaries in Axblimp1. 
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 3.7.4 Temporal and spatial expression of axblimp1 
 
Axblimp1 temporal expression was analysed by qRT-PCR (Figure 
3.11B).  The expression of axvasa and axdazl, two known markers of 
axolotl PGCs, was also examined on the same cDNA series for 
comparison (Figure 3.11A).  The expression of axdazl and axvasa was 
previously determined by RT-PCR [Johnson et al. 2001; Bachvarova et 
al. 2004].  Axdazl and axvasa exhibited very similar patterns of 
expression.  They were expressed maternally (stage 2) at a high level.  
This level of expression was maintained after the onset of zygotic 
transcription (stage 8) and throughout the early stages of gastrulation 
(stage 9-10.5).  Expression decreased towards the end of gastrulation 
(stage 12) and the reduced level of expression was then maintained to 
late-tailbud (stage 40).  Contrastingly, axblimp1 expression was 
relatively constant throughout development, from stage 2 right through 
to stage 40.  This suggests that Axblimp1 may not function in the same 
pathways as Axdazl and Axvasa during PGC development, but it does 
not rule out a role for Axblimp1 in PGC development.  The relatively 
constant level of expression may reflect a core role for Axblimp1 in the 
regulation of multiple developmental pathways, as has been suggested 
for other Blimp1 homologues [Vincent et al. 2005].  The maternal 
expression of axblimp1 may reflect a novel function as it is much earlier 
than any expression that has been detected in other vertebrates; 
Xenopus blimp1 is first expressed at the mid-blastula transition (stage 
8.5) [de Souza et al. 1999] whereas in zebrafish and mouse expression 
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 begins at early-gastrula [Chang et al. 2002; Wilm and Solnica-Krezel 
2005]. 
 
 
 
 
Figure 3.11 Temporal expression of axdazl, axvasa and axblimp1. 
Temporal expression determined by real-time PCR.  Primary data was 
analysed using the 2-ǻǻCT method [Livak and Schmittgen 2001] and was 
calibrated to expression level at stage 12 (late-gastrula).  The graphs on the 
left show expression from the 2-cell stage to late-tailbud (stage 40).  The 
graphs on the right show expression through gastrulation (stage 10.5-12) and-
early neurulation (stage 13-15) at high resolution.  A) Temporal expression of 
PGC genes Axdazl and axvasa.  B) Temporal expression of Axblimp1. 
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 A thorough examination of Axblimp1 spatial expression was carried out 
by in situ hybridisation on whole-mounts, hemisectioned embryos and 
sections in order to determine if axblimp1 is expressed in PGCs (Figure 
3.12 and 3.13).  Expression was first detected in the presumptive 
neural folds and prechordal plate at stage 12 (late-gastrula; Figure 
3.12A).  The prechordal plate is also one of the earliest blimp1 
expressing tissues in Xenopus, mouse and Zebrafish [de Souza et al. 
1999; Chang et al. 2002; Wilm and Solnica-Krezel 2005].  However, the 
expression of vertebrate blimp1 homologues has not previously been 
identified in the presumptive neural folds [de Souza et al. 1999; Chang 
et al. 2002; Wilm and Solnica-Krezel 2005].  Given the expression of 
axblimp1 in the prechordal plate it is possible that, as in Xenopus [de 
Souza et al. 1999] and Zebrafish, [Wilm and Solnica-Krezel 2005] 
axblimp1 may have a major role in the formation of anterior 
endomesodermal structures. 
 
Consistent with the expression pattern of other vertebrate blimp1 
homologues studied [de Souza et al. 1999; Chang et al. 2002; Wilm and 
Solnica-Krezel 2005], expression was subsequently detected in a wide 
array of tissues throughout neurula (Figure 3.12B-E) and tailbud stages 
(Figure 3.13).  Expression was detected in the pharyngeal arches, 
somites, tail, otic vesicles, optic vesicles, hypophysis, gut and a stripe 
bisecting the neural folds which have all been identified as Blimp1 
expressing region in at least one other vertebrate model organism [de 
Souza et al. 1999; Chang et al. 2002; Wilm and Solnica-Krezel 2005].  
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 The widespread expression of axblimp1 suggests that, as in other 
vertebrates, axblimp1 may have a role during the terminal differentiation 
of multiple tissue types [de Souza et al. 1999; Chang et al. 2002; Ha 
and Riddle 2003; Baxendale et al. 2004; Roy and Ng 2004; Wilm and 
Solnica-Krezel 2005].  The progressive expression of axblimp1 in 
somites, coinciding with somite formation from anterior to posterior, is in 
agreement with a role in terminal differentiation.  Notably, expression 
was not detected in PGCs. 
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Figure 3.12 Axblimp1 expression in late-gastrula and neurula stage embryos 
A) Expression of axblimp1 as determined by in situ hybridisation on whole-mount stage 12 embryos.  i) Fate-map for stage 12.5 (late-gasrula) 
(taken from Shook 2002).  Saggital section, stippled tissues are at the surface of the cut, while the surface of the gastrocoel curves into the 
page.  Presumptive ectoderm is highlighted in light blue (epidermis) and dark blue (neural).  Presumptive mesoderm is shown as magenta 
(notochordal), red (somatic) or orange (head, lateral and ventral mesoderm). Endodermal fate is indicated as yellowgreen (supra-blastoporal 
endoderm) or lime green (sub-blastoporal endoderm).  Expression was detected in the presumptive neural folds (NF; arrows) and the 
prechordal plate (PCP; arrow) at stage 12 (late-gastrula; ii-iv).  B- E upper panels (i) Schematic representation of axolotl embryos to show how 
embryos in panels ii and iii were hemisectioned prior to the in situ hybridisation.  B) Expression was maintained in the neural folds (NF; arrow) 
and prechordal plate (PCP; arrow) and was also detected in a block of paraxial mesoderm (P mes; arrow) at stage 14 (early-neurula; ii-iii).  C) 
Expression was detected in the pharyngeal arches (PA; arrow, ii) and the somites (S; arrow; iii) at stage 15 (mid-neurula).  D) Expression was 
maintained in the pharyngeal arches (ii) and somites (i and ii) at stage 17 (mid-neurula).  E) Expression persisted in the pharyngeal arches and 
somites, and was additionally detected in a stripe bisecting the neural folds (ii and iii) at stage 20 (late-neurula).  A = Anterior; P = Posterior; 
D= Dorsal; V = Ventral; NP = Neural plate; NF = Neural fold; PCP = Prechordal plate; P mes = Paraxial mesoderm; YP = Yolk plug; PA = 
Pharyngeal arches; S = Somite; NF = Neural fold; NT = Neural tube 
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Figure 3.13 Expression of axblimp1 in tailbud embryos 
A) Whole-mount in situ hybridisations for axblimp1 in tailbud stage embryos.  Expression was detected in the pharyngeal arches (PA; arrow), 
otic vesicles (OV; arrow), somites (S; arrow), hypophysis (H; arrow) and tip of the tail (T; arrow) at stage 25 (early-tailbud; i and ii).  Expression 
persisted in the otic vesicles, pharyngeal arches and tailfin (TF; arrow) at stage 30 (mid-tailbud; iii) and 35 (mid-tailbud, iv) and was additionally 
detected in the optic vesicles.  These regions of expression were maintained at stage 38 (late-tailbud;v), although only the posterior somites 
maintained expression.  vi-x) Schematic representation of axolotl embryos in the developmental stages indicated to show how embryos in 
panels B-F were sectioned prior to in situ hybridisation.  B) Expression in the pharyngeal arches and gills.  Expression was concentrated in the 
mesoderm and neural crest (the central core) of the pharyngeal arches at stage 30 (mid-tailbud; i).  Expression was strongest in the 
mesodermal layer of the gills at stage 38 (late-tailbud; ii). C) Expression was localised to the dermamyotome portion of the somite at stage 30 
(mid-tailbud).  D) Expression in the optic vesicles and facial glands.  Expression was detected throughout the optic vesicle at stage 35 (i), but 
became more restricted to the cilliary marginal zone (CMZ) at stage 43 (late-tailbud; ii) and was only detected in the lens (L) at larval stages (iii).  
Expression was also detected in the facial glands (Gl) at stage 43.  E) Expression was also detected in the gall bladder (Gb, i) and the lining of 
the large intestine (ii) at larval stages.  F) Expression was restricted to the mesodermal layer of the tail at stage 25 (i) and the tip of the tail at 
stage 38 (ii).  PA = Pharangeal arches; OV = Otic vesicle; S = Somite(s); H = Hypophysis; OpV = Optic vesicle; G = Gills; TF = Tailfin; 
T= tail. 
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 3.8 Epigenetic markers  
 
3.8.1 Carm1 
 
Carm1 (Coactivator-associated-protein-arginine-methyltransferase 1) is 
a coactivator of transcription [Chen et al. 2002; Lee et al. 2005].  It is 
recruited to transcriptional promoters which results in methylation of 
both histone H3 at arginine 17 and histone acetyltransferases 
p300/CBP, resulting in the activation of targets [Chen et al. 2002; Lee et 
al. 2005]. Investigations in mouse have shown that overexpression of 
histone methyltransferase, Carm1, in specific blastomeres of four-cell 
stage embryos results in increased expression of nanog and sox2 and 
those blastomeres contribute more frequently to the ICM [Torres-Padilla 
et al. 2007].  Axcarm1 was, therefore, cloned in order to investigate if it 
has a role in axolotl pluripotency.  Expression of Axcarm1 in Axnanog 
morphant embryos is examined in Chapter 4. 
 
3.8.2 Identification of an axolotl carm1 homologue (axcarm1) 
 
Degenerate PCR (described in methods 2.3.4) was carried out on 
cDNA synthesised from stage 9 embryos to clone a fragment of 
axcarm1.  A further 200 bp of axcarm1 3 coding sequence was 
obtained by performing semi-degenerate PCR on cDNA synthesised 
from stage 35 embryos.  Basic Local Alignment Search Tool (BLAST) 
searches were carried out to confirm the identity of the sequence and 
the most robust alignments were obtained with human, mouse, and rat 
homologues of carm1.  The artificially translated axcarm1 fragment 
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 shares 92% sequence identity with the human Carm1 homologue 
(Figure 3.14). 
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 CARM1   MAAAAAAVGPGAGGAGSAVPGGAGPCATVSVFPGARLLTIGDANGEIQRHAEQQALRLEVRAGPDSAGIALYSHEDVCVFKCSVSRETECSRVGKQSFII 100  
Axcarm1 -------------------------------------SIIGDANGEIXRHAEQQALRLEVRGTPEAALIALYSHEDVCVFKCSVSRETECSRVGKQSFIV 63   
     ź 
CARM1   TLGCNSVLIQFATPNDFCSFYNILKTCRGHTLERSVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHTDFKDKIVLDVGCGSGILSF 200  
Axcarm1 TLGCNSVLIQFATPNDFCSFYNILKNCRGHNSERSVFSERTEESSAVQYFQFYGYLSQQQNMMQDYVRTGTYQRAILQNHADFKDKVVLDVGCGSGILSF 163  
 
CARM1   FAAQAGARKIYAVEASTMAQHAEVLVKSNNLTDRIVVIPGKVEEVSLPEQVDIIISEPMGYMLFNERMLESYLHAKKYLKPSGNMFPTIGDVHLAPFTDE 300  
Axcarm1 FAAQAGARKVYAVEASTMAQHAELLVKSNNLTDRILVIPGKVEEISLPEQVDIIISEPMGYMLFNERMLESYLHAKKFLRPNGNMFPTIGDVHLAPFTDE 263  
 
CARM1   QLYMEQFTKANFWYQPSFHGVDLSALRGAAVDEYFRQPVVDTFDIRILMAKSVKYTVNFLEAKEGDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIM 400  
Axcarm1 QLYMEQFTKANFWYQPSFHGVDLSVLRGAAVDEYFKQPVVDTFDIRILMAKSVKYTVNFLDAKECDLHRIEIPFKFHMLHSGLVHGLAFWFDVAFIGSIM 363  
 
CARM1   TVWLSTAPTEPLTHWYQVRCLFQSPLFAKAGDTLSGTCLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFRYTGTTPSPPPGSHYTSPSENMWNTG 500  
Axcarm1 TVWLSTAPTEPLTHWYQVRCLLQSPLFTKAGDTLSGTVLLIANKRQSYDISIVAQVDQTGSKSSNLLDLKNPFFR------------------------- 438  
 
CARM1   STYNLSSGMAVAGMPTAYDLSSVIASGSSVGHNNLIPLGSSGAQGSGGGSTSAHYAVNSQFTMGGPAISMASPMSIPTNTMHYGS 585  
Axcarm1 -------------MPTAYDLSGVMGGGSTIGHNNLIPLGSAGGQG--GGNSSTHYPVNSQFTMGGPAISMASPMSITTNTMHYGS 508  
 
Figure 3.14 An alignment of the artificially translated Axcarm1 sequence with Homo sapiens Carm1. 
Homo sapiens Carm1 (NP_954592) is shown at the top and the artificially translated Axcarm1 sequence is shown underneath.  Shading 
indicates conserved amino acids.  The region underlined in green is the methyltransferase domain.  The artificially translated Axcarm1 fragment 
shares 92% sequence identity with the human Carm1 homologue.  Known intron junctions in the Axcarm1 sequence are indicated by ź.  
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 3.8.3 Temporal and spatial expression of axcarm1 
 
Temporal expression of axcarm1 was determined by RT-PCR (Figure 
3.15A).  Expression was detected at a relatively constant level 
throughout all stages examined.  This might be expected as axcarm1 is 
an epigenetic regulator and these molecules often have multiple roles 
throughout development and are regulated via localisation rather than 
transcription [e.g. NODE Liang et al. 2008]. 
 
Spatial expression was examined by in situ hybridisation on 
hemisectioned embryos (Figure 3.15D).  Interestingly, the expression 
pattern observed was strikingly similar to that reported for axnanog and 
axoct4 (Section 3.5.2).  In blastula stage embryos expression was 
detected in the presumptive ectoderm (Figure 3.15Di-ii).  This 
expression persisted in gastrulae stage embryos and expression was 
additionally detected in the presumptive mesoderm, extending vegetally 
towards the blastopore (Figure 3.15Diii-iv).  Notably, expression 
appeared to become ventrally restricted towards the end of gastrulation 
(stage 12; Figure 3.15Dvi).  This data provides compelling evidence to 
suggest as in mouse, axcarm1 may have a role in the establishment or 
maintenance of pluripotency and it is possible, given the similarity 
between the expression patterns, that axcarm1 regulates axnanog and 
axoct4 expression as in mouse [Torres-Padilla et al. 2007]. 
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Figure 3.15 Temporal and spatial expression of axcarm1 
A) Temporal expression of axcarm1 determined by real-time PCR.  Primary data was analysed using the 2-ǻǻCT method [Livak and Schmittgen 
2001] and was calibrated to expression level at stage 12 (late-gastrula).  The graphs on the left show expression from the 2-cell stage to late-
tailbud (stage 40).  The graphs on the right show expression through gastrulation (stage 10.5-12) and-early neurulation (stage 13-15) at high 
resolution.  B) Fate-maps for stage 10 (early-gastrulation) and stage 12.5 (late-gastrulation) urodele amphibians (taken from Shook et al., 
2002). Presumptive ectoderm is highlighted in light blue (epidermis) or dark blue (neural). Presumptive mesoderm is shown as magenta 
(notochordal), red (somatic) or orange (head, lateral and ventral mesoderm). Endodermal fate is indicated as yellowgreen (supra-blastoporal 
endoderm) or lime green (sub-blastoporal endoderm).  The stage 10 fate map shows only the superficial view. In general, the presumptive fates 
continue radially toward the blastocoel, except that the presumptive head mesoderm continues vegetally under the superficial layer of the 
supra-blastoporal endoderm. The stage 12.5 fate map shows a sagittal section of an embryo, such that the stippled tissues are at the face of 
the cut, while the surface of the gastrocoel cavity curves into the page.  C) Schematic representation of axolotl embryos in various 
developmental stages as indicated (i vi) to show how embryos in panels D were hemisectioned prior to the in situ hybridisations.  D) 
Expression was detected in the animal hemisphere (presumptive ectoderm) at stage 7 (early-blastula; i) and persisted in the presumptive 
ectoderm at stage 8 (mid-blastula;ii) and stage 10 (early-gastrula; iii).  In addition expression was detected in the presumptive mesoderm, 
extending vegetally towards the blastopore at stage 10 (iii).  This pattern of expression persisted at stage 10.5 (mid-gastrula; iv) and stage 
10.75 (late-gastrula; v).  At stage 12 (late-gastrula; vi), the expression appeared to become more ventrally restricted in the presumptive 
ectoderm and mesoderm. 
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 3.9 Discussion 
 
Axolotls are convenient model organisms for studying embryology given 
their large, externally developing embryos.  Additionally, gene copy 
number (predicted) and similarities between the developmental 
mechanisms in axolotl and amniotes make them ideal for studying the 
evolution of developmental processes.  Unfortunately, genomic 
sequence is unavailable; therefore, this chapter has described the 
cloning and characterisation of multiple genes for use in the 
investigations reported in Chapters 4 and 5. 
 
Interestingly, Section 3.5 described the cloning and characterisation of 
the first anamniote homologue of nanog, axnanog.  In situ 
hybridisations revealed that axnanog is co-expressed with axoct4 
during early development in undifferentiated tissues of the embryo.  
Thus, Axnanog and Axoct4 may prove to have conserved roles in the 
maintenance of multipotency/pluripotency.  The roles of Axnanog and 
Axoct4 in pluripotency are explored further in Chapter 4 and their roles 
in PGC development are explored in Chapter 5.  Furthermore, it was 
shown that axcarm1 was also expressed in equivalent regions to axoct4 
and axnanog during early development, suggesting that it may also 
have a conserved role in establishing and/or maintaining pluripotency.  
The expression of axcarm1 in Axnanog morphant embryos is described 
in Chapter 4.  The role of Axcarm1 in relation to pluripotency was not 
explored directly.  The identification of these molecules could be key to 
126 
 understanding the evolution of the mechanisms governing pluripotency 
in amniotes. 
 
Very little is known about the specification of PGCs in axolotl.  Given 
that there are a number of similarities between axolotl and mouse PGC 
development, it was considered that homologous molecules might be 
involved (Chapter 3).  Thus, a homologue of Blimp1, axblimp1, was 
cloned.  The temporal expression pattern of axblimp1 differed from that 
of other PGC-specific genes, axdazl and axvasa, suggesting that it 
does not operate in the same pathways, but this does not rule out a role 
in PGC development.  Initial analyses of expression by in situ 
hybridisation revealed a conserved pattern of expression, but 
expression was not detected in PGCs.  However, this may be 
attributable to assay sensitivity.  For most of the gene expression 
analyses described in this chapter, including those carried out by 
Swiers (2008), expression was detected by real-time PCR at stages 
when expression was not detected by in situ hybridisation, highlighting 
a lack of sensitivity in the in situ hybridisation assay.  Future work 
should include method development aiming to increase the sensitivity of 
in situ hybridisation.  The role of Axblimp1 in PGC development is 
explored further in Chapter 5. 
 
Robust markers of neural tissue, axncam, and epidermal tissue, axck, 
were also cloned.  These markers were used to determine the effect of 
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 Axnanog depletion on the development of ectodermally derived tissues 
(Chapter 4). 
 
It is important to consider that the selection of model organisms for their 
convenience, the size of embryos, availability, speed of development 
etc. may bias our understanding of development.  This chapter has 
highlighted the importance of studying developmental processes in the 
axolotl model system for furthering our understanding of the evolution of 
developmental mechanisms in amniotes.  However, only the study of 
these processes in a vast array of organisms is likely to reveal the full 
picture.  It has been argued that different model organisms should be 
used, as unique adaptations are as important as conserved features 
[Jenner 2006; Jenner and Wills 2007].  The discussion of PGC 
development in Chapter 5 highlights this issue, and describes how the 
inclusion of a wider variety of organisms changed the prominent view of 
PGC development. 
 
3.9.1 Summary 
 
1. Developmental processes in urodeles are similar to those in 
amniotes and it is, therefore, thought that amniotes might have evolved 
from a urodele-like ancestor.  Thus, studying the processes of 
development in axolotl could be key to understanding the evolution of 
developmental mechanisms in amniotes. 
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 2. The first anamniote homologue of nanog, axnanog, was identified 
and temporal and spatial expression patterns suggest it may have a 
conserved role in the establishment and/or maintenance of pluripotency 
perhaps in conjunction with Axoct4 (given the regions of co-expression).  
Chapter 4 explores this further.  The roles of Axoct4 and Axnanog in 
PGC development are explored, in Chapter 5. 
 
3. A homologue of blimp1, axblimp1, was identified in order to 
investigate its role in PGC development but initial analyses did not 
detect expression in the PGCs.  However, this may be due to the 
sensitivity of the assay.  The role of Axblimp1 in PGC development is 
explored further in Chapter 5.  
 
4. Axncam and axck were cloned as markers of neural and epidermis 
respectively.  Expression analyses revealed them to be robust markers 
of these tissues. 
 
5. A homologue of carm1, axcarm1, was cloned and its expression in 
early embryos suggests that it may have a conserved role in the 
establishment/ maintenance of pluripotency.  Expression in Axnanog 
morphant embryos is described in Chapter 4. 
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 Chapter 4. Investigating the function of 
axnanog and axoct4 using antisense 
morpholino oligonucleotides 
 
4.1 Introduction  
 
Axnanog is the first nanog homologue to be identified in an anamniote.  
This chapter describes the use of translation and splice-blocking 
morpholinos to investigate Axnanog function.  Preliminary knock-down 
data is also presented for Axoct4. 
4.2 Confirmation of the activity of axnanog 
translation-blocking and splice-blocking morpholinos 
 
Morpholinos were designed for the investigation of Axnanog function.  
Morphlinos are 25 bp antisense oligonucleotide molecules with a 
modified backbone that is resistant to nuclease activity and they are 
therefore stable in cells [Gene-Tools 2008].  Two types of morpholino 
can be used to disrupt protein expression.  Translation-blocking 
morpholinos (ATG-morpholinos) bind to the AUG start site or the 5UTR 
and block translation of the target transcript in the cytosol by blocking 
ribosome binding.  Splice-blocking morpholinos (splice-morpholinos) 
bind to splice junctions of target pre-mRNAs in the nucleus and prevent 
the production of a mature mRNA by disrupting splicing through 
blocking the binding of splicing machinery.  Both an ATG-morpholino 
and a splice-morpholino were designed to target Axnanog.   
 
ATG-morpholinos have the advantage of targeting both maternal and 
zygotic transcripts, which was a valuable property in this study as 
axnanog is maternally expressed.  The specificity and activity of the 
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 axnanog ATG-morpholino was initially determined by in vivo tests in 
Xenopus tropicalis oocytes (Figure 4.1A).  Oocytes were first injected 
with 80 ng of the ATG-morpholino or a mismatch control morpholino 
containing five base mismatches (sequences given in Section 2.4.5).  
The oocytes were cultured overnight and then injected with 500 pg of 
artificially transcribed full-length hemagluttanin (HA)-tagged axnanog 
mRNA or HA-tagged axnanog mRNA lacking the 5UTR.  After a further 
overnight incubation protein was extracted from the oocytes and was 
analysed on a western blot (Figure 4.1A).  The axnanog 
ATG-morpholino caused a complete block to the translation of 
HA-tagged axnanog mRNA, whereas no blocking occurred in the 
absence of the 5UTR, to which the morpholino was targeted entirely.  
The mismatch control morpholino did not affect the translation of 
HA-tagged axnanog RNA.  The ATG-morpholino was, therefore, shown 
to specifically and efficiently inhibit the translation of axnanog mRNA. 
 
The disadvantage of using a translation-blocking morpholino is that its 
activity in embryos can only be confirmed by using an antibody specific 
to the target protein.  In the absence of an Axnanog antibody, 
splice-morpholinos were also designed.  The function of a 
splice-morpholino can be more easily confirmed using RT-PCR to 
check for the presence of normal transcripts.  Two splice-morpholinos 
were designed and they were injected into embryos to test their activity.  
Embryos were injected with 160 ng of a splice-morpholino targeted 
either to the exon-intron boundary or to the intron-exon boundary of 
 131
 intron 1.  Only the morpholino targeted to the intron-exon boundary 
produced a phenotype.  In order to examine splicing defects by 
RT-PCR, embryos were collected at mid- to late-gastrula (stage 10.5-
11).  RT-PCR was carried out on cDNA synthesised from the embryos 
using primers designed to the coding region (Figure 4.1B). 
 
In embryos injected with the morpholino targeted to the intron-exon 
boundary only low levels of normal transcript were detected (Figure 
4.1B).  In addition, three aberrant products were detected at higher 
levels than the normal product.  These products were cloned and 
sequenced.  The largest of the products (1134 kb) contained an 
insertion of intron 1 sequence, presumably as a result of a cryptic splice 
site within intron 1.  The other two aberrant transcripts were shorter 
than the full-length axnanog coding region; the 667 bp product obtained 
lacked exon 2, and the 555 bp product lacked both exon 2 and exon 3 
(intron 3 junction predicted).  All splice variants were shown to encode 
truncated proteins lacking both the homeodomain and the short region 
of conservation upstream of the homeodomain (Appendix 8.3), thus, all 
splice-variants are expected to be non-functional.  Only normal axnanog 
transcript was detected in embryos injected with the morpholino 
targeted to the exon-intron junction.  In conclusion, as suggested by the 
observed phenotypes, the splice-morpholino targeted to the intron-exon 
boundary efficiently disrupted the production of normal axnanog 
transcript, whereas the splice-morpholino targeted to the exon-intron 
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 boundary was ineffective.  The non-functional morpholino was 
employed as a control in subsequent experiments. 
 
Both the functional splice-morpholino (targeted to the intron-exon 
boundary of intron 1) and the ATG-morpholino were used to investigate 
the function of Axnanog.  It is recommended to use both a 
splice-morpholino and a translation-blocking morpholino to investigate 
the function of a protein in order to control for off-target effects [Eisen 
and Smith 2008].  If the two morpholinos produce a similar phenotype 
one can be more confident that the phenotype is indicative of the 
targets function.  Carrying out this control in axolotl studies is 
particularly important as genome sequence is unavailable, and so the 
potential binding of the morpholino to similar sequences cannot be ruled 
out.  The Axnanog ATG-morpholino and splice-morpholino might be 
expected to give at least partially differing phenotypes because the 
ATG-morpholino targets both maternal and zygotic transcripts, whereas 
the splice-morpholino can target only zygotic transcripts.   
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 Figure 4.1 Confirmation of activity of Axnanog translation-
blocking and splice blocking morpholinos 
A) Western blots to detect hemagluttanin (HA) tagged Axnanog 
protein (top) and Mapk protein (bottom).  MapK is a loading control.  
Xenopus tropicalis oocytes were injected with 80 ng axnanog 
ATG-morpholino or a mismatch control morpholino with 5 base pair 
mismatches.  After overnight incubation they were then injected with 
full-length HA-tagged axnanog mRNA or HA tagged mRNA lacking 
the 5UTR.  Protein was extracted after a further overnight incubation.  
Each lane of the western blot was loaded with protein equivalent to 
that in 5 oocytes.  -MO = mRNA injected alone; +MO = mRNA and 
morpholino injected; Mis MO = mRNA and mismatch control 
morpholino injected; UN = uninjected.  B) RT-PCR to detect the effect 
of Axnanog splice-morpholinos on the production of normal axnanog 
transcript.  Embryos were injected at the 1-cell stage with 160 ng of 
splice-morpholino targeted to the exon-intron (ControlMo) or 
intron-exon (SpliceMo) boundary of axnanog intron 1.  Embryos were 
collected on day 2 after injection.  Uninjected embryos were 
approximately at stage 10.5-11 (mid- to late-gastrula). RT-PCR 
was carried out on cDNA synthesised from the embryos using 
primers designed to the coding region.  The schematic at the top 
represents the coding region of axnanog.  Red lines indicate sites 
targeted by morpholinos; the boxes 1-4 represent exons.  The splice-morpholino targeted to the intron-exon junction effectively blocked normal 
splicing; only a low level of normal product was detected.  Three aberrant splice products were detected; the 1137 bp product had an insertion 
of intron 1, the 667 bp product lacked exon 2 and the 555 bp product lacked exons 2 and 3.  All alternatively spliced products were sequenced 
and are predicted to produce non-functional proteins (Appendix 8.3).  The alternatively spliced products persisted on day 3 after injection (not 
shown).  Only normal product was detected in embryos injected with the splice-morpholino targeted to the exon-intron junction (ControlMo), this 
was subsequently employed as a control.  Axodc is a loading control.   
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 4.3 Depletion of Axnanog disrupts gastrulation 
 
Embryos were injected at the 1-cell stage with 160 ng of 
translation-blocking or splice-blocking morpholino.  The 
splice-morpholino and the ATG-morpholino produced similar 
phenotypes (Figure 4.2A and B).   
 
On day 2 after injection, when uninjected and control-morpholino 
injected embryos had reached late-gastrula stages (stage 10.75-12; 
Figure 4.2Ai-ii and Bi), there was no dorsal-lip visible in the vegetal 
region of Axnanog morphant embryos and they resembled late-blastula 
(stage 9) embryos (Figure 4.2Aiii and Bii).  Morphant embryos 
underwent epiboly, but the ectoderm subsequently receded.  Dorsal 
lip-like structures were sometimes visible in the vegetal pole of 
morphant embryos (19%), but the ectoderm in these embryos receded 
as in morphant embryos lacking these structures (not shown).  All 
morphant embryos exhibiting a phenotype failed to complete 
gastrulation, but ISH data suggests that some morphant embryos had 
started to gastrulate (Figure 4.4Diii). 
 
On day 3 after injection, when uninjected embryos and 
control-morpholino injected embryos had reached late-neurula to 
mid-tailbud stages (stage 19-28; Figure 4.2Aiv-v and Biii), morphant 
embryos most frequently (80%) resembled undifferentiated tissue, a ball 
of ectoderm-like tissue attached to a ball of yolky-endoderm with an 
equatorial indentation (Figure4.2Avi and Biv).  The equatorial 
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 indentation could be the formation of a circumferential blastopore and a 
site of involution.  Less frequently (18%), neural-fold like structures 
formed in the animal region of morphant embryos (Figure 4.2Avii).  
Embryos injected with 160 ng of either of the control morpholinos 
developed normally, although a slight delay in development was often 
observed (Figure 4.2Av). 
 
In conclusion, Axnanog knock-down severely disrupted gastrulation.  
The splice-morpholino and the ATG-morpholino produced similar 
phenotypes, therefore, the phenotype can be attributed confidently to 
disrupted Axnanog expression.  The high degree of similarity between 
the ATG-morphant and splice-morphant phenotype suggests that the 
role of the maternal transcript during development is minimal.  
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Figure 4.2 Axnanog morphant phenotype 
Embryos were injected at the 1-2 cell stage with 160 ng of Axnanog splice-morpholino, Axnanog ATG-morpholino or a splice-control 
morpholino.  Embryos are shown on day 2 and day 3 after injection.  A) Phenotype of morphant embryos injected with splice-morpholino.  
Uninjected (i) and control-morpholino injected embryos (ii) developed normally and on day 2 after injection were approximately stage 10.75 
(mid-gastrula).  Arrows indicate the dorsal lip.  The splice-morphant embryos (iii) however failed to gastrulate and a dorsal lip was not visible.  
On day 3 after injection the uninjected embryos (iv) had reached approximately stage 23 (early-tailbud) and control morpholino injected 
embryos (v) were slightly delayed having reached approximately stage 20 (early-tailbud).  Splice-morpholino injected embryos underwent 
epiboly but the presumptive epidermis subsequently receded (vi).  The majority of the splice-morphant embryos consisted of a ball of 
ectoderm-like tissue attached to ball of endoderm (vi), a slight indentation was visible suggesting that some involution may have occurred.  A 
small proportion of the embryos developed neural-fold like structures in the ectoderm-like portion of the embryo (vii).  B) Phenotype of morphant 
embryos injected with ATG-morpholino.  On day 2 after injection the uninjected embryos (i) were approximately stage 12 (late-gastrula).  
However, similarly to splice-morphant embryos a dorsal lip was not visible in the vegetal portion of the morphant embryos (ii).  On day 3 after 
injection the uninjected embryos (iii) reached approximately stage 25 (early-tailbud) and the morphant embryos (iv) exhibited a similar 
phenotype to splice-morphant embryos.  The blastocoel cavity in the animal region of morphant embryos sometimes collapsed, giving the 
presumptive ectoderm a wrinkly appearance because of the convoluted tissue (iv).  A = Anterior; P = Posterior; D = Dorsal; V = Ventral. 
 
Summary of morpholino phenotype occurrence (7 experiments) 
Morphant embryos on day 2 (%) Morphant embryos on day 3 (%) 
No visible dorsal lip Slightly visible dorsal lip Normal Severe phenotype Neural fold-like structures visible Normal 
80 19 1 80 18 2 
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 4.3.1 The transcription profile of axnanog morphant embryos 
 
qRT-PCR was used to analyse the expression of molecular markers in 
axnanog morphant embryos on day 2 and day 3 after injection.  
Expression was analysed in splice-morphant embryos and in 
ATG-morphant embryos.  Spatial expression of some markers was also 
analysed by ISH on hemisectioned embryos. 
 
Expression of pluripotency genes was maintained in morphant 
embryos 
 
In order to examine the effect of Axnanog depletion on the expression 
of the core pluripotency network, the expression of axnanog and axoct4 
was examined (Figure 4.3C).  There were no marked differences in 
expression on day 2 after injection.  However, on day 3 after injection 
axnanog and axoct4 expression was maintained in morphant embryos, 
whereas only background levels were detected in uninjected and 
control morpholino injected embryos (consistent with developmental 
series data; Figure 3.5).  The level of expression in morphant embryos 
was similar to that in late-gastrula (stage 10.75-11) uninjected embryos.   
 
Expression of axnanog and axoct4 was also analysed in hemisectioned 
morphant embryos collected on day 3 after injection by ISH (Figure 
4.3D).  Expression of both genes was detected in the ectodermal-like 
tissue of morphant embryos and was undetectable in control 
morpholino injected and uninjected embryos, as expected.  The pattern 
of expression was similar to that in uninjected gastrula stage embryos 
where expression of both genes can be detected throughout the 
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 ectoderm and presumptive mesoderm (Figure 3.5).  This is consistent 
with the qRT-PCR data. 
 
This data indicates that the depletion of Axnanog inhibits development 
and thus the down-regulation of pluripotency genes that accompanies 
normal development (Chapter 3).   
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Figure 4.3 Expression of pluripotency genes in morphant embryos 
A) Schematic showing temporal axoct4 and axnanog expression during 
normal development from the 2-cell stage to stage 40 (late-tailbud).  The blue 
line indicates the stage at which morphant embryos are thought to have halted 
development.  B) Schematic showing the overlapping expression (yellow-
green shading) of axoct4 and axnanog at stage 10.75 (late-gastrula).  Axoct4 
and axnanog are co-expressed in the presumptive ectoderm and presumptive 
mesoderm extending vegetally towards the blastopore.  Morphant embryos 
are thought to have halted development close to this stage.  C) Relative 
expression of axnanog (top) and axoct4 (bottom) in splice-morphant and ATG-
morphant embryos on days 2 and 3 after injection as determined by qRT-PCR 
analysis.  Data was analysed using the 2-ǻǻCT method [Livak and Schmittgen 
2001] and was calibrated to expression in the uninjected samples on day 2 
after injection.  In the splice-morpholino experiment uninjected embryos were 
approximately stage 10.5-11 (mid-late gastrula) on day 2 and approximately 
stage 19-22 (late-neurula to early-tailbud) on day 3.  Control morpholino 
injected embryos were slightly delayed by comparison, stage 10-10.75 (early-
late gastrula) on day 2 and stage 17-18 (early-neurula) on day 3.  In the 
ATG-morpholino experiment uninjected embryos were approximately stage 
10.75-11.5 (late-gastrula) on day 2 and stage 26-30 (early to mid-tailbud) on 
day 3.  Perturbations in expression were not observed on day 2 after injection.  
Differences between the expression in control and uninjected samples can be 
explained by the observed delay in development.  In both experiments the 
expression of axoct4 and axnanog was maintained on day 3 after injection 
whereas it was undetectable in the uninjected and control samples.  D) Spatial 
expression of axnanog and axoct4 in morphant embryos.  Embryos were 
collected on day 3 after injection.  In situ hybridisations were then carried out 
on hemisectioned embryos.  The schematics at the top indicate how the 
embryos on panel iii were hemisectioned; i) uninjected and control morpholino 
injected embryos, ii) morphant embryo.  Axnanog expression was not detected 
in uninjected and control morpholino injected embryos but was detected in the 
ectoderm-like tissue of morphant embryosm (iii).  Similarly, axoct4 expression 
was not detected in uninjected and control morpholino injected embryos but 
was detected in the ectoderm-like tissue of morphant embryos (iv). 
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 Expression of early mesodermal and endodermal genes was 
maintained at a high level in morphant embryos 
 
To examine the effect of Axnanog depletion on the differentiation of 
mesoderm and endoderm the expression of axbrachyury, axmix and 
axsox17 was examined by qRT-PCR (Figure 4.4C).  Axbrachyury is 
normally expressed in developing mesoderm and in later embryos 
expression is restricted to the notochord (Chapter 3).  Axmix is 
expressed in developing mesoderm and endoderm (Chapter 3).  
Axsox17 is expressed in developing endoderm [Yi Hsien unpublished; 
not shown].   
 
On day 2 after injection slight perturbations in expression of all three 
genes were observed in morphant embryos in comparison to the 
uninjected sample (Figure 4.4C).  However, where the levels of 
expression differed significantly from the uninjected sample they were 
similar to those in the control sample, suggesting these perturbations 
may be the result of a delay in development similar to that observed in 
the control sample.   
 
On day 3 after injection, similar to the pluripotency genes, expression of 
axbrachyury, axmix and axsox17 was maintained at a high level in 
morphant embryos, whereas expression decreased as expected in 
uninjected and control morpholino injected embryos.  The level of 
expression in morphant embryos was similar to levels in uninjected 
embryos on day 2 after injection (late-gastrula). 
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 The spatial expression of axbrachyury was examined in hemisectioned 
embryos collected on day 3 after injection by ISH (Figure 4.4D).  In 
uninjected and control morpholino injected embryos expression was 
detected in the notochord, as expected [Johnson et al. 2003b].  In 
morphant embryos expression was detected in a small region of 
ectodermal-like tissue adjacent to the endoderm and in a stripe of 
involuted tissue, resembling a notochord.  This suggests that some 
morphant embryos began gastrulation, forming early mesodermal 
tissue, but failed to complete it. 
 
These results indicate that morphant embryos were unable to progress 
beyond an early stage of lineage specification maintaining high levels of 
axbrachyury, axmix and axsox17 similar to a late-gastrula embryo 
(stage 10.75-12; Figure 4.4). 
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Figure 4.4 Expression of early mesodermal and endodermal genes in 
morphant embryos 
A) Schematic showing temporal expression of axbrachyury (mesoderm), 
axmix (endomesoderm) and axsox17 (endoderm) expression during normal 
development from the 2-cell stage to stage 40 (late-tailbud).  The blue line 
indicates the stage at which morphant embryos are thought to have halted 
development.  B) Schematic showing the expression of axbrachyury (pink 
shading) and axmix (yellow shading) at stage 10.75 (late-gastrula).  
Axbrachyury and axmix are co-expressed in a region of the ventral mesoderm 
and expression partially overlaps in the dorsal mesoderm.  Morphant embryos 
are thought to have halted development close to this stage.  C) Relative 
expression of axbrachyury (top), axmix (middle) and axsox17 (bottom) in 
splice-morphant and ATG-morphant embryos on day 2 and day 3 after 
injection as determined by qRT-PCR analysis.  Data was analysed using the 
2-ǻǻCT method [Livak and Schmittgen 2001] and was calibrated to expression 
in the uninjected samples on day 2 after injection.  In the splice-morpholino 
experiment uninjected embryos were approximately stage 10.5-11 (mid-late 
gastrula) on day 2 and approximately stage 19-22 (late-neurula to early-
tailbud) on day 3.  Control morpholino injected embryos were slightly delayed 
by comparison, stage 10-10.75 (early-late gastrula) on day 2 and stage 17-18 
(early-neurula) on day 3.  In the ATG-morpholino experiment uninjected 
embryos were approximately stage 10.75-11.5 (late-gastrula) on day 2 and 
stage 26-30 (early to mid-tailbud) on day 3.  Slight perturbations in expression 
were observed for all three genes on day 2 after injection.  In both 
experiments the expression of axbrachyury, axmix and axsox17 was 
maintained on day 3 after injection whereas it was undetectable in the 
uninjected and control samples.  Differences between the expression in 
control and uninjected samples can be explained by the observed delay in 
development.  D) Spatial expression of axbrachyury in morphant embryos.  
Embryos were collected on day 3 after injection.  In situ hybridisations were 
then carried out on hemisectioned embryos.  The schematics at the top 
indicate how the embryos were hemisectioned prior to the in situ hybridisation; 
i) uninjected and control morpholino injected embryos, ii) morphant embryo.  
Axbrachyury expression was detected in the notochord of uninjected and 
control morpholino injected embryos, as expected [Johnson et al. 2003b].  In 
morphant embryos expression was detected in a portion of the ectoderm-like 
tissue adjacent to the endoderm and in a stripe of involuted tissue, which 
resembled a notochord.  Thus, some morphant embryos appear to have 
commenced gastrulation, but have failed to complete it.  N = Notochord; PN 
= Presumptive notochord 
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 Expression of late mesodermal genes was not activated in 
morphant embryos 
 
The maintenance of high levels of early mesodermal genes in 
late-neurula and mid-tailbud morphant embryos suggested that 
morphant embryos were unable to progress beyond an early stage of 
lineage-specification.  In order to examine the effect of Axnanog 
depletion on the terminal differentiation of mesoderm, the expression of 
ax-Į-actin and axglobin, terminal differentiation markers of somitic 
mesoderm and blood, respectively, was examined by qRT-PCR [Masi 
et al. 2000 ; Johnson et al. unpublished; Figure 4.5B].   
 
On day 2 after injection there were no significant differences in 
expression levels.   
 
On day 3 after injection expression of both genes increased significantly 
in uninjected embryos, as expected, but only low levels of expression 
were detected in morphant embryos.  Thus, morphant embryos failed to 
activate the normal developmental program for mesodermal 
differentiation, having expression levels more similar to late-gastrula 
uninjected embryos (day 2 after injection).  Thus, morphant embryos 
seem to be unable to progress beyond an early stage of lineage 
specification. 
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Figure 4.5 Expression of late mesodermal genes in morphant embryos 
A) Schematic showing temporal expression of ax-Į-actin, a marker of somatic 
mesoderm and axglobin, a blood marker, during normal development from the 
2-cell stage to stage 40 (late-tailbud).  The blue line indicates the stage at 
which morphant embryos are thought to have halted development.  B) 
Relative expression of ax-Į-actin (top) and axglobin (bottom) in ATG-morphant 
embryos on day 2 and day 3 after injection as determined by qRT-PCR 
analysis.  Data was analysed using the 2-ǻǻCT method [Livak and Schmittgen 
2001] and was calibrated to expression in the uninjected samples on day 2 
after injection.  Uninjected embryos were approximately stage 10.75-11.5 
(late-gastrula) on day 2 and stage 26-30 (early to mid-tailbud) on day 3.  
Perturbations in expression were not observed on day 2 after injection.  On 
day 3 after injection both genes were expressed at a high level in uninjected 
embryos but were only expressed at low or background levels in morphant 
embryos.  Thus, morphant embryos failed to activate the normal 
developmental program for mesodermal differentiation.  Background levels of 
expression are indicated by an asterisk (*). 
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 Expression of late-ectodermal genes was not activated in 
morphant embryos 
 
In order to determine the effect of Axnanog depletion on the terminal 
differentiation of ectoderm the expression of axcytoskeletal keratin 
(axck), a marker of epidermis, and axncam, a marker of neural tissue, 
was examined by qRT-PCR (Figure 4.6B).   
 
On day 2 after injection there were no perturbations in expression.   
 
On day 3 after injection only low or background levels of axck and 
axncam were detected in morphant embryos, contrasting with high 
levels of expression in uninjected and control samples.  Expression 
levels were more similar to those of uninjected embryos on day 2 after 
injection (late-gastrula).  This data lends further support to the proposal 
that Axnanog depletion inhibits the terminal differentiation of morphant 
embryos and that they are unable to progress beyond an early stage of 
lineage specification maintaining an expression profile similar to a 
late-gastrula embryo (stage 10.75-11). 
 
Spatial expression of axncam and axck was examined by ISH on 
hemisectioned embryos collected on day 3 after injection (Figure 4.6C).  
Axncam expression was detected throughout the neural tube in 
uninjected and control morpholino injected embryos, as expected 
(Chapter 3).  Axncam expression was examined in a morphant embryo 
both with and without (not shown) neural-fold like structures.  
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 Expression was detected along the edge of the ectodermal-like tissue in 
the embryo with neural-fold like structures but was not detected in the 
embryo lacking these structures.  This suggests that a small proportion 
of morphant embryos (18%) were able to form differentiated neural 
tissue.  Axck expression was detected throughout the epidermis of 
uninjected and morphant embryos.  Thus, the low levels of expression 
in morphant embryos may represent a failure to expand the population 
of axck expressing cells rather than a failure to form epidermis, or these 
cells may represent presumptive epidermis rather than differentiated 
tissue.  The analysis of further epidermal markers is required to 
distinguish between these two possibilities. 
 
Summary 
Axnanog morphant embryos halted at an early stage of development 
and failed to express the normal developmental program of genes.  The 
expression profile of morphant embryos on day 3 after injection, when 
uninjected embryos had reached early-mid tailbud stages, was similar 
to that of late-gastrula uninjected embryos.  Morphant embryos 
maintained high levels of pluripotency genes and genes associated with 
early lineage-specification, but failed to express mesodermal and 
ectodermal terminal differentiation markers. 
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Figure 4.6 Expression of late ectodermal genes in morphant embryos 
A) Schematic showing axncam (neural) and axck (epidermis) temporal 
expression during normal development from the 2-cell stage to stage 40 (late-
tailbud).  The blue line indicates the stage at which morphant embryos are 
thought to have halted development.  B) Relative expression of axncam (top) 
and axck (bottom) in splice-morphant and ATG-morphant embryos on day 2 
and day 3 after injection as determined by qRT-PCR analysis.  Data was 
analysed using the 2-ǻǻCT method [Livak and Schmittgen 2001] and was 
calibrated to expression in the uninjected samples on day 2 after injection.  In 
the splice-morpholino experiment uninjected embryos were approximately 
stage 10.5-11 (mid-late gastrula) on day 2 and approximately stage 19-22 
(late-neurula to early-tailbud) on day 3.  Control morpholino injected embryos 
were slightly delayed by comparison, stage 10-10.75 (early-late gastrula) on 
day 2 and stage 17-18 (early-neurula) on day 3.  In the ATG-morpholino 
experiment uninjected embryos were approximately stage 10.75-11.5 (late-
gastrula) on day 2 and stage 26-30 (early to mid-tailbud) on day 3.  
Perturbations in expression were not observed on day 2 after injection.  On 
day 3 after injection in both experiments the two genes were expressed at a 
high level in uninjected and control samples, but only low levels of expression 
were detected in morphant embryos.  Differences between the expression in 
control and uninjected samples can be explained by the observed delay in 
development.  C) Spatial expression of axncam and axck in morphant 
embryos.  Embryos were collected on day 3 after injection.  In situ 
hybridisations were carried out on hemisectioned embryos.  The schematics at 
the top indicate how the embryos were hemisectioned prior to the in situ 
hybridisations; i) uninjected and control morpholino injected embryos, ii) 
morphant embryo.  Axncam Expression (iii) was detected throughout the 
neural tube of uninjected and control morpholino injected embryos.  
Expression was detected along the edge of the ectodermal-like tissue of a 
morphant embryo with neural fold-like structures.  Axncam expression was not 
detected in embryos lacking neural-fold like structures (not shown).  Axck 
expression  (iv) was detected throughout the epidermis of uninjected and 
morphant embryos.  NT=Neural tube; NF = Neural fold; Ect = ectoderm 
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 4.5 Confirmation of Axoct4 translation-blocking 
morpholino activity 
 
Preliminary tests were carried out in vivo in Xenopus tropicalis oocytes 
to test the activity of an Axoct4 translation-blocking morpholino (Figure 
4.7).  Oocytes were first injected with Axoct4 translation-blocking 
morpholino or Axmix translation-blocking moroholino.  After an 
overnight incubation they were then injected with full-length HA-tagged 
Axoct4 mRNA or full-length HA-tagged Axmix mRNA.  Oocytes were 
collected after a further overnight incubation and protein was extracted.  
A western blot was then carried out to detect the HA-tagged proteins 
(Figure 4.7).  The Axoct4 ATG-morpholino caused a complete block to 
the translation of HA-tagged axoct4 mRNA but appeared to have no 
effect on the translation of axmix mRNA.  The Axmix ATG-morpholino 
had no effect on the translation of axoct4 mRNA.  This data suggests 
that the Axoct4 ATG-morpholino specifically targets Axoct4.  Further 
experimentation would be required to confirm these results. 
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Figure 4.7 Confirmation of activity of Axoct4 translation-blocking 
morpholino 
Western blots to detect hemagluttanin (HA) tagged Axoct4 protein and Axmix 
protein.  Xenopus tropicalis oocytes were injected with 80 ng Axoct4 
ATG-morpholino or Axmix ATG-morpholino.  After overnight incubation they 
were then injected with full-length HA-tagged axoct4 mRNA or full-length 
HA-tagged axmix mRNA.  Protein was extracted after a further overnight 
incubation.  Each lane of the western blot was loaded with protein equivalent 
to that in 5 oocytes.  -MO = mRNA injected alone; +MO = mRNA and 
morpholino injected; Axmix MO = Axmix ATG-morpholino and axoct4 mRNA 
injected; UN = uninjected.  The Axoct4 ATG-morpholino effectively blocked the 
translation of full-length axoct4 mRNA but had no noticeable effect on the 
translation of axmix mRNA.  The Axmix ATG-morpholino did not block the 
translation of axoct4 mRNA. 
 
 
4.6 Axoct4 depletion severely disrupts gastrulation 
 
Embryos were injected at the 1-2 cell stage with 80 or 160 ng of Axoct4 
ATG-morpholino.  Preliminary data suggests, similarly to Axnanog 
morphant embryos, Axoct4 depletion severely disrupts gastrulation 
(Figure 4.8).  Embryos injected with 80 ng of morpholino gastrulated, 
but failed to progress beyond early-neurulation.  Neural-fold like 
structures were visible.  This phenotype differed from that of Axnanog 
morphant embryos.  However, embryos injected with 160 ng of 
morpholino exhibited a similar phenotype to Axnanog morphant 
embryos.  Embryos underwent epiboly but failed to form a dorsal lip and 
the ectoderm subsequently receded so that on day 3 after injection 
embryos resembled a ball of undifferentiated ectoderm attached to a 
ball of yolky-endoderm (Figure 4.8).  This data suggests that Axoct4 
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 and Axnanog may function in the same pathway during early 
development. 
 
 
 
 
 
 
Figure 4.8 Phenotype of embryos injected with Axoct4 ATG-morpholino 
Embryos were injected at the 1-2 cell stage with 80 or 160 ng of Axoct4 
ATG-morpholino.  The images show embryos on day 3 after injection.  
Uninjected embryos were approximately stage 28 (mid-tailbud).  Morphant 
embryos injected with 80 ng of morpholino exhibited a distinctive phenotype, 
they gastrulated, but failed to progress beyond an early stage of neurulation.  
Faint neural-folds are visible.  Embryos injected with 160 ng of morpholino 
exhibited a phenotype similar to Axnanog morphant embryos.  The embryos 
underwent epiboly but failed to form a dorsal-lip.  The presumptive ectoderm 
tissue subsequently receded and similarly to Axnanog morphant embryos they 
resembled a ball of undifferentiated ectoderm-like tissue attached to a ball of 
yolky-endoderm. There was an indentation between the ectoderm-like portion 
and endoderm portion suggesting that similarly to Axnanog morphant embryos 
some involution had occurred and morphant embryos had started to gastrulate 
but failed to complete it.  A = Anterior; P = Posterior; D = Dorsal; V = 
Ventral. 
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 4.7 Discussion 
 
The role of Nanog in murine embryos and ES cells is well established 
[Chambers et al. 2003; Chambers 2004; Chambers et al. 2007].  Nanog 
has been shown to have a key role in the maintenance of pluripotent 
cells both in vivo and in vitro.  In Nanog-null mice the pluripotent ICM 
fails to form and cells adopt an extraembryonic endoderm fate [Mitsui et 
al. 2003].  Nanog homologues have also been shown to have a 
conserved role in the maintenance of human and chicken pluripotent 
cells [Hyslop et al. 2005; Zaehres et al. 2005; Lavial et al. 2007].  The 
identification of Axnanog offered the first opportunity to study the role of 
Nanog in an anamniote.  The expression of axoct4 and axnanog in the 
undifferentiated tissues of early embryos (Chapter 3) suggested that 
these molecules might have conserved roles in the maintenance of 
pluripotent/multipotent tissue.  In this chapter the function of Axnanog 
and Axoct4 was investigated using morpholino knock-downs.   
 
Gastrulation was severely disrupted in morphant embryos and they 
failed to progress beyond an early stage of development; resembling a 
ball of undifferentiated ectoderm attached to a ball of undifferentiated 
endoderm with an equatorial region of indentation.  The same 
phenotype was observed with both a splice-morpholino and an 
ATG-morpholino, providing convincing evidence that the phenotype 
results from Axnanog depletion rather than off-target effects, although, 
only a rescue experiment would provide definitive evidence.  
Expression analysis revealed that pluripotency genes and markers of 
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 early-lineage specification were maintained at high levels in morphant 
embryos, similar to levels in a late-gastrula embryo, whereas, markers 
of terminal differentiation were expressed only at low levels.  This differs 
from mouse, where loss of Nanog results in the downregulation of 
pluripotency markers and the upregulation of differentiation markers, 
coincident with a failure to maintain the pluripotent cells [Mitsui et al. 
2003].  Interestingly, neural-fold like structures formed in the animal 
region of morphant embryos and axncam expression confirmed the 
induction of neural tissue in these embryos.  This phenotype occurred 
more frequently at lower doses, suggesting a dose-dependent effect 
(not shown). It is notable that axnanog expression is downregulated 
before neural induction during normal development (Chapter 3).  Thus, 
neural induction may only require a low level of axnanog expression. 
Additionally, neural crest cells are one of the lineages specified when 
Nanog is downregulated in mES cells [Ivanova et al. 2006]. 
 
One explanation for the observed phenotype is that depletion of 
Axnanog results in cell migration defects that, in effect, disrupt 
gastrulation.  Gastrulation in axolotls begins with much of the 
presumptive mesoderm in the outer superficial layer, all of which must 
migrate into the deep layers (Chapter 3).  Disruption of these cell 
migration mechanisms may have prevented the formation of terminally 
differentiated tissues in Axnanog morphant embryos.  In support of this 
hypothesis, a similar phenotype is observed when fibronectin (FN) 
dependent mesoderm migration is disrupted in Axolotl and P. waltl 
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 embryos [Boucaut et al. 1985; Darribere and Schwarzbauer 2000].  A 
FN matrix coats the inner surface of the blastocoel roof from early 
blastula to late-gastrula [Boucaut et al. 1985].  Migrating mesodermal 
cells interact with this matrix during gastrulation.  Disruption of this 
matrix by injecting a synthetic peptide containing the cell binding 
sequence of FN or the injection of mutant forms inhibits mesodermal 
cell migration and disrupts gastrulation [Boucaut et al. 1985; Darribere 
and Schwarzbauer 2000].  The embryos resemble Axnanog morphant 
embryos, having a non-involuted endodermal mass segregated in the 
vegetal region, beneath a blastopore-like structure found around the 
circumference of the embryo, and the blastocoel roof is highly 
convoluted with deep ectodermal furrows.  Furthermore, in some of the 
Axnanog morphant embryos a bulge of axbrachyury expressing cells 
was visible on the exterior of the embryo (Figure 4.4iii), these may be 
presumptive mesodermal cells that failed to migrate.  Depletion of 
fibroblast growth factors (FGFs) in both Xenopus and mouse causes 
cell migration defects, which in turn disrupts gastrulation and cellular 
differentiation [Reviewed in Heisenberg and Solnica-Krezel 2008].  In 
FGF8-null mice a bulge of presumptive mesoderm cells forms where 
they have failed to migrate through the primitive streak, similarly to 
those seen in Axnanog morphant embryos [Sun et al. 1999].  However, 
there cannot have been a complete failure in cell migration as some 
internal Axbrachyury expressing cells were detected (Figure 4.4iii) 
suggesting that some involution had occurred, forming a partial 
notochord. 
 158
  
An alternative explanation is that in the absence of Axnanog, cells are 
unable to respond to inducing signals and therefore retain the 
expression profile of a pluripotent or early differentiating cell.  The 
phenotype and transcription profile of axnanog morphant embryos 
closely resembles that of murine ES cells lacking a component of the 
NuRD (Nucleosome Remodeling and Histone Deacetylation) 
co-repressor complex, MBD3 [Kaji et al. 2006].  The NuRD complex is 
an abundant co-repressor complex that is involved in cell-fate decisions 
in many organisms one example being haematopoietic development in 
mammals [Ahringer 2000].  MBD3 is a core component of the NuRD 
complex [Zhang et al. 1999].  MBD3-/- ES cells continue to express the 
pluripotency marker oct4, and fail to differentiate in the absence of LIF, 
a cytokine required for ES cell self-renewal [Kaji et al. 2006].  MBD3-/- 
ES cells, however, are able to form neural tissues in response to 
retinoic acid, and brachyury expression was detected in some cells.  In 
this respect, also, they are similar to axnanog morphant embryos [Kaji 
et al. 2006].  Given the similarity between these phenotypes, I propose 
that during normal embryonic development Axnanog may interact with 
components of the NuRD complex or other epigenetic modifiers thus 
regulating epigenetic modifications.  Hence, in morphant embryos 
disruption of this regulation may have rendered Axnanog depleted cells 
incapable of responding to inducing signals. 
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 The expression of two epigenetic modifiers axcarm1 and axmbd3, was 
analysed in axnanog morphant embryos (not shown).  However, the 
expression of these molecules varied very little in comparison to the 
uninjected sample.  This data suggests that Axnanog does not influence 
the transcriptional regulation of these maternally expressed epigenetic 
modifiers but it does not rule out the possibility that it regulates their 
localisation.  Epigenetic modifiers have multiple roles during 
development and to allow rapid changes in epigenetic modifications, 
are often regulated by localisation rather than by transcriptional 
changes [e.g. NODE, Liang et al. 2008].  Thus, the localisation of these 
molecules could be disrupted in morphant embryos.   
 
Interestingly, Chambers et al. (2007) proposed that the function of 
murine Nanog might be to establish epigenetically erased states in 
pluripotent cells.  This was based on the observation that there are 
genome-wide epigenetic modifications at both time-points when Nanog 
function is required, establishment of the epiblast [Mitsui et al. 2003], 
and the differentiation of PGCs into mature germ cells [Chambers et al. 
2007].  Accordingly, gene deletion of epigenetic modifiers typically 
disrupts the formation of the epiblast [Surani et al. 2007].  Interactions 
have been identified between murine Nanog and multiple epigenetic 
modifiers, including the NuRD complex and polycomb group factors 
[Wang et al. 2006].  In C. elegans development a homologue of the 
NuRD complex is required for somatic differentiation; in the absence of 
NuRD, all cells are germline competent, but they cannot form somatic 
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 tissues [Shin and Mello 2003], suggesting that chromatin remodelling by 
NuRD creates a condition permissive for somatic differentiation.  
Conversely, polycomb group molecules, another group of chromatin 
remodelling molecules, are thought to maintain a suitable chromatin 
configuration in a subset of cells for germline development by modifying 
the chromatin regulatory regions of targets such as the Hox genes [Shin 
and Mello 2003].  The germ plasm specific molecule, PIE-1 is thought to 
interact with the NuRD complex and polycomb group molecules, and 
thus coordinate the segregation of the somatic cells and germline 
competent cells.  The observed surge of axnanog transcription at 
late-blastula (stage 9) may be required to establish chromatin 
modifications that ensure somatic differentiation can proceed during 
gastrulation whilst a subset of cells remain germline competent, similar 
to the role of PIE-1 in C. elegans.  Further investigation is required to 
determine if the underlying cause of the morphant phenotype is a cell 
migration defect or a block to differentiation.  Examining the expression 
of a greater array of genes in morphant embryos would help to clarify 
the phenotype.  It would also be interesting to test the ability of 
epigenetic modifiers to rescue the morphant phenotype. 
 
Nanog has not been identified in other anamniotes.  However, in 
prominent model organisms the germline is segregated early in 
development by the inheritance of maternal molecules (germ plasm) 
[Extravour and Akam 2003; Johnson et al. 2003b].  The inheritance of 
germ plasm into specific cells results in their segregation into the 
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 germline, whereas in mouse and axolotl PGCs are specified by 
inductive signals from pluripotent tissues [Sutasurja and Nieuwkoop 
1974; McLaren 2003].  It is likely that germ plasm-specific molecules 
coordinate the epigenetic events that are required to segregate the 
germline and the soma in these organisms (as in C. elegans).  In such a 
context Nanog may become expendable.  It is notable that Oct4 
function in the maintenance of pluripotent/multipotent cells may also be 
dispensible in these organisms as evidenced by the divergent role of 
Pou2 in Zebrafish development [Belting et al. 2001; Burgess et al. 2002; 
Reim and Brand 2002; Lunde et al. 2004; Reim et al. 2004; Reim and 
Brand 2006]. 
 
Preliminary data showed that Axoct4 depletion (160 ng morpholino) 
severely disrupts gastrulation similarly to that observed in Axnanog 
morphant embryos.  This suggests that Axnanog and Axoct4 might 
function in the same pathways during early development.  The recent 
identification of the NODE (Nanog and Oct4 associated histone 
deacetylase) complex in mES cells suggests that Nanog and Oct4 
might coordinately regulate epigenetic modifiers [Liang et al. 2008].  
Thus, I propose that Axnanog and Axoct4 might cooperate in the 
regulation of epigenetic modifiers during embryonic development.  The 
identification of common targets in mouse and human ES cells supports 
this hypothesis [Boyer et al. 2005; Loh et al. 2006].  Axoct4 introns have 
been cloned and splice-blocking morpholinos have been designed, 
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 thus, these could be employed in future analyses to confirm the Axoct4 
morphant phenotype (Appendix 8.2). 
 
Research presented here will provide a good foundation for further 
investigations into the pluripotency network in axolotls.  Future work 
should focus on developing greater understanding of the Axnanog 
morphant phenotype.  This should include the analysis of the 
expression of a greater array of marker genes, a demonstration that the 
phenotype can be rescued and also trying to distinguish between the 
two possible causes of the gastrulation defect, a cell migration defect or 
a developmental block.   
 
In order to demonstrate a rescue of the morphant phenotype, Axnanog 
mRNA, which cannot be bound by the morpholino, must be coinjected 
with the morpholino.  However, all attempts to inject axnanog RNA into 
either axolotl or Xenopus embryos (doses ranging from 125 pg to 1 ng) 
have been lethal (Data not shown); embryos typically survived until 
MBT.  In one of the experiments to test the effect of axnanog RNA on 
Xenopus laevis development, xvent2 (a closely related Xenopus 
homeobox gene) RNA, was also injected at the same doses.  Embryos 
injected with xvent2 survived and exhibited the expected phenotype 
[Onichtchouk et al. 1998].  This suggests that the fatality in response to 
axnanog RNA is a specific effect.  The critical role shown for Axnanog 
during development could indicate that even small perturbations in 
expression levels can have a lethal effect.  Lower doses of RNA could 
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 be investigated.  An alternative to carrying out the rescue in whole 
embryos, to avoid the lethal effects, would be to attempt the rescue in 
an animal cap assay (described below). 
 
In order to distinguish between a cell migration defect and a 
developmental block it is necessary to test the developmental 
capabilities of cells depleted of Axnanog.  Conveniently, mesoderm and 
endoderm can be induced in axolotl animal caps in response to differing 
levels of activin mRNA [Johnson et al., unpublished].  The coinjection of 
the Axnanog morpholino into animal caps would test the ability of 
Axnanog depleted cells to differentiate into mesoderm and endoderm.  
This assay could also be extended to test the ability of Axnanog 
depleted cells to differentiate into other tissue types.  For example, 
PGCs can be induced in animal caps in response to the injection of 
Xenopus eFGF and BMP4 RNA.  If the Axnanog depleted caps are able 
to respond to the inducing signals and form differentiated tissues then 
the defect is more likely to be the result of a migration defect than a 
developmental block.  If the animal cap assays were to reveal a 
developmental block, a rescue of this phenotype could then be 
attempted by coinjecting axnanog mRNA, avoiding the lethality of a 
whole embryo experiment.   
 
An alternative way to test the developmental capabilities of Axnanog 
depleted cells would be to take cells marked with a lineage tracer from 
morphant embryos and transplant them into the blastocoel of another 
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 embryo [Technique described in Wylie et al. 1985].  The ability of those 
cells to contribute to the various tissues of the embryo would then be 
revealed. 
 
4.7.1 Summary 
 
1. Axnanog is the first nanog homologue to be identified in an 
anamniote model organism.  Its coexpression with axoct4 in the 
undifferentiated tissues of early embryos suggested that it along with 
Axoct4 could have conserved roles in the maintenance of pluripotent/ 
multipotent tissue. 
 
2. Depletion of Axnanog with antisense morpholino oligonucleotides 
disrupted gastrulation.  The expression of pluripotency genes and 
markers of early differentiation was maintained whilst terminal 
differentiation markers were only expressed at low levels.  There are 
two explanations for this, a cell migration defect or a developmental 
block.  Future analyses are required to distinguish between these two 
possibilities. 
 
3. I proposed that a developmental block could be caused by disruption 
of epigenetic modifications.  Murine Nanog has been shown to interact 
with multiple epigenetic modifiers.  Thus, if Axnanog regulates 
epigenetic modifications through equivalent interactions, misregulation 
in Axnanog depleted embryos could result in a developmental block.  
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 To test this theory it would be interesting to try and rescue the morphant 
phenotype through the injection of RNA encoding epigenetic modifiers. 
 
4. Primary Axoct4 knock-down data revealed a similar morphant 
phenotype to that that caused by Axnanog depletion.  Thus, Axoct4 
may function in the same pathway, as suggested in mouse, to 
coordinately maintain pluripotent/ multipotent tissues. 
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 Chapter 5 Investigating PGC development in 
axolotl 
 
Primordial germ cells (PGCs) are the precursor cells from which sperm 
or eggs are derived.  It is essential that all sexually reproducing 
organisms produce germ cells, for without them the enduring genetic 
link between generations would be lost.  How germline fated cells 
become segregated from somatic cells during development is a 
fundamental question.  In some species, germ cells are specified very 
early in development by the localisation of maternally inherited 
determinants, either before or immediately after fertilisation 
(Preformation; Figure 5.1A).  In others, germ cells are specified later in 
development by inductive signals from surrounding tissues (epigenesis; 
Figure 5.1B) [Reviewed in Extravour and Akam 2003].  These two 
modes of PGC specification are discussed in detail below.   
 
5.1 Preformation 
 
In many species, including the model organisms Drosophila, 
C. elegans, Xenopus, zebrafish and chicken, PGCs are specified 
cell-autonomously by the inheritance of maternal molecules in the form 
of germ plasm [Houston and King 2000].  Germ plasm is a specific type 
of cytoplasm, which contains ribosomes, mitochondria, germinal 
granules and maternally inherited mRNAs and proteins.  Early in the 
development of these organisms germ plasm is segregated into specific 
cells which will form the PGCs [Houston and King 2000].   
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 Drosophila germ cell specification is perhaps one of the most 
extensively studied (Figure 5.1A).  Early in Drosophila development 
cells initially exist in a cell syncitium i.e. nuclei are not enclosed by cell 
membranes [Gilbert 2000c].  During the ninth cell division cycle, five 
nuclei migrate to the posterior pole where they become surrounded by 
pole plasm (germ plasm).  The pole plasm is assembled at the posterior 
pole of the oocyte before fertilisation [Reviewed in Mahowald 2001].  
These nuclei then become enclosed by cell membranes and the pole 
plasm is segregated into the separate cells [Gilbert 2000c].  The 
resulting cells, the pole cells, give rise to the PGCs.  If the pole plasm is 
UV irradiated, the pole cells are eradicated [Aboim 1945; Togashi and 
Okada 1986].  Transplantation of pole plasm to irradiated embryos 
restores fertility [Okada et al. 1974] and transplantation to ectopic sites 
results in the formation of ectopic PGCs [Illmensee and Mahowald 
1974].  Thus, the pole plasm is essential for the formation of the PGCs.  
Many of the molecular factors contained within Drosophila pole plasm 
have now been identified and their roles elucidated [Reviewed in Wylie 
1999; Jin and Xie 2006]. 
 
In C. elegans PGCs are specified by maternally inherited electron 
dense granules termed P-granules, the equivalent of Drosophila pole 
plasm [Gilbert 2000c].  Unlike Drosophila, the P-granules are scattered 
throughout the cytoplasm before and just after fertilisation, and then 
move to the posterior of the embryo during pronuclear fusion [Hird et al. 
1996].  The germ lineage is progressively segregated from the somatic 
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 lineages through a series of four asymmetric divisions, which segregate 
the P-granules into the germline blastomeres [Krieg et al. 1978; Wolf et 
al. 1983].  At the 16-24 cell stage the P-granules are segregated into 
the P4 blastomere, the germline precursor [Deppe et al. 1978; Strome 
and Wood 1982].  Many of the molecular regulators of germline 
development contained within the P-granules have now been identified 
[Reviewed in Strome and Lehmann 2007]. 
 
Anurans were the first vertebrate model organism in which germ plasm 
was identified [Bounoure 1939].  Maternal determinants are localised 
during Xenopus laevis oogenesis, the germ plasm begins to assemble 
in stage 2 oocytes at the mitochondrial cloud (Balbiani body) in the 
vegetal cortex [Reviewed in Kloc et al. 2001].  The germ plasm is also 
localised to the vegetal pole of stage IV and V oocytes and unfertilised 
eggs.  Following fertilisation, the germ plasm forms patchy aggregates 
in the vegetal hemisphere, which is eventually segregated into the 
vegetal cells that will become the PGCs [Houston and King 2000; Kloc 
et al. 2001].  As in C. elegans the germ plasm is initially segregated 
asymmetrically into a select few germline blastomeres.  At the end of 
cleavage the 2-6 cells containing germ plasm are the founder cells of 
the germ line.  Ablation of germ plasm in Xenopus, by excision or UV 
irradiation, results in the complete absence of germ cells [Zust and 
Dixon 1975; Ikenishi and Nieuwkoop 1978].  However, the germ plasm 
in Xenopus appears to be permissive for germ cell fate, and not 
instructive (as in Drosophila).  Transplantation of Drosophila pole plasm 
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 to an ectopic site, results in the production of PGCs at the site, whereas 
transplanted germ-lineage blastomeres from Xenopus can contribute to 
all three germ layers.  This suggests that Xenopus PGCs are not 
lineage restricted in the same way as Drosophila germ cells. [Houston 
and King 2000]. 
 
Germ plasm was first identified in Zebrafish when the localisation of 
vasa mRNA, a germ-line specific molecule, was observed.  Prior to this, 
the origin of zebrafish PGCs was unknown [Olsen et al. 1997; Yoon et 
al. 1997].  Vasa mRNA is synthesised during oogenesis and localises to 
the cleavage furrows during the first cleavages [Yoon et al. 1997].  The 
mRNA appears to form clumps, thought to be the germ plasm, which 
are segregated into four cells at the 32-cell stage.  These cells go on to 
form the PGCs [Yoon et al. 1997].  It has since been shown that other 
germline-specific mRNAs also localise to the cleavage furrows of the 
4-cell stage embryo [Koprunner et al. 2001; Weidinger et al. 2003; 
Blaser et al. 2005; Hashimoto et al. 2006; Mishima et al. 2006] and 
some of these genes have been shown to be essential for the normal 
development of Zebrafish PGCs [Koprunner et al. 2001; Weidinger et 
al. 2003].  More recently the localisation of some of the germline 
determinants has also been observed during oogenesis [Kosaka et al. 
2007].  Similarly to Xenopus, the germline specific mRNAs co-localise 
with a mitochondrial cloud and are then transported to the vegetal 
cortex during early oogenesis.  Additionally, electron microscopy has 
identified germinal granule-like structures localised to the cleavage 
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 furrows of 4-cell stage embryos [Knaut et al. 2000] and ablation of the 
cytoplasm at these sites results in the loss of PGCs [Hashimoto et al. 
2006]. 
 
In chicken, as in Zebrafish, potential germ plasm was identified through 
the analysis of the localisation of a Vasa homologue [Tsunekawa et al. 
2000].  Chicken Vasa Homolog (CVH) was found to be localised at 
cleavage furrows at early-cleavage stages, and to a region in oocytes, 
which also contained material resembling other germ plasm 
components e.g. the mitochondrial cloud.  These observations suggest 
that chickens have germ plasm [Tsunekawa et al. 2000].  However, 
transplantation experiments are required to prove that this material is 
responsible for specifying PGCs. 
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  B. Epigenesis 
A. Preformation 
Figure 5.1 Modes of germ cell specification: Preformation and 
Epigenesis  
[Taken from Extravour and Akam 2003] A) Schematic representation of 
preformation in Drosophila.  Nurse cells synthesise RNAs and proteins that 
are transported through cytoplasmic bridges (blue arrows) to the oocyte.  They 
are localised to the posterior of the oocyte forming the germ plasm.  During 
early development, the cells that inherit the germ plasm become the primordial 
germ cells (PGCs; red).  B) Schematic representation of epigenesis in mouse.  
A subpopulation of proximal epiblast cells express germ line competence 
genes (striped).  These cells respond to inductive signals from the 
neighbouring extraembryonic ectoderm (blue arrow) and extraembryonic 
endoderm (yellow arrow) and differentiate into PGCs (red).  
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 5.2 Epigenesis 
 
It was once thought that all organisms might specify germ cells via 
preformation.  However, germ plasm could not be found within the 
oocytes or early embryos of mouse and urodeles prior to PGC 
specification [Eddy 1974, 1975; Ikenishi and Nieuwkoop 1978; Johnson 
et al. 2001].   It has since been shown that these organisms do not 
contain germ plasm, and instead specify germ cells via epigenesis 
[Watson and Tam 2001; Johnson et al. 2003a].  It is now thought that 
epigenesis may be the most common way in which PGCs are specified 
and it has been suggested it may be the ancestral mode of PGC 
specification with many of the basal metazoan organisms appearing to 
produce PGCs in this way [Extravour and Akam 2003]. 
 
In mouse embryos PGCs develop from pluripotent proximal epiblast 
cells in response to TGF-ȕ (BMP) signals [McLaren 2003; Figure 5.1B].  
Gene deletion studies have shown that BMP4 and BMP8b signalling 
from the extra-embryonic ectoderm and BMP2 signalling from the 
primitive endoderm are all required for the specification of PGCs in 
mouse [Lawson and Hage 1994; Ying et al. 2003].  BMP4 or 
BMP8b-null embryos lack PGCs, and BMP2-null embryos exhibit a 
reduction in the number of PGCs [Lawson and Hage 1994; Ying et al. 
2003].  BMP4 heterozygotes exhibit a haploinsufficiency, with reduced 
numbers of PGCs, while BMP2 heterozygotes have normal numbers of 
PGCs.  Embryos that are heterozygote mutants for both BMP4 and 
BMP2 (BMP4+/-; BMP2+/-) show a greater reduction in PGCs than 
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 heterozygotes with the individual mutations showing that the two 
molecules have an additive effect on PGC induction [Ying et al. 2003].  
In addition, it was shown that both BMP4 and BMP8b are required to 
induce PGCs in cultured epiblast cells [Ying et al. 2003].  It is therefore 
considered that the coordinated action of all three molecules, BMP4, 
BMP8b and BMP2, is required for PGC induction.  Knockouts of the 
smad genes, smad 1, 4 and 5, downstream components of the TGF-ȕ 
signalling pathway, also result in a reduction in PGCs [Tremblay et al. 
2001; Chu et al. 2004].  It has been suggested that the BMP molecules 
may trigger the expression of these smads in the epiblast via the type I 
receptor Alk2 [Brons et al. 2007].  Alk2 null-embryos lack PGCs and 
constitutively active ALK2 can rescue BMP4 null embryos [Brons et al. 
2007]. 
 
Urodele amphibians, including axolotls, are also thought to specify their 
germ cells via epigenesis based on the observation that PGCs can be 
induced ectopically in animal cap cells [Sutasurja and Nieuwkoop 1974; 
Johnson et al. 2003b].  (The ectopic induction of PGCs in animal caps 
was described in detail in Section 1.6.)  However, little is known about 
the signalling that induces PGCs during normal development. 
 
5.3 Maintenance of PGCs 
 
Following the specification of PGCs, they must be maintained and 
prevented from responding to somatic inducing signals.  In organisms 
that specify their germ cells via preformation, this is achieved by the 
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 early segregation of PGCs, prior to gastrulation via the inheritance of 
maternal molecules in the form of germ plasm.  Amongst the germ 
plasm molecules are transcriptional and translational repressors that 
prevent the PGCs from responding to somatic inducing signals, thus 
restricting their developmental potential to the germ cell lineage 
[Reviewed in Nakamura and Seydoux 2008].  For example, PIE1, an 
mRNA binding protein, is a maternally inherited molecule that is 
localised to the germ plasm in C. elegans [Mello et al. 1996].  Mutations 
in PIE-1 result in the germ cells assuming a somatic cell fate [Mello et 
al. 1992; Seydoux et al. 1996].  PIE-1 mediates the repression of 
somatic gene expression through several mechanisms.  It can bind to 
mRNA, preventing elongation, or by interfering with other RNA 
processing events, thus preventing the formation of mature transcripts 
[Seydoux et al. 1996; Seydoux and Strome 1999].  Also, it has been 
shown to repress somatic gene expression through interactions with 
epigenetic modifiers [Shin and Mello 2003].  Furthermore, PIE-1 has 
been shown to promote the expression of other molecules required for 
maintaining the germline, e.g. nos-2 [Tenenhaus et al. 2001]. 
 
Similar to PGCs that are specified via germ plasm, transcriptional and 
translational repressors also play a major role in ensuring the 
maintenance of the germ line in mice [Reviewed in Nakamura and 
Seydoux 2008].  An essential factor for the maintenance of murine 
PGCs is the transcriptional regulator named Blimp1 (B-lymphocyte 
maturation factor I, also known as PRDM1).  Blimp1-null embryos lack 
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 PGCs, reflecting a critical role in the development of the PGCs [Vincent 
et al. 2005].  PGCs begin to express Blimp1 as early as E6.25, soon 
after they are specified and expression continues during migration from 
the proximal epiblast to the genital ridges, when it is downregulated 
[Ohinata et al. 2005].  PGC-like cells that form in Blimp1-null embryos 
continue to express Hoxb1 similar to the surrounding mesodermal cells 
[Ancelin et al. 2006].  Thus, it was proposed that Blimp1 functions to 
maintain the PGCs by repressing somatic gene expression. 
 
Recently, a quantitative single-cell gene expression profiling study was 
carried out to analyse the transcriptional changes that occur during 
murine PGC specification [Kurimoto et al. 2008].  PGC precursor cells, 
identified by their expression of blimp1, oct4 and brachyury, initially 
expressed mesodermal genes similarly to neighbouring cells.  
Subsequently, the expression of the mesodermal genes and many 
other somatic genes including cell-cycle regulators and epigenetic 
modifiers was repressed in the PGCs.  In addition, PGC-specific genes 
such as stella [Saitou et al. 2002], and the pluripotency associated 
transcription factors nanog and sox2 were upregulated.  In order to 
determine how Blimp1 was involved in modifying transcription in PGCs, 
expression was also examined in Blimp1-null PGC-like cells.  In the 
absence of Blimp1 the majority of the somatic genes remained active, 
and there was reduced activation of some PGC specific genes.  Thus, 
Blimp1 appears to be an essential coordinator of the transcriptional 
changes that occur during PGC specification in mouse, similar to the 
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 role of PIE-1 in C. elegans [Tenenhaus et al. 2001; Shin and Mello 
2003], mediating both repression of somatic gene expression and 
promoting the expression of PGC specific genes.  Blimp1 is thought to 
mediate repression of target genes by binding to a consensus 
sequence and recruiting epigenetic modifiers [Kuo and Calame 2004].  
Interactions have been identified with multiple epigenetic modifiers, 
including Groucho [McLaren 1999], HDAC2 [Yu et al. 2000], G9a 
[Gyory et al. 2004] and Prmt5 [Vincent et al. 2005]. 
 
Nanog and Oct4 have also been implicated in the maintenance of 
murine PGCs post-specification.  The only cells that express Oct4 and 
Nanog after the differentiation of the epiblast are the PGCs [Schöler et 
al. 1989; Yamaguchi et al. 2005].  Nanog is expressed in the PGCs 
from the moment they begin to migrate through the gut, and expression 
is extinguished once they reach the gonads and begin to differentiate, 
at the onset of meiosis in females and at the onset of mitotic arrest in 
males [Yamaguchi et al. 2005].  Oct4 is also expressed in PGCs as 
they proliferate and migrate through the gut [Schöler et al. 1989; Yeom 
et al. 1996].  Expression in female PGCs is repressed by the onset of 
meiosis and is then re-activated after birth, coinciding with the growth 
phase of oocytes.  In male embryos expression persists in germ cells 
throughout foetal development and is maintained in gonocytes, 
pro-spermatogonia, and undifferentiated spermatogonia [Pesce et al. 
1998].  Oct4 depleted ES cells cannot form PGCs in chimeric embryos 
[Okamura et al. 2008].  In addition, gene targeting experiments showed 
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 that Oct4-null PGCs cannot be maintained and consequently undergo 
apoptosis [Kehler et al. 2004].  Nanog however, is required only for the 
differentiation of PGCs into mature germ cells, once they reach the 
gonads [Chambers et al. 2007].   
 
Axolotl PGC specification shares several similarities with mouse.  In 
both organisms PGCs are mesodermally derived and are specified in 
response to inductive signals [Sutasurja and Nieuwkoop 1974; McLaren 
2003].  However, only two PGC specific molecules have been identified, 
namely axdazl and axvasa, which are expressed late in axolotl PGC 
specification, similarly to mouse [Bachvarova et al. 2004].  Molecules 
that regulate the specification and maintenance of PGCs early in 
development have not been identified.  Based on the similarities 
between axolotl and mouse PGC specification it was considered that 
homologous molecules might have a role in the development of axolotl 
PGCs.  In this chapter the roles of axblimp1, axoct4 and axnanog in 
PGC development are explored through the analysis of expression in 
oocytes and in animal caps induced to make PGCs (PGC-induced 
caps). 
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 5.4 Maternal inheritance of pluripotency genes and germ 
line marker genes 
 
It was shown previously that the pluripotency gene axoct4 and germline 
marker gene axdazl are maternally inherited and expressed in oocytes 
[Bachvarova et al. 2004].  Temporal and spatial expression data from 
early embryos suggested that axblimp1 and axnanog were similarly 
maternally inherited (Chapter 3; Figures 3.5 and 3.11-13).  To confirm 
the maternal inheritance of these genes expression was analysed on 
sections of ovary tissue by in situ hybridisation (Figure 5.2).  Similarly, 
to axdazl and axoct4, non-localised expression was detected in the 
cytoplasm of small oocytes (stage I-II) but was not detected in larger 
oocytes (IV).  Lack of detection in the larger oocytes could be due to the 
sensitivity of the assay and the dilution of the transcripts in the larger 
volume of the cytoplasm.  The maternal inheritance of axnanog, axoct4 
and axblimp1 suggests that they may have key roles during early 
development.   
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Figure 5.2 Expression of germline and PGC markers in axolotl ovary tissue. 
Panels show in situ hybridisations on sections of ovary tissue.  Expression of axdazl (i), axnanog (ii), axoct4 and axblimp1 was detected in the 
cytoplasm of stage I oocytes but was not detected in stage IV oocytes.  N = nucleus; C = Cytoplasm; CT = Connective tissue, I = stage I 
oocyte, IV = stage IV oocyte 
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 5.5 The expression of axoct4, axnanog and axblimp1 in 
PGC-induced caps  
 
Axolotl animal caps were injected with Xenopus BMP4 and eFGF RNA 
to induce PGCs (Section 1.6; Figure 1.3).  Animal caps were collected 
at stage 11.5 (late-gastrula), stage 28 (mid-tailbud) and stage 42 
(late-tailbud).  Axolotl PGCs are thought to be specified at late-gastrula 
during normal development [Sutasurja and Nieuwkoop 1974].  Thus, if 
axoct4, axnanog or axblimp1 were to have a role in PGC specification, 
an increase in expression levels would be expected in stage 11.5 
PGC-induced caps, whereas if they have a role in PGC maintenance an 
increase in expression might be expected in stage 28 and stage 42 
PGC-induced caps. 
 
Increased expression of PGC marker genes, axdazl and axvasa 
[Johnson et al. 2001; Bachvarova et al. 2004] indicated PGC induction 
in stage 28 and stage 42 PGC-induced caps (Figure 5.3i and ii).  
Additionally, increased expression of axmix and axbrachyury indicated 
the induction of PGC precursor tissue, lateral-plate mesoderm, at 
stages 11.5 and 28 (Figure 5.3v and vi).  Increased expression of 
axdazl in caps injected with BMP4 alone might be due to mesodermal 
contamination during cap cutting.   
 
The expression of axoct4 and axnanog in presumptive lateral-plate 
mesoderm (Chapter 3) suggested that they might have roles in PGC 
specification.  However, analysis of expression at stage 11.5 in 
PGC-induced caps did not reveal a marked increase in the expression 
 181
 of either gene (Figure 5.3iii and iv).  Expression of neither gene was 
detected at stage 28 and stage 42, in agreement with temporal 
expression data in embryos (Chapter 3).  Thus, it is unlikely that they 
have a role in the post-specification maintenance of PGCs, highlighting 
a difference from murine PGC development in which homologues both 
have a role in post-specification PGC maintenance. 
 
Axblimp1 expression was not detected in PGCs by in situ hybridisation 
(Chapter 3), perhaps due to insufficient assay sensitivity.  Analysis of 
expression in PGC-induced caps revealed a slight increase at stage 28 
and stage 42 (Figure 5.3viii).  These increases may be associated with 
PGC induction, but it is also possible that they are attributable to the 
induction of other mesodermal tissues and neural tissues.  Coincident 
with this, there was an almost equivalent increase in stage 42 caps 
injected with eFGF alone as in the stage 42 PGC-induced caps.  
Expression of mesodermal markers, axbrachyury and ax-Į-actin, was 
similarly increased in stage 28 and 42 PGC-induced caps and in stage 
42 caps injected with eFGF alone (Figure 5.3v and vii).  It is notable 
that ax-Į-actin is expressed in somites during normal development 
[Masi et al. 2000], a tissue in which axblimp1 expression was also 
detected (Chapter 3).  Expression of axncam, a marker of neural tissue 
(Chapter 3), was also increased in stage 28 and 42 PGC-induced caps 
and in stage 42 caps injected with eFGF alone (Figure 5.3ix).  
Furthermore, extensive expression of axblimp1 was detected in neural 
tissues by in situ hybridisation.  This data does not rule out a role for 
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 axblimp1 in post-specification PGC maintenance but it is unlikely that 
axblimp1 has a role at the onset of PGC specification. 
 
In summary, the expression of axoct4, axnanog and axblimp1 in 
PGC-induced caps indicates that they do not have a role in PGC 
specification but does not rule out a role for axblimp1 in the 
post-specification maintenance of PGCs. 
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Figure 5.3 Analysis of gene expression in PGC-induced animal caps 
Panels i-ix show the expression levels of 9 different genes, identified to the 
right of each chart i) Axdazl expression, ii) Axvasa expression, iii), Axnanog 
expression, iv) Axoct4 expression, v) Axbrachyury expression vi) Axmix 
expression, vii) Ax-Į-actin expression, viii) Axblimp1 expression, ix) Axncam 
expression.  Axolotl embryos were injected with 5 ng Xenopus BMP4 RNA 
and 20 pg Xenopus eFGF RNA at the 1-2 cell stage to induce PGCs and 
animal caps were cut at stage 9 (late-blastula).  Caps were collected at stage 
11.5 (late-gastrula), stage 28 (mid-tailbud) and stage 42 (late-tailbud) 
(indicated by numbers in red).  Uninjected caps were collected at each stage.  
In addition, at stage 42, caps injected with BMP4 or eFGF were collected.  
Primary data was analysed using the 2íǻǻCT method [Livak and Schmittgen 
2001] and was calibrated to the expression level in uninjected caps at each 
stage, except for ax-Į-actin which was calibrated to the expression level in 
stage 28 uninjected caps as there was no measurable background expression 
at stage 11.5 in either sample or in uninjected caps at stage 42.  Samples 
exhibiting background levels of expression are indicated with an asterisk (*).  
(Animal cap processing was carried out by OReilly et al and expression 
analysis by the author.) 
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 5.6 Conservation of the maternal inheritance of 
pluripotency factors 
 
Similarly to axolotl, germ plasm was not identified in the oocytes of the 
gulf sturgeon, Ascipenser oxyrhynchus [Johnson et al, unpublished].  
Vasa and dazl homologues, which are commonly localised to the germ 
plasm, are not localised in sturgeon oocytes suggesting the absence of 
germ plasm [Johnson et al, unpublished].  Thus, it was proposed that 
PGCs would be specified via epigenesis.  It was considered that the 
maternal inheritance of pluripotency factors might be peculiar to 
organisms that specify their germ cells via epigenesis.  Thus, a 
sturgeon nanog orthologue, stnanog, along with a sturgeon oct4 
orthologue, stoct4, were cloned from oocytes [J. Dixon, unpublished].  
Following this, in situ hybridisations were carried out on sections of 
sturgeon ovary tissue to analyse the localisation of transcripts 
(Figure 5.4).  Similar to observations in axolotl ovary tissue, 
non-localised expression was detected in the cytoplasm of stage I 
oocytes.  This suggests that the maternal inheritance of pluripotency 
factors might be conserved amongst anamniotes that specify their 
PGCs via epigenesis. 
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Figure 5.4 Spatial expression of stnanog and stoct4 in ovary tissue 
Panels show in situ hybridisations on sections of sturgeon ovary tissue.  
Stnanog (i) and stoct4 (ii) expression was detected in the cytoplasm of stage I 
oocytes. N = nucleus; C = Cytoplasm; CT = Connective tissue, I = stage I 
oocyte. 
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 5.7 Discussion 
 
How the germ line is segregated from somatic cells is a fundamental 
question in developmental biology.  There are two known modes of 
PGC specification, preformation and epigenesis.  A common feature of 
both appears to be the necessity to silence programs of somatic gene 
expression [Nakamura and Seydoux 2008].  Little is known about the 
molecular mechanisms governing axolotl PGC development, but given 
the similarities to murine PGC development it was considered that 
homologous molecules might be involved.  Thus, the roles of axblimp1, 
axoct4 and axnanog in PGC development were investigated. 
 
Murine Blimp1 has been shown to have a critical role in PGC 
development [Ohinata et al. 2005; Vincent et al. 2005; Ancelin et al. 
2006].  It is thought to mediate a program of epigenetic modifications in 
PGCs, which silences somatic gene expression and promotes a 
PGC-specific program of expression from the onset of PGC 
specification (E5.5) [Ancelin et al. 2006; Kurimoto et al. 2008].  
Axblimp1 expression was not detected in PGCs by in situ hybridisation 
(Chapter 3) and expression was not increased in PGC-induced caps at 
stage 11.5 (late-gastrula), the time when PGCs are believed to be 
specified.  This data suggests that Axblimp1 expression is not required 
from the onset of PGC specification as in mice.  However, it is possible 
that Axblimp1 has a role at a later stage of PGC development as 
expression was increased in stage 28 and stage 42 PGC induced caps.  
These increases may also be attributable to the induction of 
 188
 mesodermal and neural tissues, in which axblimp1 expression has been 
detected by in situ hybridisation (Chapter 3).  Expression was also 
detected in differentiated germ cells i.e. small oocytes.  The absence of 
axblimp1 expression in PGCs would be consistent with previous 
observations that PGC precursor cells in axolotl may be multipotent 
until a relatively late stage in development [Bachvarova et al. 2004].  
Bachvarova et al. (2004) identified cells co-expressing axscl, a blood 
stem cell marker, and axdazl, in an equivalent position to HSCs in 
Xenopus [Walmsley et al. 2005].  They suggested a common origin for 
blood and PGCs.  The absence of axblimp1 expression in PGCs is 
consistent with the hypothesis that the precursors of axolotl germ cells 
are multipotent as Blimp1 in murine PGCs is coincident with lineage 
restriction.  In order to definitively rule out a role for Axblimp1 in PGC 
development it will be necessary to carry out overexpression assays 
and knock-down experiments.  These experiments could be carried out 
in animal caps to avoid the potentially widespread defects, given the 
known expression pattern, of whole embryo experiments.  For example, 
an Axblimp1 morpholino could be injected along with RNAs to induce 
PGCs, in order to measure the effect of an Axblimp1 knock-down on 
PGC induction directly. 
 
Nanog and Oct4 also have roles in the maintenance of PGCs in mouse 
[Kehler et al. 2004; Chambers et al. 2007], thus axnanog and axoct4 
expression was also investigated in PGC-induced caps.  The data 
suggests that there is not a conserved role for these molecules in 
 
 post-specification PGC maintenance, however, given their expression in 
the lateral-plate mesoderm, they may be required to maintain a 
pluripotent/multipotent PGC-precursor tissue.  Notably, axnanog and 
axoct4 expression was detected in differentiated germ cells i.e. small 
oocytes.   
 
Axnanog is the first orthologue to be identified in an anamniote model 
organism.  Many prominent lower vertebrate model organisms specify 
their germ cells via maternally inherited molecules [Houston and King 
2000], germ plasm, as opposed to inductive signalling in mouse and 
axolotl [Sutasurja and Nieuwkoop 1974; McLaren 2003].  The proposed 
function of Axnanog (Chapter 4) is to coordinate the epigenetic events 
that are required to maintain germ line competent cells whilst also 
enabling somatic differentiation during embryonic development and I 
suggested that this function might not be required in organisms that 
specify their germ cells via preformation.  Similar to axolotl, germ plasm 
was not identified in the oocytes of the gulf sturgeon, Ascipenser 
oxyrhynchus [Johnson et al, unpublished] and expression of stnanog 
and stoct4 was detected in small oocytes.  This supports the hypothesis 
that Nanog function is required in organisms that specify their PGCs via 
epigenesis.  Interestingly, a nanog homologue has been identified in the 
chicken genome and chickens also specify their germ cells via germ 
plasm.  Johnson et al. (2003) previously proposed that the specification 
of PGCs via germ plasm early in development might remove an 
evolutionary constraint, thus, allowing more rapid embryogenesis and 
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 the evolution of novel mechanisms governing development.  The 
removal of this evolutionary constraint might also allow organisms to 
bypass pluripotency and may be permissive for the loss of nanog from 
the genome.  However, the presence of Nanog in the chicken genome 
suggests loss of nanog is not necessary to allow regulative specification 
of PGCs. 
 
Interestingly, both nanog and oct4 expression was detected in small 
oocytes in axolotl and sturgeon ovary tissue.  The maternal inheritance 
of Nanog is not conserved in mammals.  However, zygotic transcription 
commences at the two-cell stage in mouse embryos, whereas in 
anamniotes it does not commence until the blastula stage (MBT).  Thus, 
early development in anamniotes is governed entirely by maternally 
inherited molecules.  The maternal inheritance of Nanog in axolotl and 
sturgeon embryos may be essential for the early establishment of 
pluripotent gene expression in the absence of zygotic transcription. 
 
The molecular mechanisms governing axolotl PGC development remain 
elusive.  It is likely that as in other organisms there is a program of 
molecular events that prevent the PGCs from responding to somatic 
inducing signals and diverging from the germ line.  Future investigations 
should eliminate the possibility that Blimp1 has a role in axolotl PGC 
development through functional assays and also examine the function 
of other candidate molecules.  It will be interesting to uncover how 
divergent the axolotl mode of PGC specification is from mice, especially 
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 given the striking similarities of other developmental processes.  
Discerning the molecular mechanisms governing PGC development in 
axolotl could help us to understand the evolution of these mechanisms 
in mammals. 
 
5.7.1 Summary 
 
1. Axblimp1 expression was not detected in PGCs (Chapter 3) and 
analysis of expression in PGC-induced caps suggested that it does not 
have a role in PGC specification, but did not rule out a later role in PGC 
maintenance.  Functional analyses are required to eliminate the 
possibility that Axblimp1 has a role in PGC development. 
 
2. Analysis of axnanog and axoct4 expression in PGC-induced caps 
suggested that they do not have a role in PGC maintenance as in 
mouse.  However, their expression may be required to maintain the 
pluripotent tissue from which PGCs are specified.  This could be 
determined in animal cap assays as described in Chapter 4. 
 
3. The maternal expression of Nanog is peculiar to the anamniotes in 
which it has been identified.  I proposed that this maternal inheritance 
may be necessary in anamniotes in order to establish pluripotency as 
zygotic transcription does not commence until the mid-blastula 
transition, whereas, in mammals the onset of zygotic transcription is 
much earlier. 
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 Chapter 6 Overall conclusions 
 
Axolotls are good model organisms for studying the evolution of 
developmental processes in amniotes as there are many 
similarities between the developmental mechanisms in axolotl 
and mouse.  Additionally genes in axolotl are predicted to be 1:1 
orthologs with those in humans.   
 
Cells with pluripotent properties (animal cap cells) were first 
identified in axolotl embryos.  In this study, the cloning and 
characterisation of axnanog, the first nanog homologue to be 
identified in an anamniote model organism was described.  
Axnanog was coexpressed with axoct4 in the undifferentiated 
tissues of blastula and gastrula stage embryos, suggesting that 
these molecules may have a conserved role in 
pluripotency/multipotency. 
 
Depletion of Axnanog through the use of antisense morpholino 
oligonucleotides disrupted gastrulation.  Additionally, the 
expression of pluripotency genes and genes associated with 
early tissue specification was maintained in morphant embryos, 
whilst terminal differentiation markers were only expressed at a 
low level.  There are two explanations for this phenotype, a 
migration defect or a developmental block.  Further analyses are 
required to distinguish between these two possibilities.  I 
proposed that a developmental block might have been caused 
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 by misregulation of epigenetic regulators.  Future analyses could 
consider this possibility. 
 
Preliminary knock-down data for Axoct4 revealed a similar 
phenotype to Axnanog morphant embryos, suggesting that 
these molecules may function in the same pathways during 
development to regulate pluripotency/multipotency. 
 
Interestingly, maternal nanog expression was detected in both 
axolotl and sturgeon oocytes.  Maternal expression of nanog has 
not been detected in mammals, suggesting that this may be 
peculiar to anamniotes.  I proposed that maternal expression 
may be necessary to establish pluripotency in anamniotes as 
zygotic transcription does not commence until MBT, whereas, in 
mammals the onset of zygotic transcription is much earlier. 
 
Little is known about PGC development in axolotls.  Given that 
there are similarities between axolotl and mouse PGC 
specification it was considered that homologous molecules 
might have a role.  The roles of Axoct4, Axnanog and Axblimp1 
were investigated.  The data suggested that neither Axoct4 nor 
Axnanog have a role in PGC maintenance but it is possible that 
their expression is required to maintain the tissue from which 
PGCs are specified.  Axblimp1 expression was not detected in 
PGCs by in situ hybridisation, but this might be attributable to 
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 assay sensitivity.  Analysis of expression in PGC-induced caps 
suggested that Axblimp1 does not have a role in PGC 
specification, as in mouse, but it did not rule out a role in PGC 
maintenance.  Further functional analyses are required to 
definitively ascertain if Axblimp1 has a role in PGC development. 
 
Much remains to be discerned about both the mechanisms 
governing pluripotency/multipotency and those governing PGC 
development in axolotl.  The investigations presented here will 
provide a good foundation for future analyses. 
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 8. Appendices 
 
8.1 Nucleotide Sequences 
 
Full nucleotide sequences obtained during the study are shown below.  Regions highlighted in blue represent the fragments used 
as ISH probes.  Axnos1 sequence was obtained by screening a stage 10.5 (mid-gastrula) cDNA library with a fragment obtained 
previously by degenerate PCR.  Axpumilo sequences were both obtained by screening the same library with a fragment of the 
Xenopus pumilio homologue (Xpum: AB045628).  Further axpumilio2 sequence was obtained by 5 RACE.  Regions highlighted in 
red are ORFs. 
 
Axcarm1 
 
TCGATTATCGGGGACGCGAACGGTGAGATCNAGCGGCACGCCGAGCAGCAGGCCCTGCGGCTGGAGGTCCGGGGGACGCCCGAAGCGGCGCTCATCGCTC 100   
TCTACAGCCACGAAGATGTGTGCGTATTTAAGTGTTCGGTGTCCCGTGAAACTGAGTGCAGTCGAGTCGGCAAGCAGTCTTTTATTGTCACATTGGGCTG 200   
CAATAGTGTCCTCATACAATTTGCAACGCCCAATGATTTTTGCTCTTTTTATAATATCCTCAAGAACTGCCGGGGCCACAACTCTGAGCGGTCCGTCTTC 300   
AGTGAGCGGACGGAGGAGTCGTCAGCTGTTCAGTATTTCCAGTTCTATGGGTATCTATCACAGCAACAGAACATGATGCAGGATTATGTACGGACAGGGA 400   
CGTACCAGAGGGCTATCCTGCAGAACCATGCAGATTTTAAAGATAAAGTTGTATTAGATGTTGGGTGTGGCTCCGGAATCCTGTCCTTTTTTGCAGCACA 500   
GGCCGGAGCCAGAAAAGTCTATGCAGTGGAGGCCAGTACAATGGCGCAACATGCTGAGCTTTTAGTAAAAAGCAATAACCTCACCGACCGGATTCTGGTA 600   
ATCCCAGGGAAGGTAGAGGAGATCTCGCTCCCGGAGCAGGTGGACATAATCATCTCGGAGCCCATGGGCTACATGCTCTTTAATGAGCGCATGCTGGAGA 700   
GTTACTTGCACGCCAAGAAGTTCTTAAGGCCTAATGGTAACATGTTCCCCACTATTGGCGATGTTCATCTGGCTCCCTTCACTGACGAGCAGCTCTACAT 800   
GGAGCAGTTTACGAAGGCCAACTTCTGGTATCAGCCGTCCTTCCACGGAGTGGATTTATCTGTTCTTAGAGGTGCTGCAGTGGATGAATATTTCAAGCAG 900   
CCTGTTGTGGATACCTTTGATATCCGGATTTTAATGGCAAAGTCCGTTAAATATACAGTGAATTTCCTGGATGCCAAGGAATGTGATTTGCACAGGATAG 1000  
AGATACCCTTCAAGTTTCACATGTTGCACTCTGGTTTGGTGCATGGCCTGGCGTTCTGGTTTGACGTGGCTTTCATTGGTTCAATAATGACGGTCTGGCT 1100  
CTCCACTGCACCCACAGAGCCGTTGACACACTGGTACCAAGTACGCTGCCTACTCCAGTCACCACTATTTACAAAAGCAGGTGACACTCTCTCGGGGACT 1200  
GTCCTCCTTATAGCTAACAAAAGACAAAGTTACGACATCAGTATTGTAGCCCAGGTGGATCAGACTGGTTCCAAGTCAAGCAATCTCCTCGACTTGAAAA 1300  
ACCCCTTTTTCAGGATGCCTACTGCTTATGACCTCAGTGGAGTAATGGGCGGCGGTTCCACCATTGGACACAACAATCTGATTCCTTTAGGATCTGCTGG 1400  
TGGCCAGGGCGGAGGCAATTCAAGCACCCACTACCCCGTCAACAGCCAGTTCACAATGGGCGGACCCGCGATCTCTATGGCATCACCAATGTCCATCACC 1500  
ACCAACACAATGCACTACGGGAGC 1524   
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 Axncam 
 
ATGCTGCATACTCAGGATCTCATCTGGACTTGGCTTTTGCTGGGAACCGCAGTCTGTATTCAGGTGAACGTTGTGCCAAACCAGGTAGACGTCGATGTGG 100   
GAGAGTCCAAGTTCTTCTCATGCCAAGTAACGGGTGGGGAAGCCAAAGATATATTCTGGTTTGCCCCAAGTGGAGAGAAGATTGATTCAAATCAACAGGA 200   
GCTATCAGTTATACGAAATGATGAGGTGTCATCCACGCTTTCTATCTACAATGTTGACATCGATGACGCCGGTATCTACAAATGTGTTGCCACGACCGAA 300   
GGGGAGGGAGAAGTGGAAGCTACTGTTAATGTGCAAATTTACCAAAAAATGATTTTCAAGAATGCACCTTCACCCCAAGAATTTACAGAAGGAGAAGATG 400   
CGGTTGTCATTTGTGATGTCAGCAGCGTACAGACGCCTTCGATAATGTGGAAGCACAAAAACCGAGATGTTGTCCTTAAAAAAGACGTCCGATTTGTTGT 500   
CTTGACCAACAACTACTTGCAGATCCGAGGAATTAAGAAAACAGACGAAGGGGAGTACCGCTGTGAGGGGAGGATCCTGGCACGTGGGGAGATCGCCTTC 600   
AGGGATATCCAAGTGGTTGTGAATGTTGCCCCCGTTGTCCGGGCTCTACAGAGTACTGTCAATGCTACAGCAAACCTTGGGGAATCCGCTATCTTGGCAT 700   
GTGCTGCTGAAGGATTTCCTGACCCAGAGATAAGTTGGACAAAGGAAGGTGAAATGATTGAAGAAGACAGTGACAAATACAAGTTCACCGAAGATGGCTC 800   
CCAGATGACCATCTTCAAGGTGGACAAGAGCGATGAAGGGGATTATACTTGCATTGCAGAGAATAAGGCCGGCGAGCAAGAAGCATCTATTCTCCTGAAA 900   
GTCTACGCAAAGCCCAAGATCACATATGTGGAGAACAAAACAGCCATGGAACTGGAGGAACAGATCACTCTGACGTGCGAGGCCACAGGCGACCCCACAC 1000  
CAAGCATCACCTGGAGAATGGCGACAAGGAACATCAGCAGCGAAGAAAAGACTCTGGATGGACGTATCGTGGTGAGCAGTCACGCCAGGGTCTCGTCTCT 1100  
CACGTTGAACGACATTCAGTACACCGATGCGGGGGAGTACTTCTGCATTGCGAGCAACACCATTGGACAGGACTCTCAGGCCATGTACCTCGAAGTGCAG 1200  
TATGCCCCTAAGTTGCAAGGCCCAATTGCCGTTTACACCTGGGAAGGGAACGCAGTCAATATCACCTGTGAGGTCTTCGCTTACCCCAGCGCCGTCATTT 1300  
CTTGGTTCCGAGATGGGCAGGCCCTGCCAAGCTCCAACTACAGCAACATCAAGATATACAGCACCCCATCTGCAAGCTTCTTGGAGGTTGTTCCAGATTC 1400  
TGAAAATGATTTTGGCAACTACAACTGCACCGCCATCAACCGCATTGGCCAGGATTCTTCCGAGTTTATCCTAGTTCAAGCAGACACTCCATCCTCTCCT 1500  
TCCATTCTGAAGTTGGACCCTTACTCCAGCAGTGCCAAGATTGAGTTTGACGAGCCTGATGCCACTGGTGGAGTGCCCATCCTGAAGTACCGTGCCGAGT 1600  
GGAAAGCGGTCACTGATGAGGAGTGGAGCTCTAGAATGTATGATGCCAAGGAAGCGAGCATCGAAAATGCAGTCACCATTGTAGGCCTGAAACCGGAGAC 1700  
ATTTTATGCAGTGCGACTATCCGCCATCAACGGCAAAGGCTTGGGAGAGTACAGCTCGATATCAAAGTTCCAAACTCAGCCCGTCCAAGGGGAACCCAGT 1800  
GCTCCAAAGCTGGATGGACAGATGGGAGAGGACGGAAACTCCATAAAAGTGAACCTAATCAAGCAAGATGATGGAGGATCCCCAATCAGGCACTATCTGG 1900  
TTACGTACCGAGCAAAAAATGCTCTTGAATGGAAACCAGAAATTAAAGTTCCTTCTGGTAGCAACCACGTCATGCTCAAAGCTCTAGACTGGAATGCAGA 2000  
ATACGAAGTCTTTGTGATAGCCGAAAACCAGCAAGGCAAATCGAAACCGGCCAGCTTCTCCTTCAGGACTCTCGCCCAGCCCACTGCCATTCCAGCAGGT 2100  
CCAAGCCATGGTTCCGGGCTGGGCACTGGTGCCATCGTGGGTATCCTGATCATCGTGTTTGTCATCCTCCTGGTCGTGGTTGACGTCACCTGCTACTTCC 2200  
TGAACAAGTGTGGCCTGTTGATGTGCATCGCCGTGAACCTGTGCGGCAAATCCGGCCCAGGAGCAAAGGGCAAAGACATTGAAGAGGGGAAAGCCGCCTC 2300  
CTCGAAAGACGAATCTAAGGAGCCCATTGTGGAAGTGAGGACGGAAGAAGAGAGGACCCCAAACCACGACGGAGGCAACCAGACCGAACCCAATGAAACC 2400  
ACTCCGTTAACAGAACCTGAGAAGGCCCCTGTAGAAGAAAACTCCAAGCCCGAAGATACGGAAGCCAAGACAACTGCGCCCGAAGTCAAGACGATCCCGA 2500  
ACAATGCCCCACAGACAAACGAGAATGAGAGCAAGGCA 2538
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 Axblimp1 
 
ATGAAAATGGACATGGAGGACGCCGACATGACCCAGTGGACGGAGGCGGGGTTTGAGGAGAAGTGCACCTACATTGTGAACGATCACGCCAGGGACCCCT 100   
TGGCCGATGCCGGTTCGGCCTCGCAGGCCGAAGCGTCCCTGCCCAGGAACCTGACCTTCAAGTACTCTGACAACTACAAGGAGGTCATTGGGGTTGTCAG 200   
CAAAGAGTATATCCCAAAAGGAACCCGGTTCGGTCCCCTGGTTGGTGAGACCTACACGCCCGACACCGTTCCAAAGGATGCCAACAGAAAGTACTTTTGG 300   
CGGATTTACTCCGGTGCTGACTTCGACCATTTCATTGACGGCTTCAATGAAGATAAGAGCAACTGGATGCGCTACGTCAACCCTGCGCACTCGGTGCAGG 400   
AGCAGAGCCTGGCTGCTTGCCAGAATGGCATGGACATCTACTTCTACACCATCAAGCCCATTCCCGCCAACCAGGAGCTACTTGTCTGGTACTGTCGGGA 500   
CTTTGCAGATAGGCTGAACTACCCTTCCTCGGGAGAACTCACGATGGTGACTCCGAAACAGACCAGCATCAACCCAAAGCAACAGCACACTGAAAAGGAG 600   
GTGCTTCACCACAAAAGTGCCCCGAAAAAAGAACACAGCATGAAGGAGATTCTTAAAACTTCTGTAAGCCAATCCAAAGGCAAGGACTTCTACCTGAACC 700   
GCATTTCACCAATCACGCCAGAGAAGGACTTGGGTGACTTGAGGAAAAACTGCAGCCCGGAGAGGCCGTTCTTTCCCCGGGTGGTATACCCAATCCGGCC 800   
TCACATTCCAGAAGATTATTTGAAGGTGTCTTTAGCGTACGGGATGGACAGGCCGAATTATCTCTCGCACTCACCAATGCCATCGTCCACGACGCCCAGT 900   
CCTTCTGCACGGAGCAGCCCAGACCAAAGTTACAAAAGTTCCAGCCCGCAAAGCAGCCCAGGTGCCACAGTGTCCCCCCTCATGACTTCTTTACAAGAAC 1000  
AGCGGGAGTCTTACCCATACCTGAATGGACCGTGCAGCACAGAAGGTCTGGGATCGTATCCTGGCTACGCCCCGCACAATAGCCACCTCTCTTCGGCTTT 1100  
CCTATCTTCCTACAACCACCATTACCAAAAGTTCTTGCTACCTCCTTTCAACATGGGCTGCCCCAGCCTGAGCACCTTGAACAATATTAACAGCCTCAAC 1200  
AATTTCAGCCTCTTCCCTAAAATGTACCCGCTTTGCAACAACTTGCTCAGTGGGGGAAGCCTCTCTCACCACATGCTCAACCAGGTGGCTCTTCCATCAT 1300  
CTCTGCCCCACGAAAGTGGGCGCCGCATGCTCCACCCTGAGCAACCCCGGGACTTTCTCATTCCAGCACCCAACAGTGCCTTCTCCATCACCGGGGCGGC 1400  
TGCTAGTATGAAGGACAAGCCAAGCACTCCCACCAGCGGCTCTCCGACTGCTGCCACGGCAGCCGCTTCCGAACACTTAATGCATCCGAAAGCTACCTCA 1500  
GCTGCGCTGGCCGCCAGCAACGAAGAAGCAATGAATCTTATTAAAAATAAGAGGAACATGACTGGTTACAAAACGCTTCCATATCCGCTCAAGAAGCAGA 1600  
ACGGGAAGATTAAGTACGAGTGCAACATTTGCTCAAAGACATTTGGCCAGCTGTCAAACTTGAAGGTTCACCTGCGAGTACACAGCGGGGAGAGGCCGTT 1700  
CAAATGTCAGACGTGCAACAAAGGATTCACGCAGCTGGCCCATCTGCAGAAGCACTACCTTGTACACACGGGAGAAAAGCCACACGAATGCCAGGTCTGC 1800  
CATAAA 1806 
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 8.2 Intron sequences 
 
Full intron sequences obtained are shown below in blue.  Flanking exon sequence is shown in black.  Gaps in the sequence are 
indicated by dashes. 
 
Axnanog intron 1 
 
CGCAAATGAGGGTGCCAGGATACCAGGCCTACACGGAACTGAACCAACCGTGTGCTGTGGCGGCGAACTACGCGCCAGCATTCCAGGGGAACCTGCAGGC 100   
CGCAGAAGAGGGGCGCCCGGTCCCGGCAGgTAAACAACCTTGAAATCCAGCGGGGCATATCACGCGGCCATCGCCAGCTAGAGGGGAGGGGATGGGGGGG 200   
CTGTGTATGCCACGCAGAAGCGGAGTATTCCATGCCACTAGCCCTCATTTATTTTAGAATGCCAGCATTACCTGCGCGGATAGCTCGGCGGGTGGAGCGC 300   
GTGTTGTAAAGGCCTATTTCTACGGCCAGATAGACACCTGCCTTACTTTGATTACTTTGAAAGATACCCCCACTCTAGGGCGAGAGGTTCCCAGTCGTCA 400   
GGAACCCGACACATCATAGAAGTCTCTCCGTTTTGCGGGAAATGTGCATTGAAAAGGTGCATTCTGGCATCATGTTCCCGCACCCCGTCCCGCAACACGA 500   
ACTCGTGGCCTAACCTGGGTCTGTATTCTGGGCAGTTTCCTGTGTAATTAAACAGCGCACCTTTTTATCAACGTCAATTTTAGGCCATTTGCATTATACC 600   
TCTGCAGGGAAGTAGTTTCGGGGCGACGCGCAGGCTGGTTGTAATAGCTGGTGTTACTTTTGTAACTGTGCTCCGGGGCACTTGGTTCGCGTGCCCACCT 700   
GACTGTCTTCACCCCTGCACACTCCAATCATGGCTCCTCATCGGCATTTCCTCCTGATCTACCCTCCCCTCCATACACAGCAGCGGTTCCTGTTTTGTCC 800   
CCTCATTCCTCANCATGTCCCTCGGCTGCCCTCCCTTCTCAGTCCGCAGTGGTGCCTTCTGCACAGCAGTTCTGCCTGCCCTGCCTGTGCGTCACTGCTT 900   
TGCA--------------------GTCACTGCTTTGCAATGCATTGCGTATTAGCAGCACAGACACTTGGTGGGTGGCACCGTGCCAGGGGGTCCAAACG 980   
CAACAGTGTAAAATATTATCTGGGAATGGGGAGAGCAAAGGGGTCGCTCGATCAGCCTCTCGAGAATTGGATTCCATAAGATAAAAACGGGGGGGCAGGG 1080  
GGAGAGGCGGTCGCGCAGCGGGCTCCGTTGAAAGGGTCTTGTAGACTGGTGTGCTCGAAAAACAAAAACGTGCTTGCTTCTAAATTGTGCTGGTTGGAGG 1180  
CAAACCATGGCACATTTCCTAACACGTACAGCAGAGGGCAGCAAAGGCGTGCGCACTTGCGCTCACCACGCATTCAAGCCCCAATTTCAATGAGCAACAC 1280  
AATCGTGTTATTCCACAATTGCGACAGAGGTTGGAAAAGGCTACTTTGCGTTATGTCGTTTGTTATTATATACTATATTGCATTACATTTGATTTAGTAT 1380  
CCTAGGTTGCATGGTTTAAGTAGTGTATTTAATATTAACGGATAGAGCATATGTGATATTCTCAACGATGGTTATTTTGATCAACTTGGCAGGTCGGTGC 1480  
GGTGAAGCGAATGTGCCAGTATTCAAATGCATGCAAGTTACACGCCCGGTGGCAGGGGCATTAACCCACTGAGGCGGCGCTCCCTCCAATCGTGCACCAG 1580  
TAGACCATTCAAAACAAGGCACGGTTTCCACTCTGTGTGTAATGTGTCTGATTCCGTTTGTTGGCTGGTGGCCCCATTTGCCCGCATACTCTTTCCAGCT 1680  
GATTTCACGCGTGCCATGTCTTCGTTTTGTTTCAgTCCTGCCGTCTTCCCCCGACTCAGCCACCAGCCCAAAGGTGGATCCGTTCGCCCAGTGTGCCCCG 1780 
 
 
Axnanog intron 2 
 
CAATGCAGGCGCAGCAGCTGGCGGCGGATCTCAACCTCACATACAAGCAGGtACAGGCCTAAAGAGAGGGGCAGAGTGTGGGGGGTGATACTTCAGAAAA 100  
CAACGTGGGAAGATAGTTTAATTTTTCAATCCATCTCTTGGTAgGTGAAGAACTGGTTCCAGAACCGAAGGATGAAGCACAAACTGTCCCTGAA 194  
 
 214
 Axoct4 introns 
 
ATGGCTGGGCATTTGGGACAGGAGATTGGGCGGGCTGCCTATGGGTTCGGTGCACAGGCCTTGCACCTGGGGGCCGGGGGCCTCGAGGCGGGCGGGCCGG 100   
GCTTCCTGTCCGAGAGCTATGGGCCCTACGCCGGCTTCAAGGCGCTGGAGTATGCCCATGGCGGGGCGGAAGGAGAGGGCCGACCGGGGGCCCATGGGCT 200   
GGCACGGGCCTGGTACCCCTTCTCGGAGGCCTGGGGCCCTGTGTATGGGCAGAGCGGTGCCGGCGCAGGGTTCGAGAGCAGCCGGGTGGAGGTCAAGGTG 300   
GAGAGGCCCGACAAGGAGGCTGGCTACGGGCAGCAGCACCAGCAGGCCTGGGCTGGCTACTTCGTGCCCCAGCTGGCAGTGCCCGCCAGGTCGCCTGCGT 400   
CCGTGGCCAGCGGAGGGCAAGTACCGGCCGCACCTGCCAGCCCGTCCGATGACAGCCCGCACAGCAGCACCGCCAGCAGCAGCAGCGCCAGCCCGGACCT 500   
GGGGGCTGGGGGCGCCCCGCGGGACCTGGACAGCGGAGACGAGGAAGGGGGGACGTCGGCGGACCTTGAACAGTTTGCCAAGGAGCTGAAGCAGAAGCGC 600   
ATCACGCTGGGCTTTACGCAGGCGGATGTAGGGCTGGCGCTCGGGGCGCTGTACgGTGAGTGTCCTGGCCTATGCCTGAAGTACCCACAGTTGCACACCA 700   
AGGCTTCTAGTTTGCCATCACCTGATGGCCCATCTCCACACCTTCCCGAGGGACTGGCCACACTGCCTTCGGTTGGCATCACTGCGTGGGTCCTCCGATG 800   
GGTGGGCTGTAGGGGTACTGGAGCCCACTTGTTTGTCACCCACTCTTAAGTGCCTCTACTCTTGTGCCTTGACCCaGGGAAGATGTTCAGCCAGACGACG 900   
ATCTGCCGGTTCGAGGCCCTGCAACTGAGCTTCAAGAACATGTGTAAACTGAGACCCCTGCTCCAGCGCTGGCTGGTCGAGGCCGACACCAACGAGAACC 1000  
TGCAGGaGGTAAAGGGCTTCCGGGGAAGGGTACTTGCGGCATGATGGACCACCCTAATGCTGGGAACTCTGTCCGCACCTGTGTGGGAACCGTCATGTGC 1100  
ACCTAGGTTTGGGGGGGGGGGATCTCCATCACTTGCTTTTCTGACTGCATATTTTTCTAGGTTTGGGGGGGGGCACCTATAGGATGCAGGGACTTCAGCC 1200  
TTCCCTGACCGAGCCTTACGCACGCTTGGCCTCTGTCTTGCTTGGCCTCTGTCTTGACCGTCTCTTCTTGCATCACCCACTTcAGCTCTGCAACCTGGAG 1300  
AATGCCCTGCAACAAGCCCGGAAGAGGAAAAGAACCAGCATCGAGAACAGCGTCAAGGACAACCTGGAGGCCTTCTTCCTGAAGTGTCCGAAGCCCACCC 1400  
ATCAGGAGATCGCCCACATCTCCGAGGACCTCAATCTGGAGAAGGACgTAAGTGGCCTATAATTCCAACAGCGCTCACCCCACCTAACCTGCTCCTCGAG 1500  
ACACGGTCTAGCCCAGAGCTCACGTTCTACCATTTGGATAACTTGCCACCAAGTGTGTCTGGCACCTGGTACACCTGTTGGGCAGGTCTTTCCCACTAGC 1600  
CTCTAACTCTCCTCTCCTGCAGCGTCATACGCAGCAGAGCCAAACCGCAGGGCAGGTGGGCACCACACAGAACCATCATCATGGCCTTCTGTTGCTGATT 1700  
GGGGGGGGGGGGGGTAACAGGGTAAAAAGCCCACTCTTGGTGGGCTTGCTTTTGGGTTGGATACATAAGTGTGTTGGTAAAACGGGTCGATGATAGTTTG 1800  
GGAGGGGATTGGGCAAACAGACGTAGGTTTGTCAAGGGGCAGTGTTGGGGCAAACTAGGTCCTGAGTCTTTCCTAGAGGTTGGTTACTCTATGGTAACTT 1900  
GTTGTGGATACCCCCAAAAAGGAGCTGTTGCTTCCAGGCCAGAGTGTGCTTCTAGTTTACACCTGGTGCATGCCTGGTCTTGCCACCGCCAACTCCAGTT 2000  
TATGCCCTCGCCACCCACCTGGGATTCTCATCACTCCACACATGAAACCCGCAACCAAATTAATTATCCTAGGTGCCCTCAACCTTGGGTACAATGACCT 2100  
CTCTGACCTGAAAGCCTCTGTACTAGCTCTAGAAGACTCTCGGCTAATGCAACTATTGACATGGTCTCGCATCATGGTCCCGCATCAGTCTCACATCATG 2200  
GTCCCCATCAGTCCCACATCATGGTCCGATCACTTCTACCTGAACCTCTCTATTGCCACTCCTGCCGCGGCCCAGACTTTAGTTTTGGTTAGGAATACCT 2300  
GCAAATAGACGCACATGGTTCTAAAACAACTCTCCTGGCATCACTTAATACTACACTCTTGCCAACAAAATTCCCTCAAGACATAGCCAACCACTGCCAT 2400  
GATTGCCTACGCCGCACCATGCCCCATATCACTGCCAAGACACCCAAACCTCATCTACTCTATCAAGCACGATTTTCTTAAGGGCTACTTTTCCCTATGG 2500  
AGGCAAAGGGTGCTCAACACCTATACAAAAAGCACCCAACCGCAAGCCCGATCCCTGGCTCTTTGACCGGAGTAAAACGTTGTCCATGTACCCTGTACCA 2600  
GTGATAGCCCGTGAGTAACTGAAGGAAGGCCTTTGTCTCCCCCGCAgGTGGTCCGCGTCTGGTTCTGCAACAGGCGACAGAAGGGGAAGCGCAGCATTTG 2700  
CCGGGAGGAGTATGATGGCTTCCAGCAGTACCCAGGGATGCAGCCGGG 2748  
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 An alignment of axoct4 intron boudaries with splice-blocking morpholinos 
Exon sequences are shown in black, intron sequences are shown in blue and morpholino sequences are shown in red.  Panels A, B, and C 
show axoct4 intron boundaries and morpholino designs.  Suitable sites for morpholino design were not identified at the intron-exon boundary of 
axoct4 intron 4.  Note. PCR designed to clone axoct4 intron 1 from genomic DNA only produced products lacking an intron suggesting there 
may not be an intron at this position in axoct4.  Morpholinos would be synthesised antisense to the sequences shown. 
 
A. Oct4 Intron 2 
Exon-Intron Boundary CGCTGGGCTTTACGCAGGCGGATGTAGGGCTGGCGCTCGGGGCGCTGTACGGTGAGTGTCCTGGCCTATGCCTGAAGTACCCACAGTTGCACACCAAGGC 100  
                     -------------------------------------------GCTGTACGGTGAGTGTCCTGGCCTA-------------------------------- 25   
 
Intron-Exon Boundary CACTTGTTTGTCACCCACTCTTAAGTGCCTCTACTCTTGTGCCTTGACCCAGGGAAGATGTTCAGCCAGACGACGATCTGCCGGTTCGAGGCCCTGCAAC 100  
                     -------------------------------TACTCTTGTGCCTTGACCCAGGGAA-------------------------------------------- 25   
B. Oct4 Intron 3 
Exon-Intron Boundary CCTGCTCCAGCGCTGGCTGGTCGAGGCCGACACCAACGAGAACCTGCAGGAGGTAAAGGGCTTCCGGGGAAGGGTACTTGCGGCATGATGGACCACCCTA 100  
                     ---------------------------------------------GCAGGAGGTAAAGGGCTTCCGGGGA------------------------------ 25   
 
Intron-Exon Boundary CTGTCTTGCTTGGCCTCTGTCTTGACCGTCTCTTCTTGCATCACCCACTTCAGCTCTGCAACCTGGAGAATGCCCTGCAACAAGCCCGGAAGAGGAAAAG 100  
                     --------------------------------TTCTTGCATCACCCACTTCAGCTCT------------------------------------------- 25   
C. Oct4 Intron 4 
 
Exon-Intron Boundary CCCATCAGGAGATCGCCCACATCTCCGAGGACCTCAATCTGGAGAAGGACGTAAGTGGCCTATAATTCCAACAGCGCTCACCCCACCTAACCTGCTCCTC 100  
                     --------------------------------------------AAGGACGTAAGTGGCCTATAATTCC------------------------------- 25   
 
Intron-Exon Boundary ACCAGTGATAGCCCGTGAGTAACTGAAGGAAGGCCTTTGTCTCCCCCGCAGGTGGTCCGCGTCTGGTTCTGCAACAGGCGACAGAAGGGGAAGCGCAGCA 100  
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 Axblimp1 intron 4 
 
Partial sequence is shown the full intron was 5 kb. 
 
ACATCTACTTCTACACCATCAAGCCCATTCCCGCCAACCAGGAGCTACTTGTCTGGTACTGTCGGGACTTTGCAGATAGGCTGAACTACCCTTCCTCGGG 100   
AGAACTCACGATGGTGACTCCGAgTAAGTACTTTTGGAAGAAATTGAATCTTGCAATGCTCACGCGAGGATTTATTGGTATGCAGTACAGTCACGTAGAC 200   
GCCTCGCCAGTATTCTGATTGGAGAGACCGTGCCAGACAGTTTTAGTCCGGTCTAAAGCAGTGGTCTGGCTCTCCAGATGCTTCAGACTACCCCATCCGC 300   
TTTATCCAGCATAGTCAATGGCGAGAGGTTATGGGAGTCTTAGTCGGAAGCATCTGGCAAGCTGCCGTCTCATGGACGTCTAGACAACAAGGGCACGCGG 400   
TAGCAGCCAATGAAGATACACTTTTGAGGCCTTAATAAACATCGATGTAGGGATCTGTAGAATGAACAATGGTGGCCAGATTTGGGGGGACTTCAAACGG 500   
CAAGGCCCTCTAAAACTGATCCTAAAACTGTATCCGTATTTAAGGCAGGTAGGAGACTGCATGTATTGCACAAACGGAAAAGAATTTACACCCCAAATCA 600   
TTAATTGGCCGGGGACAAGGAACTCAAATTAAGGCTACCACAAAATAGGCCAAGTGTACAGTGTTAAGTTACAATACCCTGCACCAAAGATATTGCTCTG 700   
ACTGACTGTTGGAATGAGGGGTACTGATTGTTTTCAGTGTTGTATGTGTGAAGTGATTGCACAAAAAAAGTGATGGCTGGACCTGTTTGTGCCAATTCTG 800   
GCAATTGCATCCGTGCCCTTTACCTCTCTGGAGTTACTGGTATCGAACCAATCTCTATAAAATG----------------------~~~ATCCTTGCTGA 875   
CCGCCCCCATTGGAATGCGGACACACCCAGATTAGGTGCTGTTTAGGTCATGTTGTCAGATCGCCGCCTTCCCAATAGTTGCCCATGTATTTTTGTTTTG 975   
TTTTTAGTTGGATTATTGGCAATTAATAAAGTGCTTCATGCCGGATGCCCCCAGCTTCCAAGCGCTTGATGCAAGGCTGTTTTCCAATTGACAGTCATTG 1075  
GTGGGTGGCAGATGGGGAGAATGCCCCCCATCTCCCCAGGCCTCCCAGGTTTGCCACTCGAGGCCGAGTTCCCAACCCTGCCGAGTCTGTGTACCCATCG 1175  
CCTGTCACCACGGAATTGAGTTTGGCGGGGTATATATAACCTTGCCATTACCTGAGGGTAAGAGGTGTTGTAAGCATTATTGCATTCAATTTCTATTGTC 1275  
CCAAAGGAGTCCTCGGGGACCTTTTTAATGAGGAAAAACTGAACCCCCAAATAGAGTGGTAAACTACCATGACCGCAAGTGATAACAAGTAATTCAGCTT 1375  
TGTTGTATTAGCGGATCTAATGCTGCCACATGTGTAATTGGGTCGTGAGTCGCAGGTTGTAGTTCTTATTCCAGTGGGCGTGTCTTTACCTGTGTCTGTT 1475  
GCTTCATCTTTATGTAACCGTGGAAGAGAAACGCGTGACTAACCATTGCCTGGTATCTCCTCCATTTCAgAACAGACCAGCATCAACCCAAAGCAACAGC 1575  
ACACTGAAAAGGAGGTGCTTCACCACAAAAGTGCCCCGAAAAAAGAACACAGCATGAAGG 1635   
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 Axblimp1 intron 5 
 
Partial sequence is shown the full intron was 4 kb 
 
TGACTGGTTACAAAACGCTTCCATATCCGCTCAAGAAGCAGAACGGGAAGATTAAGTACGAGTGCAACATTTGCTCAAAGACATTTGGCCAGCTGTCAAA 100   
CTTGAAGgTAAGCGAGCCCCCTTTTCTGTATTTACTTGACAAGCAATTCTTCTTACTGCGAGCCAGAATGTAATTGACGATCCCTCCCACCTTCTCCCCG 200   
GCTATCCTGTCCGGGCACTTACTTACACTCCCGGCTGCCATAAATGAATTTAAGGGGCTGCCTTCAGTTGGCAGTGAGCCATATAAGTGGGCATACCCTT 300   
TCCTCCAAAGCCCCTTCCAAGCACCCACGGATCGGTGCTTTTGTCTGCATTGAGTTAGTGCCCACCCATTCCTACAGGACACCCTGTGTTGAGGGGTTTA 400   
GGGAGACACCTGCATCTCAGCCGTGTAGTGGG~~~~~~~~~~~~~~~~~~~~~~~~~ACCTGGTAGCGCGTGCACATTTCAAGAGGCATGCAGGTTTGCC 475   
TTAAAGTGCTCTTCAGATCTGACGGTAACGGCACAGCTCTGCTGGCGCAGCTTATCCAAACATGTCTGCGGAGCTGTG~TGGGCGAGCGTAGGCGACCAA 574   
ATCCTGGGTCCATTATTTG~TTTGGAGTATTTTTACTGCCCAATCTGTTATGCCGGGAGCATGACGTGTTTTTAGGGTGCAAATATGGCTGAAATGGTCA 673   
TCTTGAAATCGTATTGTACACAATCGACTCTAATTGGAAGATGCAACCTGTCGCATCGTTATGACCCCCCCCCAGTGGCCCGATTTTTGCGTGTGTCCAA 773   
TGTTGCCTAACAACCCTAGCCAAGAGGGAAGTCTGCGCAGAGTCTGCAACGCCCTTGGAGCACTTTACTTCATTTCCATTGTGCAACCGGTTGCTCTGCG 873   
CCGTTTTGTGGTGGTTGATATCTGACGGCACCAGATCGTACACGCTGCAAAGTTTCTGGCCTCTGCAAACCCTTTCTAAACTAGCACCATGTGTACATCT 973   
GACCCAGACATGCGCATTCTCAATATCCGCCCCTTTCATATATTTTGAAGTGTCAATTATTTGAATTGAAACGGTCTCTTATTTGTTGGAGCTGTGAGAT 1073  
GGCCTTGTTGTTTTTGAACCTGCAGCAGCCATGTTGTTTTCTTCCAgGTTCACCTGCGAGTACACAGCGGGGAGAGGCCGTTCAAATGTCAGACGTGCAA 1173  
CAAAGGATTCACGCAGCTGGCCCATCTGCAGAAGCACTACCTTGTA 1219  
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 8.3 Axnanog splice products 
Sequence of splice variants generated by targeting of axnanog splice-blocking morpholino (targeted to the intron-exon boundary of 
intron 1) and their translations are shown below.  Exons are shown in alternating colours (Black and Green).  Stars indicate stop 
codons, the first one in each sequence is highlighted in red and the homeodomain and the short region of conservation upstream of 
the homeodomain are highlighted in blue. 
 
Intron insertion (indicated by orange type) 
ATGCCCGCCCACTGCATGACCCCGCAAATGAGGGTGCCAGGATACCAGGCCTACCCGGAACTGAACCAACCGTGTGCTGTGGCGGCGAACTACGCGCCAG 100   
 M  P  A  H  C  M  T  P  Q  M  R  V  P  G  Y  Q  A  Y  P  E  L  N  Q  P  C  A  V  A  A  N  Y  A  P  
CATTCCAGGGGAACCTGCAGGCCGCAGAAGAGGGGCGCCCGGTCCCGGCAGGTCGGTGCGGTGAAGCGAATGTGCCAGTATTCAAATGCATGCAAGTTAC 200   
A  F  Q  G  N  L  Q  A  A  E  E  G  R  P  V  P  A  G  R  C  G  E  A  N  V  P  V  F  K  C  M  Q  V  T  
ACGCCCGGTGGCAGGGGCATTAACCCACTGAGGCGGCGCTCCCTCCAATCGTGCACCAGTAGACCATTCAAAACAAGGCACGGTTTCCACTCTGTGTGTA 300   
  R  P  V  A  G  A  L  T  H  *  G  G  A  P  S  N  R  A  P  V  D  H  S  K  Q  G  T  V  S  T  L  C  V  
ATGTGTCTGATTCCGTTTGTTGGCTGGTGGCCCCATTTGCCCGCATACTCTTTCCAGCTGATTTCNCGCGTGCCATGTCTTCGTTTTGTTTCAGTCCTGC 400   
 M  C  L  I  P  F  V  G  W  W  P  H  L  P  A  Y  S  F  Q  L  I  X  R  V  P  C  L  R  F  V  S  V  L  
CGTCTTCCCCCGACTCAGCCACCAGCCCAAAGGTGGATCCGTTCGCCCAGTGTGCCCCGGATGTAGCGGTGGGAGGTGAGACGAAGGCCCAGGCGAGAAA 500   
P  S  S  P  D  S  A  T  S  P  K  V  D  P  F  A  Q  C  A  P  D  V  A  V  G  G  E  T  K  A  Q  A  R  K  
GCGCACGTGCTTCAGTCAGGAACAGCTCGTGGCCCTGCACCGAATGTTCCAGAAGCAGCATTACATGAACCCAATGCAGGCGCAGCAGCTGGCGGCGGAT 600   
  R  T  C  F  S  Q  E  Q  L  V  A  L  H  R  M  F  Q  K  Q  H  Y  M  N  P  M  Q  A  Q  Q  L  A  A  D  
CTCAACCTCACATACAAGCAGGTGAAGAACTGGTTCCAGAACCGAAGGATGAAGCACAAACTGTCCCTGAAGGACTCAGTGTGGCTGGACAAGAGGTGCT 700   
 L  N  L  T  Y  K  Q  V  K  N  W  F  Q  N  R  R  M  K  H  K  L  S  L  K  D  S  V  W  L  D  K  R  C  
GGCAACCACAGGCGAGCTCAATCCTAACACCGGCTCAGCCGCAGTCCACGGGGTGCCCGGAAAGCTCCTCCCACTTGCCTCAGAGATACACAGTGCACCA 800   
W  Q  P  Q  A  S  S  I  L  T  P  A  Q  P  Q  S  T  G  C  P  E  S  S  S  H  L  P  Q  R  Y  T  V  H  H  
TAGTGCACTTGCCCAGCGAGTCACCAGTCACCCCTACCAGAAGTACAGTGGGATTCAGAACCCTCACCAGAAAGTGCTGTCAGAAGACGCAGCAACAGTG 900   
  S  A  L  A  Q  R  V  T  S  H  P  Y  Q  K  Y  S  G  I  Q  N  P  H  Q  K  V  L  S  E  D  A  A  T  V  
CAGCACAGGGAGGCCGCCCCGCAGTGCATGGGGCCACAGCAGTACATGAACAGGCACCAAAATTACCCAACCATTGAGTACGCCGGAGCAAGACCAGTAG 1000  
 Q  H  R  E  A  A  P  Q  C  M  G  P  Q  Q  Y  M  N  R  H  Q  N  Y  P  T  I  E  Y  A  G  A  R  P  V  
AAGGGTACAACCTTAAGACTCCTCTGCAGTACCCTTCGATGGCACCATACCCCAACTACTACTACCAGCAGCCACCGCCCTACATTCATCAGCAGGGCCG 1100  
E  G  Y  N  L  K  T  P  L  Q  Y  P  S  M  A  P  Y  P  N  Y  Y  Y  Q  Q  P  P  P  Y  I  H  Q  Q  G  R  
GCCCGATATCAGATTTCAGAGCACGCAGGGCATGTGA 1137  
  P  D  I  R  F  Q  S  T  Q  G  M  *  
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 Deletion of exon 2* 
ATGCCCGCCCACTGCATGACCCCGCAAATGAGGGTGCCAGGATACCAGGCCTACCCGGAACTGAACCAACCGTGTGCTGTGGCGGCGAACTACGCGCCAG 100  
 M  P  A  H  C  M  T  P  Q  M  R  V  P  G  Y  Q  A  Y  P  E  L  N  Q  P  C  A  V  A  A  N  Y  A  P  
CATTCCAGGGGAACCTGCAGGCCGCAGAAGAGGGGCGCCCGGTCCCGGCAGGTGAAGAACTGGTTCCAGAACCGAAGGATGAAGCACAAACTGTCCCTGA 200  
A  F  Q  G  N  L  Q  A  A  E  E  G  R  P  V  P  A  G  E  E  L  V  P  E  P  K  D  E  A  Q  T  V  P  E  
AGGACTCAGTGTGGCTGGACAAGAGGTGCTGGCAACCACAGGCGAGCTCAATCCTAACACCGGCTCAGCCGCAGTCCACGGGGTGCCCGGAAAGCTCCTC 300  
  G  L  S  V  A  G  Q  E  V  L  A  T  T  G  E  L  N  P  N  T  G  S  A  A  V  H  G  V  P  G  K  L  L  
CCACTTGCCTCAGAGATACACAGTGCACCATAGTGCACTTGCCCAGCGAGTCACCAGTCACCCCTACCAGAAGTACAGTGGGATTCAGAACCCTCACCAG 400  
 P  L  A  S  E  I  H  S  A  P  *  C  T  C  P  A  S  H  Q  S  P  L  P  E  V  Q  W  D  S  E  P  S  P  
AAAGTGCTGTCGGAAGACGCAGCAACAGTGCAGCACAGGGAGGCCGCCCCGCAGTGCATGGGGCCACAGCAGTACATGAACAGGCACCAAAATTACCCAA 500  
E  S  A  V  G  R  R  S  N  S  A  A  Q  G  G  R  P  A  V  H  G  A  T  A  V  H  E  Q  A  P  K  L  P  N  
CCATTGAGTACGCCGAAGCAAGACCAGTAGAAGGGTACAACCTTAAGACTCCTCTGCAGTACCCTTCGATGGCACCATACCCCAACTACTACTACCAGCA 600  
  H  *  V  R  R  S  K  T  S  R  R  V  Q  P  *  D  S  S  A  V  P  F  D  G  T  I  P  Q  L  L  L  P  A  
GCCACCGCCCTACATTCATCAGCAGGGCCGGCCCGATATCAGATTTCAGAGCACGCAGGGCATG 664  
 A  T  A  L  H  S  S  A  G  P  A  R  Y  Q  I  S  E  H  A  G  H   
 
Deletion of exons 2* and 3 
ATGCCCGCCCACTGCATGACCCCGCAAATGAGGGTGCCAGGATACCAGGCCTACCCGGAACTGAACCAACCGTGTGCTGTGGCGGCGAACTACGCGCCAG 100  
 M  P  A  H  C  M  T  P  Q  M  R  V  P  G  Y  Q  A  Y  P  E  L  N  Q  P  C  A  V  A  A  N  Y  A  P  
CATTCCAGGGGAACCTGCAGGCCGCAGAAGAGGGGCGCCCGGTCCCGGCAGGCTCAGCCGCAGTCCACGGGGTGCCCGGAAAGCTCCTCCCACTTGCCTC 200  
A  F  Q  G  N  L  Q  A  A  E  E  G  R  P  V  P  A  G  S  A  A  V  H  G  V  P  G  K  L  L  P  L  A  S  
AGAGATACACAGTGCACCATAGTGCACTTGCCCAGCGAGTCACCAGTCACCCCTACCAGAAGTACAGTGGGATTCAGAACCCTCACCAGAAAGTGCTGTC 300  
  E  I  H  S  A  P  *  C  T  C  P  A  S  H  Q  S  P  L  P  E  V  Q  W  D  S  E  P  S  P  E  S  A  V  
AGAAGACGCAGCAACAGTGCAGCACAGGGAGGCCGCCCCGCAGTGCATGGGGCCACAGCAGTACATGAACAGGCACCAAAATTACCCAACCATTGAGTAC 400  
 R  R  R  S  N  S  A  A  Q  G  G  R  P  A  V  H  G  A  T  A  V  H  E  Q  A  P  K  L  P  N  H  *  V  
GCCGGAGCAAGACCAGTAGAAGGGTACAACCTTAAGACTCCTCTGCAGTACCCTTCGATGGCACCATACCCCAACTACTACTACCAGCAGCCACCGCCCT 500  
R  R  S  K  T  S  R  R  V  Q  P  *  D  S  S  A  V  P  F  D  G  T  I  P  Q  L  L  L  P  A  A  T  A  L  
ACATTCATCAGCAGGGCCGGCCCNATATCAGATTTCAGAGCACGCAGGGCATGTGA 556  
  H  S  S  A  G  P  A  X  Y  Q  I  S  E  H  A  G  H  V   
 
*Exon 2 contains the majority of the homeodomain and the short region of conservation upstream of the homeodomain.  The 
remaining portion of the homeodomain is in exon 3 
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